Well_Id	Induction	Rel_Cell_Count	Compound_Id	Ref_Id	RefCpd_Id	Similarity	Induction_Ref	Conc_uM_Ref	Rel_Cell_Count_Ref	Trivial_Name_Ref	Known_Act_Ref	Chiral_Ref	Smiles_Ref
168309:01:07_10.00	12.1	104	168309	317004:02:10_10.00	317004	84.8	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
168309:01:07_10.00	12.1	104	168309	246846:01:05_30.00	246846	84.5	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
168309:01:07_10.00	12.1	104	168309	280732:01:03_30.00	280732	84.5	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
168309:01:07_10.00	12.1	104	168309	246742:01:04_30.00	246742	84.3	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
168309:01:07_10.00	12.1	104	168309	410708:01:04_06.00	410708	84.2	31.6	6.0	98	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
168309:01:07_10.00	12.1	104	168309	280823:01:05_10.00	280823	84.1	9.0	10.0	114	Propranolol (hydrochloride)	Propranolol hydrochloride is a nonselective .b.-adrenergic receptor (.b.AR) antagonist, has high affinity for the .b.1AR and .b.2AR with Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.	False	CC(C)NCC(O)COc1cccc2ccccc12
168309:01:07_10.00	12.1	104	168309	413171:01:02_03.00	413171	84.0	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
168309:01:07_10.00	12.1	104	168309	280309:01:03_30.00	280309	82.8	34.5	30.0	95	Benoxathian hydrochloride	selective alpha1 adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1CSc2ccccc2O1
168309:01:07_10.00	12.1	104	168309	409831:01:04_01.00	409831	82.6	34.9	1.0	103	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
168309:01:07_10.00	12.1	104	168309	413221:01:03_10.00	413221	82.1	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
170145:01:08_10.00	5.4	103	170145	280904:01:03_10.00	280904	75.6	11.9	10.0	95	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
170145:01:08_10.00	5.4	103	170145	246877:01:04_10.00	246877	75.3	6.0	10.0	97	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
170145:01:08_10.00	5.4	103	170145	280637:01:03_30.00	280637	75.2	10.4	30.0	103	IMID-4F hydrochloride	imidazoline-based K(ATP) channel blocker.	False	Fc1ccc(CN(C2=NCCN2)c2c(Cl)cccc2Cl)cc1
170145:01:08_10.00	5.4	103	170145	280179:01:03_10.00	280179	75.1	33.3	10.0	94	AMG9810	AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.	False	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1
170145:01:08_10.00	5.4	103	170145	280360:01:03_10.00	280360	73.8	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
170145:01:08_10.00	5.4	103	170145	247293:02:03_10.00	247293	73.4	29.7	10.0	104	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
170145:01:08_10.00	5.4	103	170145	246897:01:04_10.00	246897	73.1	20.9	10.0	100	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
170145:01:08_10.00	5.4	103	170145	280189:01:03_10.00	280189	72.8	13.1	10.0	101	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
170145:01:08_10.00	5.4	103	170145	404607:02:02_30.00	404607	72.1	64.8	30.0	67	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
170145:01:08_10.00	5.4	103	170145	246742:01:04_10.00	246742	72.1	25.4	10.0	107	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
181239:01:07_10.00	16.8	96	181239	413047:01:02_30.00	413047	83.8	36.6	30.0	87	Flindokalner	Flindokalner (BMS-204352) is a potassium channel modulator. Flindokalner is a positive modulator of all neuronal Kv7 channel subtypes expressed in HEK293 cells. Flindokalner is also a large conductance calcium-activated K channel (BKca) positive modulator. Flindokalner shows a negative modulatory activity at Kv7.1 channels (Ki=3.7 uM), and acts as a negative modulator of GABAA receptors. Flindokalner shows anxiolytic efficacy in vivo.	True	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21
181239:01:07_10.00	16.8	96	181239	413053:01:04_50.00	413053	83.1	31.8	50.0	95	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
181239:01:07_10.00	16.8	96	181239	246618:01:04_10.00	246618	82.5	14.0	10.0	94	Sertaconazole (nitrate)	ergosterol synthesis inhibitor.	False	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1
181239:01:07_10.00	16.8	96	181239	412996:01:04_30.00	412996	80.4	24.2	30.0	96	FPS-ZM1	FPS-ZM1 is a high-affinity RAGE inhibitor with a Ki of 25 nM.	False	O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1
181239:01:07_10.00	16.8	96	181239	246820:12:03_50.00	246820	80.2	39.6	50.0	91	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
181239:01:07_10.00	16.8	96	181239	413118:01:03_50.00	413118	79.9	57.3	50.0	89	FERb 033	Potent and selective ER.b. receptor agonist (Ki = 7.1 nM, EC50 = 4.8 nM). Displays 62-fold selectivity over ER.a..	False	O/N=C/c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O
181239:01:07_10.00	16.8	96	181239	412996:01:04_50.00	412996	79.60000000000001	51.5	50.0	87	FPS-ZM1	FPS-ZM1 is a high-affinity RAGE inhibitor with a Ki of 25 nM.	False	O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1
181239:01:07_10.00	16.8	96	181239	413121:01:03_50.00	413121	79.3	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
181239:01:07_10.00	16.8	96	181239	413013:01:03_50.00	413013	78.4	15.2	50.0	97	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
181239:01:07_10.00	16.8	96	181239	413163:01:02_05.00	413163	78.0	17.4	5.0	104		negative control to BAY-1797	False	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1
186360:01:06_10.00	11.6	107	186360	412989:01:02_30.00	412989	82.1	66.7	30.0	80	OMDM-2	OMDM-2 is an endocannabinoid analog specifically designed to be a potent and selective inhibitor of the cellular uptake of arachidonoyl ethanolamide. Structurally, OMDM-2 is the amide of (R)-tyrosinol with oleic acid. In RBL-2H3 cells, OMDM-2 inhibits the cellular uptake of tritiated AEA with an IC50 of 3 uM, with negligible effects on the CB1 receptor and VR1.	True	CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1
186360:01:06_10.00	11.6	107	186360	528557:01:02_00.30	407971	81.5	15.9	0.3	102	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	True	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
186360:01:06_10.00	11.6	107	186360	520875:01:04_50.00	520875	81.2	54.2	50.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
186360:01:06_10.00	11.6	107	186360	392592:01:09_02.00	392592	80.9	24.4	2.0	101	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
186360:01:06_10.00	11.6	107	186360	520875:01:04_30.00	520875	80.60000000000001	57.9	30.0	91	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
186360:01:06_10.00	11.6	107	186360	528557:01:02_00.50	407971	80.60000000000001	15.5	0.5	109	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	True	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
186360:01:06_10.00	11.6	107	186360	413179:01:02_05.00	413179	79.4	26.4	5.0	104		PPTN is an antagonist of P2RY14 (GPR105). IC50 = 0.5 nM (FLIPR assay). Negative control = PPTN-1-NC	False	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
186360:01:06_10.00	11.6	107	186360	408952:02:04_10.00	408952	79.3	76.5	10.0	100		BI-4659 is a potent inhibitor of Alk5 (TGFÃR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
186360:01:06_10.00	11.6	107	186360	411099:01:12_00.50	411099	79.10000000000001	7.3	0.5	104	LDN193189 hydrochloride, DM-;3189	potent and selective ALK2 and ALK3 inhibitor (IC50 values are 5 and 30 nM, respectively); inhibits BMP4-mediated Smad1/5/8 activation. Exhibits &gt;200-fold selectivity for BMP signaling over TGF-? signaling. Also exhibits selectivity over AMPK, PDGFR and MAPK signaling.	False	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1
186360:01:06_10.00	11.6	107	186360	391935:01:02_02.00	391935	79.0	20.9	2.0	95		inhibitor of GSK3-beta (IC50 = 0.1 ÂµM); Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.  Bioorg Med Chem Lett.  (2004),  14(9),  2121-2125.	False	COc1cc(/C=N/Nc2ncnc3c2cnn3-c2ccccc2)ccc1O
189445:01:05_10.00	5.2	96	189445	246365:01:04_30.00	246365	83.39999999999999	20.9	30.0	102	Lobelanidine hydrochloride	nicotinic ligand.	False	CN1C(CC(O)c2ccccc2)CCCC1CC(O)c1ccccc1
189445:01:05_10.00	5.2	96	189445	246632:01:04_30.00	246632	83.2	25.6	30.0	95	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
189445:01:05_10.00	5.2	96	189445	410645:01:03_02.00	410645	83.2	24.7	2.0	95	NPS-2143	NPS-2143 (SB-262470A), an orally active calcilytic agent, is a selective and potent calcium ion-sensing receptor (CaSR) antagonist. NPS-2143 (SB-262470A) blocks increases in cytoplasmic Ca2+ concentrations (IC50=43 nM) elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.	True	CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N
189445:01:05_10.00	5.2	96	189445	410057:01:03_02.00	410057	82.6	50.6	2.0	93	DDR1-IN-1	DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with an IC50 of 105 nM; 4-fold less potent for DDR2 (IC50 = 413 nM).	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
189445:01:05_10.00	5.2	96	189445	246903:01:04_30.00	246903	81.89999999999999	30.1	30.0	94	Nicergoline	Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of .a.1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer&#x27;s disease.	True	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13
189445:01:05_10.00	5.2	96	189445	281051:01:03_30.00	281051	81.2	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
189445:01:05_10.00	5.2	96	189445	410762:01:03_02.00	410762	80.80000000000001	26.4	2.0	95	Linrodostat	Linrodostat (BMS-986205) is a selective and irreversible indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with an IC50 value of 1.1 nM in IDO1-HEK293 cells. Linrodostat is well tolerated with potent pharmacodynamic activity in advanced cancers.	True	C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1
189445:01:05_10.00	5.2	96	189445	246419:01:08_30.00	246419	80.4	37.0	30.0	94	Quinidine hydrochloride monohydrate	heme polymerase inhibitor.	True	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
189445:01:05_10.00	5.2	96	189445	280189:01:03_30.00	280189	80.30000000000001	65.1	30.0	74	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
189445:01:05_10.00	5.2	96	189445	246861:01:12_03.00	246861	80.0	19.2	3.0	100	Astemizole	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.	False	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
203468:01:05_10.00	35.9	81	203468	409831:01:03_03.00	409831	86.3	78.9	3.0	82	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
203468:01:05_10.00	35.9	81	203468	410118:02:05_50.00	410118	85.5	84.1	50.0	67	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
203468:01:05_10.00	35.9	81	203468	410624:01:05_00.60	410624	85.2	77.0	0.6	73	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
203468:01:05_10.00	35.9	81	203468	413090:01:05_50.00	413090	84.3	48.5	50.0	83	VU591	VU591 is a potent, selective renal outer medullary potassium channel (ROMK or Kir1.1) inhibitor, with an IC50 of 0.24 uM.	False	O=[N+]([O-])c1ccc2[nH]c(COCc3nc4cc([N+](=O)[O-])ccc4[nH]3)nc2c1
203468:01:05_10.00	35.9	81	203468	410624:01:04_00.60	410624	83.89999999999999	74.8	0.6	76	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
203468:01:05_10.00	35.9	81	203468	382124:04:03_00.20	382124	83.8	36.4	0.2	96	A-769662	A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 uM.	False	N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O
203468:01:05_10.00	35.9	81	203468	413049:01:04_50.00	413049	83.39999999999999	64.4	50.0	90	4-CMTB	(+/-)-4-CMTB is a positive allosteric modulator of free fatty acid receptor 2 (FFAR2/GPR43) with an EC50 value of 0.42 uM for [35S]GTP.g.S binding to 293 T-REx cell membranes expressing the human receptor. It selectively induces ERK1/2 phosphorylation in 293 T-REx cells expressing human FFAR2, but not FFAR1 or FFAR3.	False	CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
203468:01:05_10.00	35.9	81	203468	246899:01:05_10.00	246899	83.3	67.5	10.0	100	Tamoxifen (Citrate)	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 uM and 1.8 uM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis.	False	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
203468:01:05_10.00	35.9	81	203468	407736:02:04_10.00	407736	83.0	68.0	10.0	84	ML347	ML347(DN193719) is a highly selective ALK1/ALK2 inhibitor with IC50s of 46/32 nM; shows &gt;300-fold selectivity for ALK2 vs. ALK3.IC50 value:Target: ALK1/ALK2ML347 has IC50Âs of 46 and 32 nM, respectively, against ALK1 and ALK2; however, the IC50 against ALK3 is 10,800 nM, &gt;300-fold selective over ALK3. ML347 is completely inactive against allthe other kinases tested (with weak activity against ALK6, 9830 nM and KDR (VEGFR2)19,700 nM). ML347 is potent in the BMP4 cell assay (152 nM).	False	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1
203468:01:05_10.00	35.9	81	203468	391925:03:05_00.20	391925	82.69999999999999	73.7	0.2	62	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 ÂµM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 ÂµM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
206069:01:05_10.00	5.4	95	206069	410285:01:04_03.00	410285	81.6	36.4	3.0	102	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
206069:01:05_10.00	5.4	95	206069	410285:01:03_03.00	410285	80.4	34.9	3.0	100	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
206069:01:05_10.00	5.4	95	206069	246554:01:05_10.00	246554	79.80000000000001	12.8	10.0	95	Dehydroisoandrosterone 3-acetate	Dehydroepiandrosterone 3-acetate is a testosterone/estrogen precursor and known modulator of vertebrate aggression.	True	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C1
206069:01:05_10.00	5.4	95	206069	246889:02:03_10.00	246889	79.5	42.8	10.0	107	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
206069:01:05_10.00	5.4	95	206069	528542:01:02_05.00	528542	79.3	16.6	5.0	96			False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5ccc6c(c5)NC(=O)CO6)cc4)CC3)c2c1
206069:01:05_10.00	5.4	95	206069	410516:01:04_10.00	410516	79.2	39.7	10.0	95		it is a very potent and highly selective inhibitor of the enzymatic activity of Cathepsin C. It blocks human CatC in vitro with an IC50 of 1.8 nM and shows &gt; 1500x selectivity versus the related proteases Cathepsin B, F, H, K, L and S. BI-9740 displays no activity against 34 unrelated proteases from different classes up to a concentration of 10 ÂµM. BI-9740 fully inhibits the production of active neutrophil elastase in the human U937 cell line with an IC50 of 5.4 nM.	True	CN1C(=O)Cc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@H]4N[C@@H]5CC[C@H]4C5)c(F)c3)cc21
206069:01:05_10.00	5.4	95	206069	247155:02:03_10.00	247155	78.5	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
206069:01:05_10.00	5.4	95	206069	246877:02:03_10.00	246877	78.2	11.1	10.0	103	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
206069:01:05_10.00	5.4	95	206069	283253:01:04_10.00	283253	78.0	35.4	10.0	99	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
206069:01:05_10.00	5.4	95	206069	280757:01:04_10.00	280757	77.60000000000001	34.7	10.0	89	Naloxonazine dihydrochloride	potent mu1 opioid receptor antagonist.	False	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@@H]2/C(=N/N=C2\CC[C@@]4(O)C6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@@H]2O8)CC[C@@]3(O)C1C5
221967:01:05_10.00	13.3	103	221967	413085:01:03_03.00	413085	86.7	38.7	3.0	91	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
221967:01:05_10.00	13.3	103	221967	280086:01:03_10.00	280086	86.5	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
221967:01:05_10.00	13.3	103	221967	519808:01:04_30.00	519808	85.7	57.5	30.0	96		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
221967:01:05_10.00	13.3	103	221967	520969:01:04_30.00	520969	85.5	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
221967:01:05_10.00	13.3	103	221967	520969:01:04_50.00	520969	84.7	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
221967:01:05_10.00	13.3	103	221967	413085:01:03_10.00	413085	84.39999999999999	41.8	10.0	85	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
221967:01:05_10.00	13.3	103	221967	409343:02:02_03.00	409343	84.1	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
221967:01:05_10.00	13.3	103	221967	412484:01:04_50.00	412484	83.6	31.6	50.0	94		BI-0115 is a small molecule inhibitor of LOX-1 (lectin-like oxidized LDL receptor-1). BI-0115 shows an IC50 potency of 5.4 ÂµM in the LOX-1 cellular uptake assay.	False	CCCN1C(=O)c2ccc(Cl)cc2Nc2ncccc21
221967:01:05_10.00	13.3	103	221967	280519:01:03_30.00	280519	83.2	37.1	30.0	95	DCEBIO	increases epithelial chloride secretion through the synergistic activation of a basolateral membrane-located K+ channel (hlK1) and an apical membrane Cl- conductance.	False	CCn1c(=O)[nH]c2cc(Cl)c(Cl)cc21
221967:01:05_10.00	13.3	103	221967	412263:01:03_10.00	412263	82.8	18.8	10.0	101	BI-3663	BI-3663 is a degrader that tethers a highly selective PTK2 Kinase inhibitor to a CRL4CRBN E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein. BI-3663 potently and rapidly induces reversible, long-lasting, and preferential removal of PTK2 in cells.	False	COc1cc(C(=O)NCCOCCOCCOCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
231134:01:05_10.00	15.7	100	231134	520969:01:04_30.00	520969	85.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
231134:01:05_10.00	15.7	100	231134	246859:01:04_30.00	246859	84.3	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
231134:01:05_10.00	15.7	100	231134	246363:01:04_30.00	246363	84.0	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
231134:01:05_10.00	15.7	100	231134	520746:01:02_50.00	520746	83.8	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
231134:01:05_10.00	15.7	100	231134	247209:01:04_30.00	247209	83.6	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
231134:01:05_10.00	15.7	100	231134	246847:01:04_30.00	246847	83.5	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
231134:01:05_10.00	15.7	100	231134	413121:01:03_30.00	413121	83.5	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
231134:01:05_10.00	15.7	100	231134	246500:01:04_30.00	246500	83.39999999999999	18.7	30.0	105	Racecadotril	enkephalinase inhibitor.	False	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1
231134:01:05_10.00	15.7	100	231134	247095:02:03_30.00	247095	83.2	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
231134:01:05_10.00	15.7	100	231134	409889:01:02_10.00	409889	83.1	11.6	10.0	99	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
235142:01:07_10.00	7.8	100	235142	280753:01:03_10.00	280753	81.2	20.0	10.0	100	Nylidrin (hydrochloride)	Nylidrin hydrochloride was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and of IgG1-mediated release of histamine from passively sensitized guinea pig lung slices.	False	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1
235142:01:07_10.00	7.8	100	235142	280791:01:03_10.00	280791	80.4	6.9	10.0	96	Olomoucine	potent and selective inhibitor of cdc2, cdk and cyclin-dependent kinases.	False	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21
235142:01:07_10.00	7.8	100	235142	280491:01:03_10.00	280491	80.0	24.4	10.0	84	(-)-alpha-Methylnorepinephrine, Levonordefrin	active enantiomer, adrenoceptor agonist, vasoconstrictor, antihypertensive.	False	CC(N)[C@H](O)c1ccc(O)c(O)c1
235142:01:07_10.00	7.8	100	235142	246538:01:04_10.00	246538	79.0	18.5	10.0	96	Dipivefrin hydrochloride	Beta-2 adrenergic receptor agonist (EC50 = 7.13 ÂµM)	False	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
235142:01:07_10.00	7.8	100	235142	280754:01:03_10.00	280754	78.9	17.3	10.0	105	Naltriben methanesulfonate, NTB	highly selective delta2 opioid receptor antagonist.	False	Oc1ccc2c3c1O[C@H]1c4oc5ccccc5c4C[C@@]4(O)C(C2)N(CC2CC2)CCC314
235142:01:07_10.00	7.8	100	235142	413035:01:02_50.00	413035	78.4	10.2	50.0	103	Dalbavancin	Dalbavancin is a semisynthetic glycopeptide antibiotic. It inhibits the growth of Gram-positive bacteria in vitro, including S. pneumoniae, S. pyogenes, vancomycin-sensitive Enterococcus species, and various methicillin-resistant staphylococci (MIC50s = 0.03, &lt;=0.002, 0.13, and 0.03-0.13 mg/L, respectively).	True	CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O
235142:01:07_10.00	7.8	100	235142	410994:01:03_02.00	410994	77.9	41.5	2.0	64	MZP-54	MZP-54 is a selective degrader of BRD3/4 based on PROTAC technology, with a Kd of 4 nM for Brd4BD2.	False	CC(=O)N1c2ccc(-c3ccc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
235142:01:07_10.00	7.8	100	235142	411033:02:04_03.00	411033	77.5	28.3	3.0	67	MZ 1	MZ 1 is a BRD4 protein degrader based on PROTAC technology.	False	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
235142:01:07_10.00	7.8	100	235142	280318:02:03_10.00	280318	76.9	43.5	10.0	104	(Â±)-Butaclamol hydrochloride, AY 23028	dopamine receptor antagonist, selective for D2 over D1.	False	CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
235142:01:07_10.00	7.8	100	235142	410285:01:04_03.00	410285	76.7	36.4	3.0	102	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
240329:01:05_10.00	12.1	99	240329	247293:02:03_10.00	247293	82.39999999999999	29.7	10.0	104	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
240329:01:05_10.00	12.1	99	240329	280637:01:03_30.00	280637	81.6	10.4	30.0	103	IMID-4F hydrochloride	imidazoline-based K(ATP) channel blocker.	False	Fc1ccc(CN(C2=NCCN2)c2c(Cl)cccc2Cl)cc1
240329:01:05_10.00	12.1	99	240329	246896:01:04_30.00	246896	81.5	39.0	30.0	94	Olanzapine	may involve antagonism at serotonin receptors, antipsychotic.	False	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
240329:01:05_10.00	12.1	99	240329	247331:02:03_30.00	247331	80.10000000000001	32.0	30.0	99	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
240329:01:05_10.00	12.1	99	240329	246835:01:04_30.00	246835	80.10000000000001	16.2	30.0	99	Buspirone (hydrochloride)	5-HT1A Serotonin receptor agonist, non-benzodiazepine anxiolytic, serotonin receptor agonist, 5ht1a receptor agonist.	False	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
240329:01:05_10.00	12.1	99	240329	410797:01:03_00.20	410797	80.0	6.7	0.2	96	BIX-01294	BIX-01294 is an inhibitor of G9a Histone Methyltransferase with an IC50 of 1.9 ÂµM.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
240329:01:05_10.00	12.1	99	240329	280128:01:04_10.00	280128	79.0	51.3	10.0	99	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
240329:01:05_10.00	12.1	99	240329	281030:01:03_10.00	281030	78.8	32.8	10.0	91	U-74389G maleate	free radical lipid peroxidation inhibitor.	False	C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12
240329:01:05_10.00	12.1	99	240329	246877:01:04_10.00	246877	78.7	6.0	10.0	97	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
240329:01:05_10.00	12.1	99	240329	413126:02:02_00.30	413126	78.5	37.5	0.3	98		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
240406:01:05_10.00	9.2	92	240406	392515:01:09_00.20	392515	72.39999999999999	9.3	0.2	97	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
240406:01:05_10.00	9.2	92	240406	280630:01:11_01.00	280630	70.39999999999999	12.1	1.0	91	IC261	IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 uM, 1 uM, 16 uM for Cki.d., Cki.e. and Cki.a.1, respectively.	False	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1
240406:01:05_10.00	9.2	92	240406	392500:03:03_02.00	392500	70.19999999999999	13.3	2.0	84	MLN8054	MLN8054 is a potent, selective and orally available aurora A kinase inhibitor with an IC50 of 4 nM.	False	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1
240406:01:05_10.00	9.2	92	240406	246898:01:04_10.00	246898	69.19999999999999	5.5	10.0	95	Oxfendazole	Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. Target: AntiparasiticOxfendazole is the sulfoxide form of fenbendazole, a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms.. Pigs in the treated group received Oxfendazole orally at 30 mg/kg dose. At five days post-treatment, animals were sacrificed and the clinical efficacy of the Oxfendazole treatment was established following the currently available WAAVP guidelines for a controlled efficacy test. None of the animals involved in this experiment showed any adverse events during the study. Oxfendazole treatment given as a single 30 mg/kg oral dose showed a 100% efficacy against all the nematode parasites present in the three experiments. In conclusion, under the current experimental conditions, Oxfendazole orally administered to naturally parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult stages of A. suum, Oesophagostomum spp., T. suis and Metastrongylus spp . 	False	COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1
240406:01:05_10.00	9.2	92	240406	392722:01:09_02.00	392722	68.4	23.3	2.0	94	Triciribine	Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.	False	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23
240406:01:05_10.00	9.2	92	240406	280986:01:03_30.00	280986	67.5	13.1	30.0	86	AG-494	AG-494 (Tyrphostin AG 494) is a potent and selective EGFR tyrosine kinase inhibitor (IC50=0.7 uM). AG-494 inhibits the autophosphorylation of EGFR, ErbB2, HER1-2 and PDGF-R with IC50s 1.1, 39, 45 and 6 uM, respectively. AG-494 blocks Cdk2 activation and inhibits EGF-dependent DNA synthesis.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1
240406:01:05_10.00	9.2	92	240406	392641:01:09_00.20	392641	65.9	10.0	0.2	89	Milciclib	PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is &gt;3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.	False	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2
240406:01:05_10.00	9.2	92	240406	410613:01:05_00.60	410613	65.10000000000001	8.6	0.6	100	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
241943:01:06_10.00	5.5	97	241943	413171:01:02_03.00	413171	86.2	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
241943:01:06_10.00	5.5	97	241943	245325:02:04_10.00	245325	83.5	51.3	10.0	97	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
241943:01:06_10.00	5.5	97	241943	520875:02:02_01.00	520875	82.5	27.5	1.0	105	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
241943:01:06_10.00	5.5	97	241943	246433:01:04_10.00	246433	82.39999999999999	14.3	10.0	106	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
241943:01:06_10.00	5.5	97	241943	520969:01:04_50.00	520969	82.3	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
241943:01:06_10.00	5.5	97	241943	520969:01:04_30.00	520969	82.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
241943:01:06_10.00	5.5	97	241943	528524:01:02_03.00	528524	81.8	26.9	3.0	88		negative control to MRIA9	True	CN(C)c1ncc2cc(-c3ccc(-c4ncccc4F)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1
241943:01:06_10.00	5.5	97	241943	247233:01:04_30.00	247233	81.6	24.0	30.0	98	Citalopram (hydrobromide)	Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression.	False	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
241943:01:06_10.00	5.5	97	241943	280193:01:03_10.00	280193	80.7	33.5	10.0	95	Fulvestrant	selective estrogen receptor downregulator (SERD). First pure antiestrogen with no agonistic activity both in vitro and in vivo.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
241943:01:06_10.00	5.5	97	241943	413092:01:04_30.00	413092	80.60000000000001	57.5	30.0	102	Zamifenacin	Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome.	True	c1ccc(C(O[C@@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1
242128:01:05_10.00	9.3	92	242128	280127:01:04_30.00	280127	79.2	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
242128:01:05_10.00	9.3	92	242128	280962:01:03_30.00	280962	78.9	32.6	30.0	100	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
242128:01:05_10.00	9.3	92	242128	283242:02:06_30.00	283242	78.8	23.7	30.0	100	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
242128:01:05_10.00	9.3	92	242128	247042:01:04_30.00	247042	78.2	32.0	30.0	89	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
242128:01:05_10.00	9.3	92	242128	280670:01:03_30.00	280670	78.0	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
242128:01:05_10.00	9.3	92	242128	407880:01:03_10.00	407880	78.0	28.2	10.0	97	ML385	ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 uM.	False	Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21
242128:01:05_10.00	9.3	92	242128	247082:01:04_30.00	247082	77.8	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
242128:01:05_10.00	9.3	92	242128	280574:01:04_30.00	280574	77.8	30.9	30.0	96	Guanidinyl-naltrindole di-trifluoroacetate	selective kappa opioid receptor antagonist.	False	N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5
242128:01:05_10.00	9.3	92	242128	280086:01:03_10.00	280086	77.60000000000001	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
242128:01:05_10.00	9.3	92	242128	410937:01:03_02.00	410937	77.3	29.2	2.0	92	PF-06700841 (P-Tosylate)	PF-06700841 P-Tosylate is a potent dual  Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. PF-06700841 P-Tosylate also inhibits JAK2 and JAK3 with IC50s of 77 nM and 6.49 uM, respectively.	False	Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1
413569:01:03_10.00	11.4	84	413569	409848:01:02_10.00	409848	91.2	19.7	10.0	84	Olaparib	Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator.	False	O=C(c1cc(Cc2nnc(O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
413569:01:03_10.00	11.4	84	413569	246646:01:04_10.00	246646	89.4	35.8	10.0	70	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
413569:01:03_10.00	11.4	84	413569	280707:01:03_10.00	280707	88.9	19.7	10.0	73	Melphalan, L-Phenylalanine mustard	antineoplastic, forms DNA intrastrand crosslinks by bifunctional alkylation in 5&#x27;-GGC sequences.	False	NC(Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O
413569:01:03_10.00	11.4	84	413569	410891:01:03_00.20	410891	88.9	22.8	0.2	83	Valrubicin	Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 uM, respectively, and has antitumor and antiinflammatory activity.	False	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
413569:01:03_10.00	11.4	84	413569	410830:01:03_00.20	410830	87.6	18.3	0.2	86	Talazoparib tosylate	Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.	False	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1
413569:01:03_10.00	11.4	84	413569	409912:01:02_10.00	409912	85.8	42.0	10.0	60	BAY-299	BAY-299 is a very potent, dual inhibitor with IC50s of 67 nM for BRPF2 bromodomains (BD), 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.	False	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C
413569:01:03_10.00	11.4	84	413569	247284:01:04_10.00	247284	85.6	13.0	10.0	88	Vidarabine	adenosine antimetabolite.	True	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
413569:01:03_10.00	11.4	84	413569	246646:02:04_06.00	246646	85.0	22.1	6.0	77	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
413569:01:03_10.00	11.4	84	413569	409992:01:05_10.00	409992	85.0	10.4	10.0	88	Evofosfamide	Evofosfamide (TH-302) is a hypoxia-activated prodrug with IC50 of 10 uM and 1000 uM in hypoxia (N2) and normoxia (21% O2), respectively.	False	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]
413569:01:03_10.00	11.4	84	413569	409913:01:02_10.00	409913	84.89999999999999	31.1	10.0	75	Talazoparib	Talazoparib (BMN-673) is a highly potent, orally available PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with Kis of 1.2 and 0.87 nM, respectively. Talazoparib has antitumor activity.	True	Cn1ncnc1[C@H]1c2nnc(O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1
413675:01:03_10.00	9.8	96	413675	520969:01:04_30.00	520969	85.6	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
413675:01:03_10.00	9.8	96	413675	246883:01:04_30.00	246883	84.0	22.8	30.0	96	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
413675:01:03_10.00	9.8	96	413675	280282:01:03_30.00	280282	83.8	48.4	30.0	92	Amperozide hydrochloride	atypical antipsychotic drug with high affinity for serotonin receptors and low affinity for D2 dopamine receptors.	False	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
413675:01:03_10.00	9.8	96	413675	281051:01:03_30.00	281051	83.3	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
413675:01:03_10.00	9.8	96	413675	247067:01:04_10.00	247067	83.3	21.8	10.0	103	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
413675:01:03_10.00	9.8	96	413675	520969:01:04_50.00	520969	83.2	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
413675:01:03_10.00	9.8	96	413675	246846:01:05_30.00	246846	83.1	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
413675:01:03_10.00	9.8	96	413675	247342:01:05_10.00	247342	83.0	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
413675:01:03_10.00	9.8	96	413675	280193:01:03_10.00	280193	82.69999999999999	33.5	10.0	95	Fulvestrant	selective estrogen receptor downregulator (SERD). First pure antiestrogen with no agonistic activity both in vitro and in vivo.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
413675:01:03_10.00	9.8	96	413675	246859:01:04_30.00	246859	82.69999999999999	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
413719:01:03_10.00	14.5	91	413719	280697:01:03_30.00	280697	69.39999999999999	49.9	30.0	103	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
413719:01:03_10.00	14.5	91	413719	410613:01:04_00.60	410613	69.1	15.5	0.6	86	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
413719:01:03_10.00	14.5	91	413719	410072:01:03_02.00	410072	68.5	17.8	2.0	83	TH287	TH287 is a potent and selective inhibitor of MTH1, with an IC50 of 0.8 nM. TH287 is highly selective towards MTH1, with no relevant inhibition of MTH2, NUDT5, NUDT12, NUDT14, NUDT16, dCTPase, dUTPase and ITPA at 100 uM. TH287 could act as a chemotherapeutic agent for cancer research.	False	CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1
413719:01:03_10.00	14.5	91	413719	409891:01:05_03.00	409891	68.0	78.4	3.0	74	NVS-CECR2-1	it is a potent inhibitor of CECR2 (cat eye syndrome chromosome region, candidate 2), a component of chromatin complexes that regulate gene expression controlling development. It binds CECR2 with high affinity (IC50 = 0.047 ÂµM by Alpha screen, Kd = 0.80 ÂµM by ITC). NVS-CECR2-1 demonstrates no crossreactivity in a panel of 48 bromodomains and has no major activity in kinase, protease, and receptor panels. It shows robust activity in cells by FRAP assay, due to its slow off-rate, and has no acute toxicity. See the Structural Genomics Consortium (SGC) website for more information.	False	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1
413719:01:03_10.00	14.5	91	413719	392203:01:02_00.20	392203	67.30000000000001	16.9	0.2	87		Inhibitor of B-Raf V600E mutant (IC50 = 0.0005 ÂµM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
413719:01:03_10.00	14.5	91	413719	280697:01:03_10.00	280697	67.0	20.0	10.0	88	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
413719:01:03_10.00	14.5	91	413719	409829:01:05_50.00	409829	66.8	18.1	50.0	70	A-1155463	A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell.	False	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1
413719:01:03_10.00	14.5	91	413719	413085:01:06_10.00	413085	66.7	44.2	10.0	103	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
413719:01:03_10.00	14.5	91	413719	528531:01:02_05.00	528531	66.5	36.1	5.0	82		MU1210 is a potent probe for CLK1/2/4 with IC50 values of 8/20/12 nM, respectively with corresponding good cellular potency in NanoBRET assays (84/91/23 nM), respectively. CLK3 was not inhibited by MU1210 at concentrations up to 3 ÂµM.	False	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1
413719:01:03_10.00	14.5	91	413719	410613:01:05_00.60	410613	66.0	8.6	0.6	100	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
413779:01:03_10.00	15.2	77	413779	410973:02:02_10.00	410973	77.3	55.6	10.0	53	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
413779:01:03_10.00	15.2	77	413779	410884:02:04_50.00	410884	73.1	78.6	50.0	53	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of &lt;1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
413779:01:03_10.00	15.2	77	413779	412999:01:02_30.00	412999	73.1	55.3	30.0	53	Geldanamycin	Geldanamycin is a Hsp90 inhibitor with antimicrobial activity against many Gram-positive and some Gram-negative bacteria. Geldanamycin has anti-influenza virus H5N1 activities.	True	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C/C=C(\C)C(=O)/N=C(\C=C1O)C2=O
413779:01:03_10.00	15.2	77	413779	104614:02:17_30.00	104614	73.1	63.7	30.0	66	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/Ã-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
413779:01:03_10.00	15.2	77	413779	392542:01:09_00.20	392542	72.0	66.1	0.2	59	Rigosertib (ON-01910)	Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.	False	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
413779:01:03_10.00	15.2	77	413779	409341:02:02_03.00	409341	71.8	10.5	3.0	95	ABT-100	ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity.	True	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
413779:01:03_10.00	15.2	77	413779	392343:01:02_02.00	392343	71.8	28.7	2.0	79		inhibitor of PLK1 kinase (IC50 = 0.035 ÂµM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1ccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)cc1
413779:01:03_10.00	15.2	77	413779	413105:01:05_50.00	413105	70.6	56.0	50.0	65	GSK137647A	GSK137647A is a selective FFA4 agonist. IC50 value: 6.3/6.2/6.1 (pEC50, for human/mouse/rat FFA4). The pEC50s for Human, Mouse and Rat FFA1/2/3 are &lt; 4.5. GSK137647A is evaluated against a panel of 65 targets in both full curve functional and binding assays and was shown to provide at least 100-fold selectivity against the panel which included 41 G-protein-coupled receptors (GPCRs), including additional members of the free fatty acid receptors (FFA1, FFA2, and FFA3). GSK137647A produces a concentration-dependent increase in glucose stimulated insulin secretion under high glucose conditions (25 mM).	False	COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1
413779:01:03_10.00	15.2	77	413779	104614:02:17_50.00	104614	70.3	68.9	50.0	60	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/Ã-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
413779:01:03_10.00	15.2	77	413779	413223:01:04_50.00	413223	69.8	14.2	50.0	89	UCSF924	UCSF924 is a selective, high-affinity dopamine D4 receptor (DRD4) partial agonist (Ki = 3 nM for human D4) with a 7.4-fold bias toward arrestin recruitment over G.a.i (G.a.i/0; Gi/G0) signaling activation with respect to quinpirole. UCSF924 exhibits no detectable affinity for D2, D3 or the F261V/L328F D4 mutant and no agonist activity toward a panel of 320 nonolfactory GPCRs even at a high concentration of 1 uM.	False	Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
413782:01:03_10.00	8.3	110	413782	282300:02:03_50.00	282300	83.7	17.3	50.0	106	Tacrolimus, FK506	immune suppressant, antifungal.	False	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC
413782:01:03_10.00	8.3	110	413782	520875:02:03_01.00	520875	81.6	16.8	1.0	99	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413782:01:03_10.00	8.3	110	413782	413167:01:02_05.00	413167	81.6	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
413782:01:03_10.00	8.3	110	413782	246344:01:04_10.00	246344	79.3	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
413782:01:03_10.00	8.3	110	413782	520875:02:03_03.00	520875	79.2	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413782:01:03_10.00	8.3	110	413782	280179:01:03_10.00	280179	79.0	33.3	10.0	94	AMG9810	AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.	False	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1
413782:01:03_10.00	8.3	110	413782	520875:01:04_10.00	520875	78.4	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413782:01:03_10.00	8.3	110	413782	247275:01:04_10.00	247275	78.2	5.9	10.0	99	Phenazopyridine (hydrochloride)	Phenazopyridine hydrochloride is a chemical, which has a local analgesic effect, often used to alleviate the pain, irritation, discomfort, or urgency caused by urinary tract infections, surgery, or injury to the urinary tract.	False	Nc1ccc(/N=N/c2ccccc2)c(N)n1
413782:01:03_10.00	8.3	110	413782	247167:01:04_10.00	247167	78.0	7.3	10.0	100	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
413782:01:03_10.00	8.3	110	413782	247042:02:05_03.00	247042	77.9	30.7	3.0	101	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
413839:01:03_10.00	13.3	106	413839	520969:01:04_50.00	520969	84.39999999999999	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
413839:01:03_10.00	13.3	106	413839	409893:01:03_50.00	409893	83.5	29.9	50.0	96	MS049 (hydrochloride)	it is a potent and selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM). It is less active against additional type I PRMTs (IC50s = &gt;130, &gt;220, and 1.6 ÂµM for PRMT1, PRMT3, and PRMT8, respectively) and displays no inhibition against type II or type III PRMTs nor any additional methyltransferases or nonepigenetic targets tested. MS049 has been shown to reduce the H3R2me2a mark in HEK293 cells with an IC50 value of 0.97 ÂµM and also, unexpectedly, to reduce H4R3me2a in HEK293 cells. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(OCc2ccccc2)CC1
413839:01:03_10.00	13.3	106	413839	409906:01:03_30.00	409906	83.0	84.1	30.0	73	BMX-IN-1	BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related BrutonÂs tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.	False	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C
413839:01:03_10.00	13.3	106	413839	247019:04:04_06.00	247019	82.5	10.9	6.0	89	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
413839:01:03_10.00	13.3	106	413839	382120:03:04_06.00	382120	82.39999999999999	33.7	6.0	87	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/&lt;5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
413839:01:03_10.00	13.3	106	413839	412484:01:04_50.00	412484	82.39999999999999	31.6	50.0	94		BI-0115 is a small molecule inhibitor of LOX-1 (lectin-like oxidized LDL receptor-1). BI-0115 shows an IC50 potency of 5.4 ÂµM in the LOX-1 cellular uptake assay.	False	CCCN1C(=O)c2ccc(Cl)cc2Nc2ncccc21
413839:01:03_10.00	13.3	106	413839	520969:01:04_30.00	520969	82.19999999999999	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
413839:01:03_10.00	13.3	106	413839	520875:02:03_03.00	520875	81.8	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413839:01:03_10.00	13.3	106	413839	413206:01:02_03.00	413206	81.8	50.9	3.0	98		An inhibitor of MAPK14 with an IC50 = 0.2 nM (ELISA, cell free). NanoBRET: MAPK14 IC50 = 14.9 nM; MAPK11 IC50 = 16.9 nM. Negative control = FM-743	False	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2
413839:01:03_10.00	13.3	106	413839	409914:01:03_03.00	409914	81.69999999999999	75.1	3.0	90	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and &gt;3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
413857:01:03_10.00	40.6	52	413857	245363:03:14_00.10	245363	75.3	55.8	0.1	51	Colchicine	prevents tubulin polymerization, antimitotic, antigout agent.	False	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
413857:01:03_10.00	40.6	52	413857	419166:01:03_100.00	419166	74.5	39.6	100.0	59	Diroximel fumarate	Diroximel fumarate (ALKS 8700) is an orally-active and well-tolerated monomethyl fumarate (MMF) prodrug in a controlled-release formulation. Diroximel fumarate is considered as active equivalent to its active metabolite dimethyl fumarate (DMF). Diroximel fumarate has a favorable safety and efficacy profile, has the potential for the study of multiple sclerosis (MS).	False	COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
413857:01:03_10.00	40.6	52	413857	413204:01:02_05.00	413204	70.0	45.3	5.0	70	CLK-IN-T3	CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity.	False	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1
413857:01:03_10.00	40.6	52	413857	413031:01:04_10.00	413031	69.89999999999999	26.1	10.0	99	CC-401	CC-401 is a potent inhibitor of all three JNK isoforms (Ki values range from 25 to 50 nM). It has at least 40-fold selectivity for JNK compared with other related kinases.	False	c1cc(OCCN2CCCCC2)cc(-c2[nH]nc3ccc(-c4nc[nH]n4)cc23)c1
413857:01:03_10.00	40.6	52	413857	413122:01:03_30.00	413122	69.6	44.4	30.0	59	Mirk-IN-1	Potent and selective DYRK1A/B inhibitor (IC50 values are 22 and 68 nM respectively). Selective for DYRK1A/B over a panel of other kinases. Reduces accumulation of quiescent Panc1 pancreatic cancer cells in G0 under serum free conditions. Also induces DNA damage and apoptosis in quiescent Panc1 cells.	False	COc1ncc2cc(C(=O)Nc3cc(C(=O)NCc4cccc(Cl)c4)ccc3Cl)c(O)nc2n1
413857:01:03_10.00	40.6	52	413857	246353:01:04_30.00	246353	69.0	33.2	30.0	79	Harmine hydrochloride	Interleukin-8 inhibitor (IC50 = 6.96 ÂµM)	False	COc1ccc2c(c1)[nH]c1c(C)nccc12
413857:01:03_10.00	40.6	52	413857	413111:01:04_02.00	413111	68.5	26.3	2.0	79	Ingenol Mebutate	Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-.a., PKC-.b., PKC-.g., PKC-.d., and PKC-.e., respectively, and has antiinflammatory and antitumor activity.	True	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C
413857:01:03_10.00	40.6	52	413857	280659:01:03_10.00	280659	68.10000000000001	23.7	10.0	89	Kenpaullone	Kenpaullone is a potent inhibitor of CDK1/cyclin B and GSK-3.b., with IC50s of 0.4 uM and 23 nM, and also inhibits CDK2/cyclin A, CDK2/cyclin E, and CDK5/p25 with IC50s of 0.68 uM, 7.5 uM, 0.85 uM, respectively. Kenpaullone, a small molecule inhibitor of KLF4, reduces self-renewal of breast cancer stem cells and cell motility in vitro.; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1
413857:01:03_10.00	40.6	52	413857	413190:01:02_03.00	413190	67.60000000000001	11.1	3.0	104	BAY-985	BAY-985 is a highly potent, orally active and selective ATP-competitive dual inhibitor of TBK1 and IKK.e. with IC50s of 2/30 and 2 nM for TBK1 (low/high ATP) and IKK.e., respectively. Antitumor efficacy.	True	C[C@H](c1ccnc(Nc2nc3cc(-c4cc(N(C)C)ncn4)ccc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1
413857:01:03_10.00	40.6	52	413857	529518:01:05_01.00	529518	67.30000000000001	46.5	1.0	61	CR8	CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9). CR8 is a more potent pyridyl analogue of roscovitine. In comparison to roscovirtine, the compound gains in potency toward CK1, which is involved in amyloid-.b. formation. CR8 is around 30 times more potent at cellular assay than roscovitine. Acts as a molecular glue to induce cyclin K degradation.	True	CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1
413876:01:03_10.00	5.4	96	413876	522774:02:04_50.00	522774	78.60000000000001	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
413876:01:03_10.00	5.4	96	413876	522774:02:04_30.00	522774	78.4	23.0	30.0	92	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
413876:01:03_10.00	5.4	96	413876	413005:01:02_30.00	413005	77.10000000000001	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
413876:01:03_10.00	5.4	96	413876	413005:01:02_50.00	413005	77.10000000000001	17.1	50.0	98	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
413876:01:03_10.00	5.4	96	413876	522774:02:04_10.00	522774	73.1	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
413876:01:03_10.00	5.4	96	413876	280891:01:03_30.00	280891	72.7	9.8	30.0	103	REV 5901	leukotriene D4 receptor antagonist.	False	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1
413876:01:03_10.00	5.4	96	413876	281040:01:03_10.00	281040	72.6	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
413876:01:03_10.00	5.4	96	413876	247380:02:03_30.00	247380	72.0	11.2	30.0	85	Nimodipine	potent L-type Ca2+ channel antagonist, Calcium channel blocker, vasodilator.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
413876:01:03_10.00	5.4	96	413876	280970:01:03_30.00	280970	71.39999999999999	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
413876:01:03_10.00	5.4	96	413876	413121:01:03_30.00	413121	71.2	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
413920:01:03_10.00	8.3	99	413920	246456:01:04_10.00	246456	86.4	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
413920:01:03_10.00	8.3	99	413920	409916:01:04_03.00	409916	85.9	29.0	3.0	96	TP-064	it is a potent inhibitor of protein arginine methyltransferase 4 (PRMT4, IC50 50 = 43 nM) in vitro. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1
413920:01:03_10.00	8.3	99	413920	409343:02:02_03.00	409343	85.3	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
413920:01:03_10.00	8.3	99	413920	280360:01:03_10.00	280360	84.7	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
413920:01:03_10.00	8.3	99	413920	247178:01:04_10.00	247178	84.6	18.1	10.0	94	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
413920:01:03_10.00	8.3	99	413920	246897:02:03_10.00	246897	84.2	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
413920:01:03_10.00	8.3	99	413920	280858:01:03_10.00	280858	84.0	23.3	10.0	95	Pergolide methanesulfonate, propylergoline methanesulfonate	dopamine receptor agonist, antiparkinsonian.	False	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
413920:01:03_10.00	8.3	99	413920	247342:01:05_10.00	247342	83.7	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
413920:01:03_10.00	8.3	99	413920	286060:01:16_10.00	286060	83.7	20.4	10.0	97	Cyclopamine, V. californicum	it inhibits the Hedgehog signaling pathway with an IC50 of 46 nM, and blocks the activity of human Smo receptor expressed in CHO-K1 cells in [3H]Hh-Ag binding assay with an IC50 of 280 nM. Cyclopamine significantly inhibits Hedgehog pathway activity in a dose-dependent manner in gut-derived tumor cell lines expressing Patched (PTCH) mRNA, and induces growth inhibition of those tumor cell lines by 75-95% at the concentration of 3 ÂµM, but ineffective towards the colon tumor cells without PTCH mRNA expression, suggesting the effects of Cyclopamine treatment are Hedgehog pathway related rather than generally cytotoxic. By blocking Hedgehog signaling through direct interaction with Smo, Cyclopamine (10 ÂµM) inhibits the proliferation of SMOhigh Cyclopamine-responsive cell lines L3.6sl and Panc 05.04 by 75-80%, and increases the apoptosis by 2.5- to 3.5-fold, without affecting the BxPC3-SMOlow cell line. Cyclopamine treatment significantly decreases of Snail mRNA and increasea E-cadherin transcripts in the E3LZ10.7 cell line. Independent of inhibition of cell growth, Cyclopamine treatment significantly inhibits the invasive phenotype of Hedgehog-dependent L3.6pl cells, causing a &gt;500-fold reduction in the number of transmigrating cells, but not that of the Hedgehog-independent cell line Panc-1.	False	CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
413920:01:03_10.00	8.3	99	413920	287906:02:09_10.00	287906	83.39999999999999	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
413926:01:03_10.00	5.2	100	413926	245325:02:04_10.00	245325	82.0	51.3	10.0	97	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
413926:01:03_10.00	5.2	100	413926	520875:02:03_03.00	520875	80.5	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413926:01:03_10.00	5.2	100	413926	520875:01:04_10.00	520875	80.30000000000001	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413926:01:03_10.00	5.2	100	413926	412259:01:02_10.00	412259	79.7	55.3	10.0	66	BI-0319	BI-0319 is a degrader that tethers a highly selective PTK2 Kinase inhibitor BI-4464  to a CRL2VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein.The binary affinities for BI-0319 to PTK2 and to the VCB complex CRL2VHL are 19 and 114 nM respectively. BI-0319 degrades the PTK2 protein in A549 cells with a DC50 of 243 nM to about 80%	False	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
413926:01:03_10.00	5.2	100	413926	413206:01:02_03.00	413206	79.5	50.9	3.0	98		An inhibitor of MAPK14 with an IC50 = 0.2 nM (ELISA, cell free). NanoBRET: MAPK14 IC50 = 14.9 nM; MAPK11 IC50 = 16.9 nM. Negative control = FM-743	False	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2
413926:01:03_10.00	5.2	100	413926	413162:01:02_03.00	413162	79.4	58.0	3.0	90		negative control to Skepinone-L	False	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F
413926:01:03_10.00	5.2	100	413926	404607:02:02_30.00	404607	79.4	64.8	30.0	67	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
413926:01:03_10.00	5.2	100	413926	520875:02:03_01.00	520875	78.9	16.8	1.0	99	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
413926:01:03_10.00	5.2	100	413926	381945:02:02_10.00	381945	78.3	61.0	10.0	94	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
413926:01:03_10.00	5.2	100	413926	247095:01:04_10.00	247095	78.2	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
413934:01:03_10.00	19.0	104	413934	281040:01:03_10.00	281040	82.8	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
413934:01:03_10.00	19.0	104	413934	247067:02:03_10.00	247067	81.39999999999999	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
413934:01:03_10.00	19.0	104	413934	280474:01:03_30.00	280474	80.4	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
413934:01:03_10.00	19.0	104	413934	280970:01:03_30.00	280970	80.2	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
413934:01:03_10.00	19.0	104	413934	281001:01:03_30.00	281001	79.80000000000001	7.4	30.0	103	F3	nicotinic acetylcholine receptor antagonist.	False	CC(COc1ccc(/C=C/c2ccccc2)cc1)[N+](C)(C)C
413934:01:03_10.00	19.0	104	413934	409837:01:03_10.00	409837	79.60000000000001	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
413934:01:03_10.00	19.0	104	413934	317004:02:10_10.00	317004	78.8	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
413934:01:03_10.00	19.0	104	413934	412487:01:03_50.00	412487	78.7	6.7	50.0	102		BI-7656 serves as negative control to BI 207127 which is a highly potent and specific inhibitor of HCV polymerase activity (IC50 = 50 nM).	False	Cn1c(C2(NC(=O)c3ccc(NCC4CCCCC4)nc3)CCC2)nc2ccc(/C=C/C(=O)O)cc21
413934:01:03_10.00	19.0	104	413934	280355:01:03_30.00	280355	78.3	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
413934:01:03_10.00	19.0	104	413934	522774:02:04_30.00	522774	78.10000000000001	23.0	30.0	92	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
413951:01:03_10.00	20.6	102	413951	280907:01:03_10.00	280907	78.5	13.3	10.0	94	(Â±)-6-Chloro-PB hydrobromide, (Â±)-SKF-81297 hydrobromide	D1 dopamine receptor agonist.	False	Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
413951:01:03_10.00	20.6	102	413951	392641:01:09_00.20	392641	76.0	10.0	0.2	89	Milciclib	PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is &gt;3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.	False	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2
413951:01:03_10.00	20.6	102	413951	246898:01:04_10.00	246898	74.2	5.5	10.0	95	Oxfendazole	Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. Target: AntiparasiticOxfendazole is the sulfoxide form of fenbendazole, a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms.. Pigs in the treated group received Oxfendazole orally at 30 mg/kg dose. At five days post-treatment, animals were sacrificed and the clinical efficacy of the Oxfendazole treatment was established following the currently available WAAVP guidelines for a controlled efficacy test. None of the animals involved in this experiment showed any adverse events during the study. Oxfendazole treatment given as a single 30 mg/kg oral dose showed a 100% efficacy against all the nematode parasites present in the three experiments. In conclusion, under the current experimental conditions, Oxfendazole orally administered to naturally parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult stages of A. suum, Oesophagostomum spp., T. suis and Metastrongylus spp . 	False	COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1
413951:01:03_10.00	20.6	102	413951	280630:01:11_01.00	280630	73.7	12.1	1.0	91	IC261	IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 uM, 1 uM, 16 uM for Cki.d., Cki.e. and Cki.a.1, respectively.	False	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1
413951:01:03_10.00	20.6	102	413951	392593:01:09_00.20	392593	73.3	7.3	0.2	92	TAK-901	TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.	False	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1
413951:01:03_10.00	20.6	102	413951	280413:01:03_30.00	280413	72.5	34.5	30.0	84	2-CADO	adenosine receptor agonist with selectivity for A1 over A2.	False	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1O
413951:01:03_10.00	20.6	102	413951	246857:01:04_10.00	246857	71.89999999999999	7.9	10.0	104	Tulobuterol	beta-2-adrenergic receptor agonist.	False	CC(C)(C)NCC(O)c1ccccc1Cl
413951:01:03_10.00	20.6	102	413951	392203:01:02_00.20	392203	71.2	16.9	0.2	87		Inhibitor of B-Raf V600E mutant (IC50 = 0.0005 ÂµM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
413951:01:03_10.00	20.6	102	413951	392515:01:09_00.20	392515	70.89999999999999	9.3	0.2	97	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
413951:01:03_10.00	20.6	102	413951	280958:01:03_10.00	280958	69.0	10.5	10.0	98	Semaxinib	Semaxinib (SU5416) is a potent and selective inhibitor of VEGFR (Flk-1/KDR) with an IC50 of 1.23 uM.	False	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
414092:01:03_10.00	11.7	98	414092	283253:01:04_10.00	283253	86.1	35.4	10.0	99	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
414092:01:03_10.00	11.7	98	414092	280757:01:04_10.00	280757	84.89999999999999	34.7	10.0	89	Naloxonazine dihydrochloride	potent mu1 opioid receptor antagonist.	False	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@@H]2/C(=N/N=C2\CC[C@@]4(O)C6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@@H]2O8)CC[C@@]3(O)C1C5
414092:01:03_10.00	11.7	98	414092	412997:01:03_02.00	412997	83.1	39.7	2.0	99	MCOPPB (hydrochloride)	The nociceptin/orphanin FQ peptide (NOP, ORL1, or OP4) receptor is a member of the opioid family of receptors that integrates the emotional components of anxiety, fear, and stress. MCOPPB is a potent agonist for the NOP receptor (pKi = 10.1, EC50 = 0.39 nM) with 12-, 270-, and &gt;1,000-fold selectivity over the u-, ÃÂº-, and .d.-opioid receptors.	True	CC1(N2CCC(n3c([C@@H]4CCCNC4)nc4ccccc43)CC2)CCCCCCC1
414092:01:03_10.00	11.7	98	414092	409860:01:04_01.00	409860	82.19999999999999	45.8	1.0	93	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of &lt;2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
414092:01:03_10.00	11.7	98	414092	247033:01:04_10.00	247033	82.1	21.6	10.0	99	Trazodone (hydrochloride)	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	False	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
414092:01:03_10.00	11.7	98	414092	409860:01:03_01.00	409860	81.8	30.2	1.0	89	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of &lt;2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
414092:01:03_10.00	11.7	98	414092	410285:01:04_03.00	410285	81.8	36.4	3.0	102	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
414092:01:03_10.00	11.7	98	414092	245383:02:04_30.00	245383	81.6	16.8	30.0	102	Xylometazoline (hydrochloride)	Xylometazoline hydrochloride is an .a.-adrenoceptor agonist commonly used as nasal decongestant.Target: .a.-AdrenoceptorXylometazoline hydrochloride is a nasal decongestant spray that constricts nasal blood vessels and increases nasal airflow, enabling patients with a blocked nose to breathe more easily. Xylometazoline hydrochloride is an effective and well-tolerated decongestant nasal spray that significantly relieved nasal congestion compared with placebo in the common cold and provided long-lasting relief with just 1 spray, helping patients to breathe more easily for a longer period of time . Xylometazoline hydrochloride exhibits in radioligand competition studies higher affinities than the catecholamines adrenaline and noradrenaline at most .a.-adrenoceptor subtypes. Xylometazoline behaved at .a.(2B) -adrenoceptors as full agonists .	False	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
414092:01:03_10.00	11.7	98	414092	413119:01:04_10.00	413119	81.5	43.7	10.0	100	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and &gt; 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
414092:01:03_10.00	11.7	98	414092	246562:01:04_10.00	246562	81.39999999999999	10.9	10.0	104	Alfadolone acetate	nociception blocker.	True	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
414156:01:03_10.00	8.3	96	414156	280532:01:03_30.00	280532	84.0	25.2	30.0	107	Eliprodil	Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50&gt; 100 uM).IC50 value:Target: NR2B-NMDA antagonistHuman N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).	False	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1
414156:01:03_10.00	8.3	96	414156	246889:01:09_01.00	246889	83.3	12.4	1.0	91	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
414156:01:03_10.00	8.3	96	414156	528526:01:02_05.00	528526	83.1	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
414156:01:03_10.00	8.3	96	414156	246448:01:04_30.00	246448	82.8	32.5	30.0	93	Clebopride maleate	Inhibition of Dopamine D2 receptor (IC50 = 17 nM); Inhibition of human ERG ( IC50 = 602.56 nM 6.22); Inhibiton of Acetylcholinesterase (IC50 = 890 nM)	False	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
414156:01:03_10.00	8.3	96	414156	246866:02:03_10.00	246866	82.6	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414156:01:03_10.00	8.3	96	414156	247094:02:03_30.00	247094	82.19999999999999	20.7	30.0	102	Betaxolol hydrochloride	selective beta1 adrenoceptor antagonist, Beta adrenergic antagonist.	False	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
414156:01:03_10.00	8.3	96	414156	528561:01:02_05.00	528561	81.89999999999999	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414156:01:03_10.00	8.3	96	414156	407974:01:04_10.00	407974	81.8	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
414156:01:03_10.00	8.3	96	414156	409343:02:02_01.00	409343	81.69999999999999	19.0	1.0	100	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
414156:01:03_10.00	8.3	96	414156	519823:01:02_10.00	519823	81.0	9.8	10.0	94		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
414271:01:03_10.00	34.7	105	414271	392775:01:09_02.00	392775	86.1	26.4	2.0	101	GSK1904529A	GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50&gt;1 uM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity.	False	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1
414271:01:03_10.00	34.7	105	414271	281019:01:03_30.00	281019	85.9	30.1	30.0	103	U-69593	selective kappa opioid receptor agonist.	False	CN(C(=O)Cc1ccccc1)[C@@H]1CC[C@]2(CCCO2)C[C@H]1N1CCCC1
414271:01:03_10.00	34.7	105	414271	413096:01:06_10.00	413096	85.9	48.2	10.0	103	BAN-ORL-24	BAN ORL 24 is a potent and selective NOP receptor antagonist. (IC50 values are 0.27, 2500, 6700 and &gt; 10000 nM for NOP, .k.-, .m.- and .d.-receptors respectively). BAN ORL 24 inhibits nociceptin-induced stimulation of [35S]-GTP.g.S binding and Ca2+ mobilization in CHO cells in vitro.	True	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1
414271:01:03_10.00	34.7	105	414271	280902:01:03_30.00	280902	84.89999999999999	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
414271:01:03_10.00	34.7	105	414271	280483:01:03_30.00	280483	84.8	49.2	30.0	100	Dihydroergotamine methanesulfonate	ergot alkaloid, vasoconstrictor, competitive serotonin receptor antagonist, partial agonist at alpha adrenoceptors and D2 dopamine receptors, vasoconstrictor, antimigraine.	False	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
414271:01:03_10.00	34.7	105	414271	409894:01:03_30.00	409894	84.6	25.6	30.0	97	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
414271:01:03_10.00	34.7	105	414271	247034:01:04_30.00	247034	84.3	21.1	30.0	97	Pergolide (mesylate)	Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson&#x27;s disease and hyperprolactinaemia research.	True	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
414271:01:03_10.00	34.7	105	414271	246903:01:04_30.00	246903	84.1	30.1	30.0	94	Nicergoline	Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of .a.1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer&#x27;s disease.	True	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13
414271:01:03_10.00	34.7	105	414271	280875:01:09_30.00	280875	84.0	48.5	30.0	85	Quinine sulfate	K+ channel blocker, antimalarial, anticholinergic, antihypertensive and hypoglycemic agent, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12
414271:01:03_10.00	34.7	105	414271	528529:01:02_05.00	528529	83.8	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
414464:01:03_10.00	11.4	101	414464	280944:01:03_10.00	280944	81.10000000000001	48.7	10.0	96	SKF 95282 dimaleate, Zolantidine	H2 Histamine receptor antagonist.	False	c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3s2)c1
414464:01:03_10.00	11.4	101	414464	247293:02:03_10.00	247293	80.5	29.7	10.0	104	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
414464:01:03_10.00	11.4	101	414464	280179:01:03_10.00	280179	80.4	33.3	10.0	94	AMG9810	AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.	False	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1
414464:01:03_10.00	11.4	101	414464	247196:01:04_10.00	247196	80.0	21.8	10.0	102	Acepromazine maleate	dopaminergic antagonist ?, sedative.	False	CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
414464:01:03_10.00	11.4	101	414464	410797:01:03_00.20	410797	79.60000000000001	6.7	0.2	96	BIX-01294	BIX-01294 is an inhibitor of G9a Histone Methyltransferase with an IC50 of 1.9 ÂµM.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
414464:01:03_10.00	11.4	101	414464	280678:01:03_10.00	280678	79.3	25.7	10.0	101	L-687,384 hydrochloride	putative sigma-1 receptor agonist.	False	c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1
414464:01:03_10.00	11.4	101	414464	413110:01:04_50.00	413110	78.9	37.5	50.0	107	Ibutilide (fumarate)	Ibutilide fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm.Target: Calcium ChannelIbutilide fumarate is the first &#x27;pure&#x27; class III antiarrhythmic drug to become available. Its predominant action is prolongation of the myocardial action potential duration. Intravenous ibutilide 0.01 to 0.025 mg/kg or 1 to 2 mg successfully converted atrial flutter or fibrillation to sinus rhythm in 33 to 49% of patients in 2 placebo-controlled trials involving 439 patients with sustained arrhythmia . Ibutilide fumarate appears to be an effective alternative method for rapid conversion of recent-onset AF or AFl. The drug may be particularly useful in patients who have undergone recent cardiac surgery or those who are not ideal candidates for DCC .	False	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1
414464:01:03_10.00	11.4	101	414464	247070:02:03_10.00	247070	78.7	34.4	10.0	85	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
414464:01:03_10.00	11.4	101	414464	280127:01:04_10.00	280127	78.3	21.9	10.0	101	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
414464:01:03_10.00	11.4	101	414464	280360:01:03_10.00	280360	77.9	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
414501:01:03_10.00	13.8	97	414501	413167:01:02_03.00	413167	82.1	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
414501:01:03_10.00	13.8	97	414501	519823:01:02_30.00	519823	78.5	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
414501:01:03_10.00	13.8	97	414501	409878:01:04_50.00	409878	78.10000000000001	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
414501:01:03_10.00	13.8	97	414501	247095:01:04_10.00	247095	78.0	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
414501:01:03_10.00	13.8	97	414501	413167:01:02_05.00	413167	77.8	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
414501:01:03_10.00	13.8	97	414501	409878:01:04_30.00	409878	77.10000000000001	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
414501:01:03_10.00	13.8	97	414501	280483:01:03_10.00	280483	76.2	8.3	10.0	96	Dihydroergotamine methanesulfonate	ergot alkaloid, vasoconstrictor, competitive serotonin receptor antagonist, partial agonist at alpha adrenoceptors and D2 dopamine receptors, vasoconstrictor, antimigraine.	False	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
414501:01:03_10.00	13.8	97	414501	528561:01:02_03.00	528561	76.1	10.5	3.0	102		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414501:01:03_10.00	13.8	97	414501	522774:02:04_50.00	522774	76.0	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414501:01:03_10.00	13.8	97	414501	282300:02:03_50.00	282300	75.9	17.3	50.0	106	Tacrolimus, FK506	immune suppressant, antifungal.	False	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC
414502:01:03_10.00	12.3	95	414502	528526:01:02_05.00	528526	80.30000000000001	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
414502:01:03_10.00	12.3	95	414502	280355:01:03_30.00	280355	80.10000000000001	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
414502:01:03_10.00	12.3	95	414502	519823:01:02_10.00	519823	79.80000000000001	9.8	10.0	94		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
414502:01:03_10.00	12.3	95	414502	281047:01:03_30.00	281047	79.80000000000001	21.9	30.0	93	YS-035 hydrochloride	L-type Ca2+ channel blocker, verapamil derivative.	False	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC
414502:01:03_10.00	12.3	95	414502	392523:01:09_02.00	392523	78.8	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
414502:01:03_10.00	12.3	95	414502	407974:01:04_10.00	407974	78.5	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
414502:01:03_10.00	12.3	95	414502	522774:02:04_10.00	522774	78.10000000000001	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414502:01:03_10.00	12.3	95	414502	280076:01:03_30.00	280076	78.10000000000001	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
414502:01:03_10.00	12.3	95	414502	280341:01:03_30.00	280341	77.5	6.6	30.0	98	(+)-Brompheniramine maleate, Dexbrompheniramine maleate	H1 Histamine receptor antagonist.	False	CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1
414502:01:03_10.00	12.3	95	414502	283242:02:05_10.00	283242	77.0	24.0	10.0	100	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
414504:01:03_10.00	5.7	107	414504	280904:01:03_30.00	280904	83.7	45.4	30.0	101	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
414504:01:03_10.00	5.7	107	414504	317004:02:10_10.00	317004	81.89999999999999	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
414504:01:03_10.00	5.7	107	414504	413121:01:03_30.00	413121	81.69999999999999	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
414504:01:03_10.00	5.7	107	414504	410031:02:03_30.00	410031	81.5	39.9	30.0	96	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
414504:01:03_10.00	5.7	107	414504	409837:01:03_10.00	409837	81.2	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
414504:01:03_10.00	5.7	107	414504	246883:01:04_10.00	246883	81.2	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
414504:01:03_10.00	5.7	107	414504	280468:01:03_30.00	280468	81.2	31.1	30.0	95	WB-4101 hydrochloride	alpha1A Adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
414504:01:03_10.00	5.7	107	414504	410622:01:04_10.00	410622	81.10000000000001	47.5	10.0	98	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
414504:01:03_10.00	5.7	107	414504	410031:02:03_50.00	410031	80.9	63.7	50.0	95	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
414504:01:03_10.00	5.7	107	414504	247238:02:03_30.00	247238	80.80000000000001	50.6	30.0	104	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
414508:01:03_10.00	6.7	99	414508	247044:01:04_10.00	247044	79.9	18.1	10.0	110	Mebeverine hydrochloride	phosphodiesterase inhibitor, muscle relaxant (smooth).	False	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1
414508:01:03_10.00	6.7	99	414508	247101:02:03_10.00	247101	79.0	21.4	10.0	92	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
414508:01:03_10.00	6.7	99	414508	246877:02:03_10.00	246877	78.7	11.1	10.0	103	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
414508:01:03_10.00	6.7	99	414508	392793:01:09_02.00	392793	78.60000000000001	32.6	2.0	95	Osimertinib	Osimertinib (AZD-9291) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.	False	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
414508:01:03_10.00	6.7	99	414508	413107:01:04_30.00	413107	78.3	42.1	30.0	106	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
414508:01:03_10.00	6.7	99	414508	246877:01:04_10.00	246877	77.60000000000001	6.0	10.0	97	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
414508:01:03_10.00	6.7	99	414508	413171:01:02_03.00	413171	77.5	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
414508:01:03_10.00	6.7	99	414508	280695:01:03_30.00	280695	77.3	28.3	30.0	104	p-MPPI hydrochloride	selective 5-HT1A serotonin receptor antagonist which crosses the blood-brain barrier.	False	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1
414508:01:03_10.00	6.7	99	414508	409861:01:03_01.00	409861	77.2	45.4	1.0	100	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of &lt;10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
414508:01:03_10.00	6.7	99	414508	412477:01:03_50.00	412477	77.2	55.8	50.0	93		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 &gt; 50 ÂµM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
414535:01:03_10.00	5.4	92	414535	281025:01:03_30.00	281025	83.3	27.5	30.0	99	U-101958 maleate	selective D4 dopamine receptor antagonist.	False	CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1
414535:01:03_10.00	5.4	92	414535	281051:01:03_30.00	281051	82.5	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
414535:01:03_10.00	5.4	92	414535	280190:01:03_30.00	280190	82.39999999999999	31.6	30.0	95	Caroverine hydrochloride	nonselective NMDA and AMPA glutamate receptor antagonist.	False	CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21
414535:01:03_10.00	5.4	92	414535	523782:02:04_03.00	523782	82.19999999999999	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
414535:01:03_10.00	5.4	92	414535	287906:02:09_10.00	287906	82.1	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
414535:01:03_10.00	5.4	92	414535	246815:01:12_03.00	246815	82.1	16.2	3.0	95	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
414535:01:03_10.00	5.4	92	414535	280117:01:03_30.00	280117	81.89999999999999	24.5	30.0	95	Paliperidone	Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at .a.1 and .a.2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia.	False	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O
414535:01:03_10.00	5.4	92	414535	246861:01:12_03.00	246861	81.8	19.2	3.0	100	Astemizole	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.	False	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
414535:01:03_10.00	5.4	92	414535	528561:01:02_05.00	528561	81.69999999999999	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414535:01:03_10.00	5.4	92	414535	519823:01:02_30.00	519823	81.3	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
414564:01:03_10.00	10.7	97	414564	392756:02:03_02.00	392756	84.1	5.4	2.0	93	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414564:01:03_10.00	10.7	97	414564	246498:01:04_30.00	246498	83.3	30.2	30.0	79	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
414564:01:03_10.00	10.7	97	414564	407872:02:03_02.00	407872	83.0	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414564:01:03_10.00	10.7	97	414564	392758:02:05_10.00	392758	78.0	14.7	10.0	90	GNE-7915	GNE-7915 is a potent, selective and brain-penetrant inhibitor of LRRK2 with an IC50 of 9 nM.	False	CCNc1nc(Nc2cc(F)c(C(=O)N3CCOCC3)cc2OC)ncc1C(F)(F)F
414564:01:03_10.00	10.7	97	414564	246753:01:04_30.00	246753	77.0	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
414564:01:03_10.00	10.7	97	414564	247127:01:04_30.00	247127	76.7	11.4	30.0	85	Cyclosporin A	IL 2 synthesis inhibitor.	True	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
414564:01:03_10.00	10.7	97	414564	407872:02:04_06.00	407872	75.5	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414564:01:03_10.00	10.7	97	414564	410689:01:04_10.00	410689	73.9	15.4	10.0	102	GSK 2830371	GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.	True	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1
414564:01:03_10.00	10.7	97	414564	392756:02:04_06.00	392756	73.8	29.4	6.0	95	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414564:01:03_10.00	10.7	97	414564	280402:04:03_10.00	280402	73.8	20.0	10.0	92	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
414572:01:03_10.00	12.6	104	414572	281051:01:03_30.00	281051	82.69999999999999	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
414572:01:03_10.00	12.6	104	414572	246859:01:04_30.00	246859	82.69999999999999	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
414572:01:03_10.00	12.6	104	414572	409343:02:02_03.00	409343	82.5	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
414572:01:03_10.00	12.6	104	414572	280706:01:03_30.00	280706	82.5	33.3	30.0	108	MRS 1523	selective A3 adenosine receptor antagonist in rat.	False	CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC
414572:01:03_10.00	12.6	104	414572	246632:01:04_30.00	246632	82.39999999999999	25.6	30.0	95	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
414572:01:03_10.00	12.6	104	414572	247019:02:03_30.00	247019	82.39999999999999	21.9	30.0	94	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
414572:01:03_10.00	12.6	104	414572	247229:01:05_30.00	247229	82.19999999999999	32.5	30.0	97	Isoxsuprine hydrochloride	Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 .m. and 3.48 .m. for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.	False	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
414572:01:03_10.00	12.6	104	414572	280858:01:03_10.00	280858	81.69999999999999	23.3	10.0	95	Pergolide methanesulfonate, propylergoline methanesulfonate	dopamine receptor agonist, antiparkinsonian.	False	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
414572:01:03_10.00	12.6	104	414572	247419:02:03_30.00	247419	81.69999999999999	72.2	30.0	96	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
414572:01:03_10.00	12.6	104	414572	247020:01:04_10.00	247020	81.39999999999999	24.4	10.0	97	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
414612:01:03_10.00	13.6	102	414612	413121:01:03_30.00	413121	78.2	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
414612:01:03_10.00	13.6	102	414612	246624:01:04_30.00	246624	77.60000000000001	37.0	30.0	95	Tribenoside	vitamin.	False	CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O
414612:01:03_10.00	13.6	102	414612	280891:01:03_30.00	280891	77.5	9.8	30.0	103	REV 5901	leukotriene D4 receptor antagonist.	False	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1
414612:01:03_10.00	13.6	102	414612	410031:02:03_30.00	410031	75.9	39.9	30.0	96	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
414612:01:03_10.00	13.6	102	414612	410755:01:03_02.00	410755	75.1	21.2	2.0	99	L755507	L-755,507 is characterized as a potent and selective Ã3 adrenergic receptor partial agonist with EC50 of 0.43 nM. It is also recently identified to enhance CRISPR-mediated homology-directed repair (HDR) efficiency in human induced pluripotent stem cells (iPSCs) and other cell types.	True	CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1
414612:01:03_10.00	13.6	102	414612	101009:01:16_50.00	101009	74.8	17.1	50.0	85	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
414612:01:03_10.00	13.6	102	414612	280076:01:03_30.00	280076	73.9	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
414612:01:03_10.00	13.6	102	414612	280355:01:03_30.00	280355	73.6	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
414612:01:03_10.00	13.6	102	414612	280943:01:03_30.00	280943	73.5	23.7	30.0	97	SB 222200	non-peptide NK3 tachykinin receptor antagonist.	False	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1
414612:01:03_10.00	13.6	102	414612	101009:01:19_30.00	101009	73.2	30.9	30.0	89	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
414680:01:03_10.00	6.6	99	414680	413161:01:02_03.00	413161	71.8	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
414680:01:03_10.00	6.6	99	414680	280107:01:03_30.00	280107	69.39999999999999	30.4	30.0	83	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
414680:01:03_10.00	6.6	99	414680	247278:01:04_30.00	247278	69.1	12.8	30.0	97	Chlorotrianisene	nuclear receptor ligand, estrogen.	False	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1
414680:01:03_10.00	6.6	99	414680	280705:01:03_30.00	280705	69.0	5.9	30.0	102	MRS 1845, N-Propargylnitrendipene	store-operated calcium (SOC) channel inhibitor.	False	C#CCN1C(C)=C(C(=O)OC)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OCC)=C1C
414680:01:03_10.00	6.6	99	414680	245387:02:04_30.00	245387	68.5	15.9	30.0	104	Tolnaftate	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	False	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1
414680:01:03_10.00	6.6	99	414680	413117:01:03_10.00	413117	68.5	12.4	10.0	95	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
414680:01:03_10.00	6.6	99	414680	280943:01:03_30.00	280943	67.10000000000001	23.7	30.0	97	SB 222200	non-peptide NK3 tachykinin receptor antagonist.	False	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1
414680:01:03_10.00	6.6	99	414680	410094:01:03_02.00	410094	66.7	20.9	2.0	92	Belumosudil	Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 uM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties.	False	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1
414680:01:03_10.00	6.6	99	414680	407872:02:04_06.00	407872	65.60000000000001	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414680:01:03_10.00	6.6	99	414680	407872:02:04_10.00	407872	65.4	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414686:01:03_10.00	13.1	91	414686	410072:01:03_02.00	410072	74.8	17.8	2.0	83	TH287	TH287 is a potent and selective inhibitor of MTH1, with an IC50 of 0.8 nM. TH287 is highly selective towards MTH1, with no relevant inhibition of MTH2, NUDT5, NUDT12, NUDT14, NUDT16, dCTPase, dUTPase and ITPA at 100 uM. TH287 could act as a chemotherapeutic agent for cancer research.	False	CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1
414686:01:03_10.00	13.1	91	414686	410692:01:04_00.60	410692	74.0	58.9	0.6	61	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
414686:01:03_10.00	13.1	91	414686	246972:12:05_00.60	246972	73.9	50.6	0.6	71	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
414686:01:03_10.00	13.1	91	414686	280954:01:07_03.00	280954	73.8	30.7	3.0	79	SKF-96365	selective inhibitor of receptor-mediated and voltage-gated Ca2+ entry.	False	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1
414686:01:03_10.00	13.1	91	414686	246972:12:04_00.60	246972	73.7	62.3	0.6	69	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
414686:01:03_10.00	13.1	91	414686	410613:01:05_00.60	410613	73.5	8.6	0.6	100	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
414686:01:03_10.00	13.1	91	414686	413105:01:05_30.00	413105	73.3	26.1	30.0	75	GSK137647A	GSK137647A is a selective FFA4 agonist. IC50 value: 6.3/6.2/6.1 (pEC50, for human/mouse/rat FFA4). The pEC50s for Human, Mouse and Rat FFA1/2/3 are &lt; 4.5. GSK137647A is evaluated against a panel of 65 targets in both full curve functional and binding assays and was shown to provide at least 100-fold selectivity against the panel which included 41 G-protein-coupled receptors (GPCRs), including additional members of the free fatty acid receptors (FFA1, FFA2, and FFA3). GSK137647A produces a concentration-dependent increase in glucose stimulated insulin secretion under high glucose conditions (25 mM).	False	COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1
414686:01:03_10.00	13.1	91	414686	410613:01:04_00.60	410613	73.0	15.5	0.6	86	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
414686:01:03_10.00	13.1	91	414686	528531:01:02_05.00	528531	72.8	36.1	5.0	82		MU1210 is a potent probe for CLK1/2/4 with IC50 values of 8/20/12 nM, respectively with corresponding good cellular potency in NanoBRET assays (84/91/23 nM), respectively. CLK3 was not inhibited by MU1210 at concentrations up to 3 ÂµM.	False	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1
414686:01:03_10.00	13.1	91	414686	410692:01:05_00.60	410692	72.6	60.8	0.6	65	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
414695:01:03_10.00	16.4	109	414695	413000:01:02_10.00	413000	70.3	31.8	10.0	99	Arcyriaflavin-a	Arcyriaflavin A is an inhibitor of cyclin-dependent kinase 4 (CDK4; IC50 = 140 nM) and calcium/calmodulin-dependent protein kinase II (CaMKII; IC50 = 25 nM). It is selective for CDK4 and CaMKII over protein kinase A (PKA) and PKC (IC50s = &gt;2 and &gt;100 uM, respectively). In vitro, arcyriaflavin A inhibits replication of human cytomegalovirus (HCMV; IC50 = 200 nM), as well as proliferation of HCT116 and NCI H460 human carcinoma cells (IC50s = 850 and 590 nM, respectively).	False	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21
414695:01:03_10.00	16.4	109	414695	413196:01:02_05.00	528551	69.39999999999999	6.0	5.0	99		An inhibitor of Complex I quinone binding site (core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase). Active in cellular mechanistic assay demonstrating cellular target engagement. Proliferation assays: IC50 = 79 nM (H1299 (human lung); IC50 = 33 nM (H1299 (human lung). Negative control = BAY-070	False	c1ccc2oc(-c3csc(C4CCN(Cc5nc6cccnc6[nH]5)CC4)n3)cc2c1
414695:01:03_10.00	16.4	109	414695	247296:01:04_30.00	247296	67.60000000000001	20.2	30.0	98	Clobetasol propionate	Glucocorticoid receptor (IC50 = 1.456 nM); Progesterone receptor (IC50 = 3.17 nM)	False	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
414695:01:03_10.00	16.4	109	414695	392895:01:08_03.00	392895	66.0	32.8	3.0	86	GSK2334470	GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activate SGK, S6K1 and RSK as well as suppress the activation of Akt.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
414695:01:03_10.00	16.4	109	414695	413053:01:04_30.00	413053	65.7	15.5	30.0	93	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
414695:01:03_10.00	16.4	109	414695	392756:02:04_06.00	392756	65.4	29.4	6.0	95	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414695:01:03_10.00	16.4	109	414695	413031:01:04_06.00	413031	65.3	16.1	6.0	110	CC-401	CC-401 is a potent inhibitor of all three JNK isoforms (Ki values range from 25 to 50 nM). It has at least 40-fold selectivity for JNK compared with other related kinases.	False	c1cc(OCCN2CCCCC2)cc(-c2[nH]nc3ccc(-c4nc[nH]n4)cc23)c1
414695:01:03_10.00	16.4	109	414695	392756:02:04_10.00	392756	65.2	29.5	10.0	89	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414740:01:03_10.00	8.5	94	414740	281042:01:03_30.00	281042	86.7	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
414740:01:03_10.00	8.5	94	414740	409894:01:03_50.00	409894	85.2	23.3	50.0	109	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
414740:01:03_10.00	8.5	94	414740	409894:01:03_30.00	409894	84.0	25.6	30.0	97	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
414740:01:03_10.00	8.5	94	414740	281040:01:03_30.00	281040	84.0	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
414740:01:03_10.00	8.5	94	414740	246330:01:04_10.00	246330	83.89999999999999	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
414740:01:03_10.00	8.5	94	414740	528526:01:02_05.00	528526	83.8	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
414740:01:03_10.00	8.5	94	414740	247081:01:05_30.00	247081	82.8	16.9	30.0	101	Troleandomycin	ribosomal protein synthesis inhibitor.	True	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
414740:01:03_10.00	8.5	94	414740	280454:01:03_30.00	280454	82.69999999999999	18.5	30.0	96	R(+)-SCH-23390 hydrochloride	selective D1 dopamine receptor antagonist.	False	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
414740:01:03_10.00	8.5	94	414740	410014:01:04_10.00	410014	82.6	16.8	10.0	110	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
414740:01:03_10.00	8.5	94	414740	528561:01:02_05.00	528561	82.6	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414747:01:03_10.00	5.9	103	414747	280474:01:03_30.00	280474	82.3	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
414747:01:03_10.00	5.9	103	414747	410708:01:04_06.00	410708	81.8	31.6	6.0	98	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
414747:01:03_10.00	5.9	103	414747	409853:02:03_02.00	409853	81.39999999999999	14.7	2.0	97	Tubacin	Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1.	True	O=C(CCCCCCC(=O)Nc1ccc([C@H]2O[C@@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)C[C@@H](c3ccc(CO)cc3)O2)cc1)NO
414747:01:03_10.00	5.9	103	414747	246883:07:04_06.00	246883	80.80000000000001	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
414747:01:03_10.00	5.9	103	414747	280970:01:03_30.00	280970	80.60000000000001	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
414747:01:03_10.00	5.9	103	414747	528561:01:02_05.00	528561	80.5	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414747:01:03_10.00	5.9	103	414747	247095:02:03_30.00	247095	79.9	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
414747:01:03_10.00	5.9	103	414747	528526:01:02_05.00	528526	79.7	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
414747:01:03_10.00	5.9	103	414747	410080:01:03_02.00	410080	79.5	15.0	2.0	96	GSK503	GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Kiapp values of 3 to 27 nM.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(O)n1
414747:01:03_10.00	5.9	103	414747	317004:02:10_10.00	317004	79.4	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
414754:01:03_10.00	7.9	99	414754	413130:01:02_03.00	413130	80.80000000000001	7.4	3.0	88		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
414754:01:03_10.00	7.9	99	414754	381945:01:12_10.00	381945	80.0	46.5	10.0	102	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
414754:01:03_10.00	7.9	99	414754	392482:01:09_02.00	392482	79.9	7.9	2.0	102	Pazopanib (Hydrochloride)	Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR.b., c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.	False	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
414754:01:03_10.00	7.9	99	414754	413167:01:02_05.00	413167	79.80000000000001	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
414754:01:03_10.00	7.9	99	414754	413130:01:02_05.00	413130	79.60000000000001	23.5	5.0	99		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
414754:01:03_10.00	7.9	99	414754	392592:03:03_10.00	392592	79.5	52.3	10.0	98	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
414754:01:03_10.00	7.9	99	414754	520875:01:04_10.00	520875	79.2	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
414754:01:03_10.00	7.9	99	414754	246866:02:03_30.00	246866	79.2	49.4	30.0	87	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414754:01:03_10.00	7.9	99	414754	247095:01:04_10.00	247095	79.10000000000001	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
414754:01:03_10.00	7.9	99	414754	381945:02:02_10.00	381945	79.0	61.0	10.0	94	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
414779:01:03_10.00	7.9	98	414779	246859:01:04_30.00	246859	85.0	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
414779:01:03_10.00	7.9	98	414779	520969:01:04_30.00	520969	84.89999999999999	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
414779:01:03_10.00	7.9	98	414779	281051:01:03_30.00	281051	84.89999999999999	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
414779:01:03_10.00	7.9	98	414779	281040:01:03_30.00	281040	84.5	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
414779:01:03_10.00	7.9	98	414779	528561:01:02_05.00	528561	84.1	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
414779:01:03_10.00	7.9	98	414779	280190:01:03_30.00	280190	84.0	31.6	30.0	95	Caroverine hydrochloride	nonselective NMDA and AMPA glutamate receptor antagonist.	False	CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21
414779:01:03_10.00	7.9	98	414779	246866:02:03_10.00	246866	84.0	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414779:01:03_10.00	7.9	98	414779	246330:01:04_10.00	246330	83.89999999999999	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
414779:01:03_10.00	7.9	98	414779	246846:02:03_30.00	246846	83.89999999999999	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
414779:01:03_10.00	7.9	98	414779	246846:01:05_30.00	246846	83.6	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
414801:01:03_10.00	10.5	110	414801	410755:01:03_02.00	410755	80.4	21.2	2.0	99	L755507	L-755,507 is characterized as a potent and selective Ã3 adrenergic receptor partial agonist with EC50 of 0.43 nM. It is also recently identified to enhance CRISPR-mediated homology-directed repair (HDR) efficiency in human induced pluripotent stem cells (iPSCs) and other cell types.	True	CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1
414801:01:03_10.00	10.5	110	414801	245387:02:04_30.00	245387	79.7	15.9	30.0	104	Tolnaftate	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	False	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1
414801:01:03_10.00	10.5	110	414801	392523:01:09_02.00	392523	78.8	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
414801:01:03_10.00	10.5	110	414801	246753:01:04_30.00	246753	78.2	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
414801:01:03_10.00	10.5	110	414801	407872:02:03_02.00	407872	77.4	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414801:01:03_10.00	10.5	110	414801	410626:01:03_02.00	410626	76.0	11.2	2.0	98	Nebivolol HCl	Nebivolol HCl selectively inhibits Ã1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
414801:01:03_10.00	10.5	110	414801	280355:01:03_30.00	280355	75.9	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
414801:01:03_10.00	10.5	110	414801	280670:01:03_30.00	280670	75.9	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
414801:01:03_10.00	10.5	110	414801	280424:01:03_30.00	280424	75.5	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
414801:01:03_10.00	10.5	110	414801	247334:01:04_30.00	247334	74.7	8.6	30.0	97	Levobunolol (hydrochloride)	Levobunolol hydrochloride is a non-selective beta blocker. It is used topically to manage glaucoma.	True	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O
414802:01:03_10.00	9.2	94	414802	246498:01:04_30.00	246498	82.1	30.2	30.0	79	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
414802:01:03_10.00	9.2	94	414802	407872:02:03_02.00	407872	81.0	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414802:01:03_10.00	9.2	94	414802	392756:02:03_02.00	392756	79.3	5.4	2.0	93	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414802:01:03_10.00	9.2	94	414802	411901:01:07_01.00	411901	79.3	11.1	1.0	101		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	CN1C(=O)C2(C(=O)N(Cc3ccncc3)c3ccc(OC(F)(F)F)cc32)c2ccccc21
414802:01:03_10.00	9.2	94	414802	392758:02:05_10.00	392758	78.4	14.7	10.0	90	GNE-7915	GNE-7915 is a potent, selective and brain-penetrant inhibitor of LRRK2 with an IC50 of 9 nM.	False	CCNc1nc(Nc2cc(F)c(C(=O)N3CCOCC3)cc2OC)ncc1C(F)(F)F
414802:01:03_10.00	9.2	94	414802	247127:01:04_30.00	247127	78.2	11.4	30.0	85	Cyclosporin A	IL 2 synthesis inhibitor.	True	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
414802:01:03_10.00	9.2	94	414802	392545:01:10_00.20	392545	75.0	9.2	0.2	99	TCS7010	TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC50 of 3.4 nM.	False	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1
414802:01:03_10.00	9.2	94	414802	246753:01:04_30.00	246753	74.4	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
414802:01:03_10.00	9.2	94	414802	246355:01:04_30.00	246355	73.9	14.3	30.0	98	Heptaminol (hydrochloride)	Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.in vivo: In the rat, Heptaminol hydrochloride prevents orthostatic hypotension, and increases the noradrenaline plasma concentration. In bovine chromaffin cells maintained in primary cultures, Heptaminol hydrochloride is found to be a competitive inhibitor of noradrenaline uptake.	False	CC(N)CCCC(C)(C)O
414802:01:03_10.00	9.2	94	414802	407872:02:04_06.00	407872	73.3	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414803:01:03_10.00	13.5	95	414803	407872:02:03_02.00	407872	82.1	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414803:01:03_10.00	13.5	95	414803	246498:01:04_30.00	246498	79.80000000000001	30.2	30.0	79	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
414803:01:03_10.00	13.5	95	414803	392756:02:03_02.00	392756	79.3	5.4	2.0	93	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414803:01:03_10.00	13.5	95	414803	246753:01:04_30.00	246753	78.5	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
414803:01:03_10.00	13.5	95	414803	280101:01:03_30.00	280101	77.9	7.9	30.0	92	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
414803:01:03_10.00	13.5	95	414803	407872:02:04_06.00	407872	75.3	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414803:01:03_10.00	13.5	95	414803	245387:02:04_30.00	245387	75.3	15.9	30.0	104	Tolnaftate	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	False	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1
414803:01:03_10.00	13.5	95	414803	410094:01:03_02.00	410094	75.2	20.9	2.0	92	Belumosudil	Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 uM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties.	False	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1
414803:01:03_10.00	13.5	95	414803	247127:01:04_30.00	247127	74.8	11.4	30.0	85	Cyclosporin A	IL 2 synthesis inhibitor.	True	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
414803:01:03_10.00	13.5	95	414803	407872:02:04_10.00	407872	74.2	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414805:01:03_10.00	8.8	97	414805	392736:02:03_02.00	392736	73.3	16.1	2.0	93	TAK-632	TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively.	False	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12
414805:01:03_10.00	8.8	97	414805	413005:01:02_30.00	413005	71.8	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
414805:01:03_10.00	8.8	97	414805	280101:01:03_30.00	280101	71.3	7.9	30.0	92	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
414805:01:03_10.00	8.8	97	414805	407872:02:04_10.00	407872	70.39999999999999	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414805:01:03_10.00	8.8	97	414805	407872:01:06_10.00	407872	69.19999999999999	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414805:01:03_10.00	8.8	97	414805	247296:01:04_30.00	247296	66.9	20.2	30.0	98	Clobetasol propionate	Glucocorticoid receptor (IC50 = 1.456 nM); Progesterone receptor (IC50 = 3.17 nM)	False	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
414805:01:03_10.00	8.8	97	414805	407872:02:04_06.00	407872	65.9	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414805:01:03_10.00	8.8	97	414805	280629:01:03_30.00	280629	65.3	46.8	30.0	63	Indirubin-3'-oxime	protein kinase inhibitor; inhibits cyclin-dependent kinases (IC50 = 0.18 - 3.33 ÂµM) and GSK-3Ã (IC50 = 0.19 ÂµM). Inhibits CDK5- and GSK-3Ã-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation.	False	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O
414808:01:03_10.00	26.1	92	414808	407872:02:03_02.00	407872	72.89999999999999	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414808:01:03_10.00	26.1	92	414808	413005:01:02_30.00	413005	72.0	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
414808:01:03_10.00	26.1	92	414808	392756:02:03_02.00	392756	67.60000000000001	5.4	2.0	93	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414808:01:03_10.00	26.1	92	414808	246498:01:04_30.00	246498	67.2	30.2	30.0	79	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
414808:01:03_10.00	26.1	92	414808	522774:02:04_10.00	522774	65.60000000000001	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414812:01:03_10.00	5.4	105	414812	280127:01:04_30.00	280127	83.5	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
414812:01:03_10.00	5.4	105	414812	413107:01:04_10.00	413107	82.19999999999999	14.2	10.0	106	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
414812:01:03_10.00	5.4	105	414812	246847:01:04_30.00	246847	81.8	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
414812:01:03_10.00	5.4	105	414812	280670:01:03_30.00	280670	81.5	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
414812:01:03_10.00	5.4	105	414812	280474:01:03_30.00	280474	81.2	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
414812:01:03_10.00	5.4	105	414812	246363:01:04_30.00	246363	81.0	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
414812:01:03_10.00	5.4	105	414812	247095:02:03_30.00	247095	80.7	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
414812:01:03_10.00	5.4	105	414812	246859:01:04_30.00	246859	80.30000000000001	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
414812:01:03_10.00	5.4	105	414812	246445:01:04_10.00	246445	80.2	8.1	10.0	101	Ketanserin tartrate hydrate	5-HT2 antagonist.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
414812:01:03_10.00	5.4	105	414812	247042:01:04_30.00	247042	79.9	32.0	30.0	89	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
414839:01:03_10.00	33.3	99	414839	247296:01:04_30.00	247296	73.9	20.2	30.0	98	Clobetasol propionate	Glucocorticoid receptor (IC50 = 1.456 nM); Progesterone receptor (IC50 = 3.17 nM)	False	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
414839:01:03_10.00	33.3	99	414839	280101:01:03_30.00	280101	71.2	7.9	30.0	92	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
414839:01:03_10.00	33.3	99	414839	407872:02:04_10.00	407872	71.1	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414839:01:03_10.00	33.3	99	414839	392756:02:04_06.00	392756	70.6	29.4	6.0	95	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414839:01:03_10.00	33.3	99	414839	280629:01:03_30.00	280629	70.5	46.8	30.0	63	Indirubin-3'-oxime	protein kinase inhibitor; inhibits cyclin-dependent kinases (IC50 = 0.18 - 3.33 ÂµM) and GSK-3Ã (IC50 = 0.19 ÂµM). Inhibits CDK5- and GSK-3Ã-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation.	False	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O
414839:01:03_10.00	33.3	99	414839	410511:01:03_30.00	410511	69.5	34.2	30.0	88		negative control of BI-1942.	True	CC[C@@H](C(=O)OC)n1c(=O)c2ccccc2n(Cc2cn(C)c3cccc(C)c23)c1=O
414839:01:03_10.00	33.3	99	414839	392756:02:04_10.00	392756	68.10000000000001	29.5	10.0	89	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
414839:01:03_10.00	33.3	99	414839	413013:01:03_30.00	413013	67.7	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
414839:01:03_10.00	33.3	99	414839	407872:02:04_06.00	407872	67.30000000000001	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414839:01:03_10.00	33.3	99	414839	407872:01:06_10.00	407872	66.7	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
414864:01:03_10.00	5.0	108	414864	519808:01:04_30.00	519808	84.5	57.5	30.0	96		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
414864:01:03_10.00	5.0	108	414864	520969:01:04_50.00	520969	82.8	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
414864:01:03_10.00	5.0	108	414864	246811:02:03_30.00	246811	82.5	43.5	30.0	89	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
414864:01:03_10.00	5.0	108	414864	246811:02:03_50.00	246811	82.0	44.6	50.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
414864:01:03_10.00	5.0	108	414864	280500:01:03_10.00	280500	81.6	14.3	10.0	100	N-Methyldopamine hydrochloride, Epinine hydrochloride	dopamine receptor agonist.	False	CNCCc1ccc(O)c(O)c1
414864:01:03_10.00	5.0	108	414864	280086:01:03_10.00	280086	81.39999999999999	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414864:01:03_10.00	5.0	108	414864	413032:01:03_50.00	413032	81.10000000000001	38.2	50.0	100	NS309	NS309 is a potent and selective opener of the small or intermediate conductance Ca2+-activated K+ (SK or IK, respectively) channels, but displays no activity at BK channels.	False	O=Nc1c(O)[nH]c2c(Cl)c(Cl)ccc12
414864:01:03_10.00	5.0	108	414864	528532:01:02_05.00	528532	81.0	6.4	5.0	104		negative control to SGC-CK2-1	False	Cc1ccc(N(C)c2cc(NC3CC3)n3ncc(C#N)c3n2)cc1N(C)C(=O)C1CC1
414864:01:03_10.00	5.0	108	414864	247099:02:03_10.00	247099	81.0	12.3	10.0	98	Carbetapentane (citrate)	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.	False	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
414864:01:03_10.00	5.0	108	414864	246414:01:04_10.00	246414	80.7	76.2	10.0	94	Fendiline (hydrochloride)	Fendiline hydrochloride is a nonselective calcium channel blocker.	False	CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1
414904:01:03_10.00	24.5	100	414904	246866:02:03_10.00	246866	84.3	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414904:01:03_10.00	24.5	100	414904	528526:01:02_05.00	528526	84.0	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
414904:01:03_10.00	24.5	100	414904	522774:02:04_50.00	522774	83.6	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414904:01:03_10.00	24.5	100	414904	409837:01:03_10.00	409837	83.39999999999999	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
414904:01:03_10.00	24.5	100	414904	413167:01:02_03.00	413167	83.3	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
414904:01:03_10.00	24.5	100	414904	522774:02:04_30.00	522774	82.19999999999999	23.0	30.0	92	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414904:01:03_10.00	24.5	100	414904	101009:01:19_30.00	101009	81.8	30.9	30.0	89	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
414904:01:03_10.00	24.5	100	414904	407974:01:04_10.00	407974	80.9	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
414904:01:03_10.00	24.5	100	414904	522774:02:04_10.00	522774	80.5	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
414904:01:03_10.00	24.5	100	414904	408877:01:04_50.00	408877	80.4	29.7	50.0	91	Acid Ceramidase Inhibitor 17a, ;ARN14974	it is a benzoxazolone carboxamide that potently inhibits acid ceramidase (IC50 = 79 nM). This effect is persistent, as it inhibits acid ceramidase activity in cells for up to 24 hours. ARN14974 is extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice. It causes a significant reduction in acid ceramidase activity in multiple organs in mice, including brain, liver, heart, lungs, and kidney.	False	O=C(NCCCCc1ccccc1)n1c(=O)oc2cc(-c3ccc(F)cc3)ccc21
414970:01:03_10.00	11.4	102	414970	280732:01:03_30.00	280732	89.0	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
414970:01:03_10.00	11.4	102	414970	246742:01:04_30.00	246742	88.2	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
414970:01:03_10.00	11.4	102	414970	280902:01:03_30.00	280902	88.1	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
414970:01:03_10.00	11.4	102	414970	287906:02:09_10.00	287906	88.0	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
414970:01:03_10.00	11.4	102	414970	413171:01:02_03.00	413171	87.8	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
414970:01:03_10.00	11.4	102	414970	280483:01:03_30.00	280483	87.3	49.2	30.0	100	Dihydroergotamine methanesulfonate	ergot alkaloid, vasoconstrictor, competitive serotonin receptor antagonist, partial agonist at alpha adrenoceptors and D2 dopamine receptors, vasoconstrictor, antimigraine.	False	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
414970:01:03_10.00	11.4	102	414970	247233:01:04_30.00	247233	87.1	24.0	30.0	98	Citalopram (hydrobromide)	Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression.	False	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
414970:01:03_10.00	11.4	102	414970	246877:02:03_30.00	246877	87.0	57.7	30.0	103	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
414970:01:03_10.00	11.4	102	414970	246445:01:04_30.00	246445	86.8	29.5	30.0	100	Ketanserin tartrate hydrate	5-HT2 antagonist.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
414970:01:03_10.00	11.4	102	414970	280282:01:03_30.00	280282	86.7	48.4	30.0	92	Amperozide hydrochloride	atypical antipsychotic drug with high affinity for serotonin receptors and low affinity for D2 dopamine receptors.	False	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
414998:01:03_10.00	11.6	96	414998	409343:02:02_03.00	409343	83.1	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
414998:01:03_10.00	11.6	96	414998	246456:01:04_10.00	246456	82.6	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
414998:01:03_10.00	11.6	96	414998	247197:01:04_10.00	247197	81.6	30.4	10.0	102	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
414998:01:03_10.00	11.6	96	414998	413221:01:03_10.00	413221	81.3	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
414998:01:03_10.00	11.6	96	414998	246433:01:04_10.00	246433	81.10000000000001	14.3	10.0	106	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
414998:01:03_10.00	11.6	96	414998	280086:01:03_10.00	280086	80.7	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
414998:01:03_10.00	11.6	96	414998	247342:01:05_10.00	247342	80.4	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
414998:01:03_10.00	11.6	96	414998	280127:01:04_10.00	280127	80.10000000000001	21.9	10.0	101	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
414998:01:03_10.00	11.6	96	414998	246453:01:04_10.00	246453	80.10000000000001	20.9	10.0	99	Benperidol	dopamine antagonist.	False	O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
414998:01:03_10.00	11.6	96	414998	280961:01:03_10.00	280961	79.9	52.5	10.0	102	SR 59230A oxalate	beta3-Adrenoceptor antagonist.	False	CCc1ccccc1OC[C@@H](O)CN[C@H]1CCc2ccccc2C1
415043:01:03_10.00	9.3	109	415043	520875:02:03_01.00	520875	78.10000000000001	16.8	1.0	99	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415043:01:03_10.00	9.3	109	415043	280660:01:06_03.00	280660	75.5	5.2	3.0	108	L-703,606, oxalate	potent and selective non-peptide NK-1 tachykinin receptor antagonist.	False	Ic1ccccc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1
415043:01:03_10.00	9.3	109	415043	519823:01:02_30.00	519823	75.1	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
415043:01:03_10.00	9.3	109	415043	528561:01:02_03.00	528561	75.1	10.5	3.0	102		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
415043:01:03_10.00	9.3	109	415043	247331:02:03_30.00	247331	74.8	32.0	30.0	99	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
415043:01:03_10.00	9.3	109	415043	280637:01:03_30.00	280637	74.8	10.4	30.0	103	IMID-4F hydrochloride	imidazoline-based K(ATP) channel blocker.	False	Fc1ccc(CN(C2=NCCN2)c2c(Cl)cccc2Cl)cc1
415043:01:03_10.00	9.3	109	415043	528524:01:02_03.00	528524	74.7	26.9	3.0	88		negative control to MRIA9	True	CN(C)c1ncc2cc(-c3ccc(-c4ncccc4F)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1
415043:01:03_10.00	9.3	109	415043	246344:01:04_10.00	246344	74.6	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
415043:01:03_10.00	9.3	109	415043	409878:01:04_50.00	409878	74.2	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
415043:01:03_10.00	9.3	109	415043	282300:02:03_50.00	282300	73.7	17.3	50.0	106	Tacrolimus, FK506	immune suppressant, antifungal.	False	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC
415104:01:03_10.00	15.0	97	415104	382124:04:03_00.20	382124	78.5	36.4	0.2	96	A-769662	A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 uM.	False	N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O
415104:01:03_10.00	15.0	97	415104	410118:02:05_50.00	410118	75.3	84.1	50.0	67	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
415104:01:03_10.00	15.0	97	415104	410985:01:03_02.00	410985	73.7	54.2	2.0	94	(-)-Indolactam V	(-)-Indolactam V is a PKC activator, with Kis of 3.36 nM, 1.03 ÂµM for Â¿-CRD2 (PKCÂ¿ surrogate peptide), .g.-CRD2 (PKC.g. surrogate peptide), and Kds of 5.5 nM (Â¿-C1B), 7.7 nM (Â¿-C1B), 8.3 nM (.d.-C1B), 18.9 nM (.b.-C1A-long), 20.8 nM (.a.-C1A-long), 137 nM (.b.-C1B), 138 nM (.g.-C1A), 213 nM (.g.-C1B), and has antitumor activity.	False	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C
415104:01:03_10.00	15.0	97	415104	246486:01:04_10.00	246486	73.1	59.9	10.0	86	Prenylamine lactate	ca 2+ channel activator.	False	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1
415104:01:03_10.00	15.0	97	415104	410624:01:04_00.60	410624	72.8	74.8	0.6	76	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
415104:01:03_10.00	15.0	97	415104	410624:01:05_00.60	410624	72.7	77.0	0.6	73	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
415104:01:03_10.00	15.0	97	415104	246899:01:05_10.00	246899	72.6	67.5	10.0	100	Tamoxifen (Citrate)	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 uM and 1.8 uM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis.	False	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
415104:01:03_10.00	15.0	97	415104	385860:01:01_00.20	385860	72.39999999999999	50.1	0.2	79	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is &gt;130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
415104:01:03_10.00	15.0	97	415104	410936:01:03_02.00	410936	72.39999999999999	53.9	2.0	87	MG 149	MG149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF (IC50= 47 uM); little potent for PCAF and p300 (IC50 &gt;200 uM).	False	CCCCCCCc1ccc(CCc2cccc(O)c2C(=O)O)cc1
415104:01:03_10.00	15.0	97	415104	108014:02:03_30.00	108014	71.89999999999999	55.4	30.0	76	Rutaecarpine	Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 uM.	False	O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12
415158:01:03_10.00	20.4	102	415158	520969:01:04_50.00	520969	88.8	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415158:01:03_10.00	20.4	102	415158	520969:01:04_30.00	520969	88.7	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415158:01:03_10.00	20.4	102	415158	413171:01:02_03.00	413171	88.7	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
415158:01:03_10.00	20.4	102	415158	246883:01:04_30.00	246883	87.6	22.8	30.0	96	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415158:01:03_10.00	20.4	102	415158	413107:01:03_10.00	413107	86.1	17.4	10.0	95	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
415158:01:03_10.00	20.4	102	415158	413094:01:04_30.00	413094	85.8	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
415158:01:03_10.00	20.4	102	415158	246981:02:03_30.00	246981	85.6	53.9	30.0	92	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
415158:01:03_10.00	20.4	102	415158	246673:02:09_02.00	246673	85.5	32.1	2.0	103	Lapatinib (ditosylate)	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
415158:01:03_10.00	20.4	102	415158	280193:01:03_10.00	280193	85.2	33.5	10.0	95	Fulvestrant	selective estrogen receptor downregulator (SERD). First pure antiestrogen with no agonistic activity both in vitro and in vivo.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415158:01:03_10.00	20.4	102	415158	280871:01:03_30.00	280871	85.1	9.7	30.0	99	Quipazine, 6-nitro-, maleate	potent and selective serotonin reuptake inhibitor.	False	O=[N+]([O-])c1ccc2nc(N3CCNCC3)ccc2c1
415235:01:03_10.00	25.0	105	415235	246330:01:04_10.00	246330	86.7	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
415235:01:03_10.00	25.0	105	415235	520969:01:04_30.00	520969	86.3	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415235:01:03_10.00	25.0	105	415235	246846:01:05_30.00	246846	85.8	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
415235:01:03_10.00	25.0	105	415235	246866:02:03_10.00	246866	85.6	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
415235:01:03_10.00	25.0	105	415235	246859:01:04_30.00	246859	85.39999999999999	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
415235:01:03_10.00	25.0	105	415235	528561:01:02_05.00	528561	85.0	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
415235:01:03_10.00	25.0	105	415235	246846:02:03_30.00	246846	85.0	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
415235:01:03_10.00	25.0	105	415235	247200:01:04_30.00	247200	85.0	26.3	30.0	102	Lobeline alpha (-) hydrochoride	nicotinic receptor ligand.	True	CN1[C@@H](CC(=O)c2ccccc2)CCC[C@H]1C[C@H](O)c1ccccc1
415235:01:03_10.00	25.0	105	415235	317004:02:10_10.00	317004	84.89999999999999	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415235:01:03_10.00	25.0	105	415235	528526:01:02_05.00	528526	84.89999999999999	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
415401:01:03_10.00	6.9	95	415401	408385:01:05_10.00	408385	75.8	45.1	10.0	88		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	Brc1ccc2[nH]c3c(c2c1)CCOC31CCCCC1
415401:01:03_10.00	6.9	95	415401	407972:01:04_10.00	407972	73.1	16.2	10.0	97	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
415401:01:03_10.00	6.9	95	415401	411398:01:04_50.00	411398	72.1	35.1	50.0	92	Antimycin A		True	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C
415401:01:03_10.00	6.9	95	415401	382165:01:03_10.00	382165	70.0	30.7	10.0	88	IQ 1	enables Wnt/Ã-catenin-driven expansion of ESCs, prevents spontaneous differentiation.	False	CC(=O)c1ccc(/N=N/C(C(N)=O)=C2/NC(C)(C)Cc3ccccc32)cc1
415401:01:03_10.00	6.9	95	415401	280107:01:03_10.00	280107	69.89999999999999	5.4	10.0	97	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
415401:01:03_10.00	6.9	95	415401	408881:01:19_30.00	408881	69.69999999999999	10.0	30.0	99		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	O=C(O)c1cc(-c2ccc(-c3ccccc3)cc2)nc2ccccc12
415401:01:03_10.00	6.9	95	415401	392609:01:09_02.00	392609	69.39999999999999	23.5	2.0	103	CCT128930	CCT128930 is a potent and selective inhibitor of Akt2 (IC50 6 nM) with 28-fold selectivity over the closely related PKA kinase (IC50 168 nM), as well as 20-fold selectivity over p70S6K (IC50 120 nM).	False	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
415401:01:03_10.00	6.9	95	415401	412368:01:08_03.00	412368	69.39999999999999	39.0	3.0	94		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	True	COc1ccc2[nH]c3c(c2c1)CCOC31CC[C@@]2(Oc3c(Cl)c(OC)cc(OC)c3C2=O)[C@H](C)C1
415401:01:03_10.00	6.9	95	415401	246891:01:04_30.00	246891	69.19999999999999	21.4	30.0	95	Mitotane	Mitotane(2,4-DDD), an isomer of DDD and derivative of DDT, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.IC50 value: Target: Mitotane alters steroid peripheral metabolism, directly suppresses the adrenal cortex and alters cortisone metabolism leading to hypocortisolism. Side effects as reported by Schteinberg et al. include anorexia and nausea (88%), diarrhea (38%), vomiting (23%), decreased memory and ability to concentrate (50%), rash (23%), gynecomastia (50%), arthralgia (19%), and leukopenia (7%).	False	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1
415401:01:03_10.00	6.9	95	415401	247340:01:04_10.00	247340	68.30000000000001	10.7	10.0	96	Beclometasone dipropionate	Betamethasone dipropionate, the prodrug of Betamethasone, is an orally active and potent glucocorticoid with anti-inflammatory and immunosuppressive activity. Betamethasone appears to be an effective inhibitor of LPS-induced inflammation and MMP release.	True	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
415422:01:03_10.00	5.0	114	415422	246811:02:03_30.00	246811	83.39999999999999	43.5	30.0	89	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
415422:01:03_10.00	5.0	114	415422	246811:02:03_50.00	246811	83.1	44.6	50.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
415422:01:03_10.00	5.0	114	415422	413169:01:02_05.00	413169	82.19999999999999	9.2	5.0	100		negative control to BAY-885	False	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1
415422:01:03_10.00	5.0	114	415422	413094:01:04_30.00	413094	80.9	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
415422:01:03_10.00	5.0	114	415422	520875:02:03_03.00	520875	80.2	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415422:01:03_10.00	5.0	114	415422	413171:01:02_03.00	413171	80.2	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
415422:01:03_10.00	5.0	114	415422	413096:01:04_03.00	413096	80.0	17.8	3.0	94	BAN-ORL-24	BAN ORL 24 is a potent and selective NOP receptor antagonist. (IC50 values are 0.27, 2500, 6700 and &gt; 10000 nM for NOP, .k.-, .m.- and .d.-receptors respectively). BAN ORL 24 inhibits nociceptin-induced stimulation of [35S]-GTP.g.S binding and Ca2+ mobilization in CHO cells in vitro.	True	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1
415422:01:03_10.00	5.0	114	415422	245388:03:03_10.00	245388	79.80000000000001	32.3	10.0	96	Amiodarone (hydrochloride)	Non selective compound: intended target=KCNH2, number of targets=103. Alpha and beta adrenoceptor agonist, inhibits binding of 1,4-dihydropyridine to L-type Ca2+ channels, coronary vasodilator, Na+ channel blocker, adrenergic agonist, ca channel blocker, broad spectrum ion channel blocker, antiarrhythmic, selectively inhibi.; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
415422:01:03_10.00	5.0	114	415422	245325:02:04_10.00	245325	79.7	51.3	10.0	97	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
415422:01:03_10.00	5.0	114	415422	520875:01:04_10.00	520875	79.60000000000001	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415612:01:03_10.00	15.9	97	415612	280474:01:03_30.00	280474	85.5	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
415612:01:03_10.00	15.9	97	415612	317004:02:10_10.00	317004	82.39999999999999	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415612:01:03_10.00	15.9	97	415612	280904:01:03_30.00	280904	82.3	45.4	30.0	101	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
415612:01:03_10.00	15.9	97	415612	523782:02:04_03.00	523782	82.19999999999999	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
415612:01:03_10.00	15.9	97	415612	280732:01:03_30.00	280732	81.8	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
415612:01:03_10.00	15.9	97	415612	246883:07:04_06.00	246883	80.60000000000001	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415612:01:03_10.00	15.9	97	415612	280282:01:03_30.00	280282	80.5	48.4	30.0	92	Amperozide hydrochloride	atypical antipsychotic drug with high affinity for serotonin receptors and low affinity for D2 dopamine receptors.	False	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
415612:01:03_10.00	15.9	97	415612	281040:01:03_30.00	281040	80.5	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
415612:01:03_10.00	15.9	97	415612	280902:01:03_30.00	280902	80.5	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
415612:01:03_10.00	15.9	97	415612	280916:01:03_30.00	280916	80.4	7.6	30.0	99	SB 204741	5-HT2B serontonin receptor antagonist.	False	Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1
415649:01:03_10.00	26.9	103	415649	409878:01:04_50.00	409878	88.0	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
415649:01:03_10.00	26.9	103	415649	382120:03:04_06.00	382120	87.2	33.7	6.0	87	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/&lt;5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
415649:01:03_10.00	26.9	103	415649	392762:02:04_10.00	392762	86.4	77.9	10.0	84	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
415649:01:03_10.00	26.9	103	415649	523782:02:04_03.00	523782	85.9	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
415649:01:03_10.00	26.9	103	415649	280998:01:03_10.00	280998	85.8	7.1	10.0	102	Tulobuterol (hydrochloride)	Tulobuterol hydrochloride (C-78) is a long-acting .b.2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation.	False	CC(C)(C)NCC(O)c1ccccc1Cl
415649:01:03_10.00	26.9	103	415649	519823:01:02_30.00	519823	85.7	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
415649:01:03_10.00	26.9	103	415649	520746:01:02_50.00	520746	85.3	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
415649:01:03_10.00	26.9	103	415649	409839:01:06_30.00	409839	85.2	76.3	30.0	95	CPI-637	CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 uM, 0.051 uM and 11.0 uM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 uM for CBP.	True	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1
415649:01:03_10.00	26.9	103	415649	247159:01:04_30.00	247159	85.1	34.7	30.0	104	Biperiden hydrochloride	anticholinergic.	False	OC(CCN1CCCCC1)(c1ccccc1)C1C[C@@H]2C=C[C@H]1C2
415649:01:03_10.00	26.9	103	415649	280884:01:03_30.00	280884	85.1	42.3	30.0	93	Riluzole, Rilutek	it is a glutamate release inhibitor with neuroprotective, anticonvulsant, anxiolytic and anesthetic qualities. Riluzole inhibits the release of glutamic acid from cultured neurons, and from brain slices. These effects may be partly due to inactivation of voltage-dependent sodium channels on glutamatergic nerve terminals, as well as activation of a G-protein-dependent signal transduction process. Electrophysiologic experiments performed on isolated excitatory amino acid receptors expressed in the Xenopus oocyte have revealed that Riluzole inhibits currents evoked by N-methyl-D-aspartate (NMDA) (IC50 = 18 ÂµM) and kainic acid (IC50 = 167 ÂµM). Riluzole has been shown to stabilize inactivated sodium channels in frog sciatic nerve, in rat cerebellar granule cells, and on recombinant rat sodium channels expressed in Xenopus oocytes (Ki = 0.2 ÂµM). Riluzole also blocks some of the postsynaptic effects of glutamic acid by noncompetitive blockade of NMDA receptors. Tiluzole protects cultured neurons from anoxic damage, from the toxic effects of glutamic-acid-uptake inhibitors, and from the toxic factor in the CSF of patients with amyotrophic lateral sclerosis.	False	Nc1nc2ccc(OC(F)(F)F)cc2s1
415706:01:03_10.00	24.0	105	415706	247155:02:03_10.00	247155	87.3	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
415706:01:03_10.00	24.0	105	415706	382185:03:06_10.00	382185	85.0	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
415706:01:03_10.00	24.0	105	415706	247101:02:03_10.00	247101	82.89999999999999	21.4	10.0	92	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
415706:01:03_10.00	24.0	105	415706	247419:02:03_10.00	247419	82.8	6.4	10.0	106	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
415706:01:03_10.00	24.0	105	415706	247101:01:04_10.00	247101	82.19999999999999	27.5	10.0	99	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
415706:01:03_10.00	24.0	105	415706	246877:02:03_10.00	246877	81.3	11.1	10.0	103	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
415706:01:03_10.00	24.0	105	415706	247361:01:04_10.00	247361	81.2	18.5	10.0	110	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
415706:01:03_10.00	24.0	105	415706	280165:01:03_30.00	280165	80.9	37.5	30.0	100	A-3 (hydrochloride)	A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. It against PKA (Ki=4.3 uM), casein kinase II (Ki=5.1 uM) and myosin light chain kinase (MLCK) (Ki=7.4 uM). A-3 hydrochloride also inhibits PKC and casein kinase I with Ki values of 47 uM and 80 uM, respectively.	False	NCCNS(=O)(=O)c1cccc2c(Cl)cccc12
415706:01:03_10.00	24.0	105	415706	413094:01:04_50.00	413094	80.9	38.9	50.0	99	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
415706:01:03_10.00	24.0	105	415706	247044:01:04_10.00	247044	80.80000000000001	18.1	10.0	110	Mebeverine hydrochloride	phosphodiesterase inhibitor, muscle relaxant (smooth).	False	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1
415708:01:03_10.00	32.1	99	415708	246866:02:03_10.00	246866	88.6	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
415708:01:03_10.00	32.1	99	415708	280732:01:03_30.00	280732	88.5	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
415708:01:03_10.00	32.1	99	415708	246742:01:04_30.00	246742	88.1	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
415708:01:03_10.00	32.1	99	415708	317004:02:10_10.00	317004	88.0	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415708:01:03_10.00	32.1	99	415708	246846:01:05_30.00	246846	87.8	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
415708:01:03_10.00	32.1	99	415708	280474:01:03_30.00	280474	87.8	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
415708:01:03_10.00	32.1	99	415708	280902:01:03_30.00	280902	87.5	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
415708:01:03_10.00	32.1	99	415708	246859:01:04_30.00	246859	87.2	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
415708:01:03_10.00	32.1	99	415708	413121:01:03_30.00	413121	86.9	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
415708:01:03_10.00	32.1	99	415708	523782:02:04_03.00	523782	86.6	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
415726:01:03_10.00	18.0	96	415726	317004:02:10_10.00	317004	87.4	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415726:01:03_10.00	18.0	96	415726	280474:01:03_30.00	280474	87.2	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
415726:01:03_10.00	18.0	96	415726	246866:02:03_10.00	246866	85.3	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
415726:01:03_10.00	18.0	96	415726	246846:01:05_30.00	246846	84.3	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
415726:01:03_10.00	18.0	96	415726	528561:01:02_05.00	528561	84.0	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
415726:01:03_10.00	18.0	96	415726	246883:07:04_06.00	246883	83.8	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415726:01:03_10.00	18.0	96	415726	280732:01:03_30.00	280732	83.8	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
415726:01:03_10.00	18.0	96	415726	246742:01:04_30.00	246742	83.8	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
415726:01:03_10.00	18.0	96	415726	280970:01:03_30.00	280970	83.7	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
415726:01:03_10.00	18.0	96	415726	247082:01:04_30.00	247082	83.6	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
415736:01:03_10.00	34.0	84	415736	280355:01:03_30.00	280355	77.5	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
415736:01:03_10.00	34.0	84	415736	407872:01:06_10.00	407872	77.2	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
415736:01:03_10.00	34.0	84	415736	381945:02:03_01.00	381945	77.10000000000001	6.4	1.0	112	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
415736:01:03_10.00	34.0	84	415736	407872:01:03_10.00	407872	74.9	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
415736:01:03_10.00	34.0	84	415736	280970:01:03_30.00	280970	73.9	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
415736:01:03_10.00	34.0	84	415736	392097:01:02_02.00	392097	73.7	15.4	2.0	100		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.025 ÂµM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.028 ÂµM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1
415736:01:03_10.00	34.0	84	415736	412487:01:03_50.00	412487	73.5	6.7	50.0	102		BI-7656 serves as negative control to BI 207127 which is a highly potent and specific inhibitor of HCV polymerase activity (IC50 = 50 nM).	False	Cn1c(C2(NC(=O)c3ccc(NCC4CCCCC4)nc3)CCC2)nc2ccc(/C=C/C(=O)O)cc21
415736:01:03_10.00	34.0	84	415736	280101:01:03_30.00	280101	73.3	7.9	30.0	92	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
415736:01:03_10.00	34.0	84	415736	247067:02:03_10.00	247067	72.7	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
415736:01:03_10.00	34.0	84	415736	281040:01:03_10.00	281040	72.39999999999999	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
415740:01:03_10.00	8.3	103	415740	409894:01:03_50.00	409894	85.1	23.3	50.0	109	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
415740:01:03_10.00	8.3	103	415740	528561:01:02_05.00	528561	84.6	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
415740:01:03_10.00	8.3	103	415740	409858:01:02_10.00	409858	84.3	16.2	10.0	97	I-CBP112 (hydrochloride)	it is a selective inhibitor of CBP and EP300 that directly binds their bromodomains (Kds = 0.142 and 0.625 ÂµM, respectively). Developed by the Structural Genomics Consortium (SGC), this compound shows only weak cross-reactivity with the bromodomains of bromodomain and extra-terminal proteins and shows no interaction with other bromodomains.	True	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1
415740:01:03_10.00	8.3	103	415740	247200:01:04_30.00	247200	84.2	26.3	30.0	102	Lobeline alpha (-) hydrochoride	nicotinic receptor ligand.	True	CN1[C@@H](CC(=O)c2ccccc2)CCC[C@H]1C[C@H](O)c1ccccc1
415740:01:03_10.00	8.3	103	415740	528529:01:02_01.00	528529	83.89999999999999	9.2	1.0	102		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
415740:01:03_10.00	8.3	103	415740	246859:01:04_30.00	246859	83.8	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
415740:01:03_10.00	8.3	103	415740	281042:01:03_30.00	281042	83.8	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
415740:01:03_10.00	8.3	103	415740	410014:01:04_06.00	410014	83.8	29.0	6.0	100	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
415740:01:03_10.00	8.3	103	415740	317004:02:10_10.00	317004	83.7	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415740:01:03_10.00	8.3	103	415740	246846:01:05_30.00	246846	83.6	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
415744:01:03_10.00	10.5	103	415744	381945:02:03_01.00	381945	80.10000000000001	6.4	1.0	112	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
415744:01:03_10.00	10.5	103	415744	280355:01:03_30.00	280355	76.1	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
415744:01:03_10.00	10.5	103	415744	408117:01:02_10.00	408117	75.4	7.9	10.0	95	(Â±)-SLV 319	potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. Orally active.	False	C/N=C(/NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
415744:01:03_10.00	10.5	103	415744	407872:01:06_10.00	407872	74.5	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
415744:01:03_10.00	10.5	103	415744	101009:01:16_30.00	101009	73.1	13.3	30.0	96	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
415744:01:03_10.00	10.5	103	415744	281040:01:03_10.00	281040	72.3	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
415744:01:03_10.00	10.5	103	415744	413013:01:03_30.00	413013	69.89999999999999	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
415744:01:03_10.00	10.5	103	415744	280970:01:03_30.00	280970	69.8	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
415744:01:03_10.00	10.5	103	415744	413005:01:02_30.00	413005	69.3	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
415744:01:03_10.00	10.5	103	415744	247067:02:03_10.00	247067	68.0	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
415767:01:03_10.00	11.6	98	415767	247095:01:04_10.00	247095	83.7	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
415767:01:03_10.00	11.6	98	415767	413130:01:02_05.00	413130	83.3	23.5	5.0	99		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
415767:01:03_10.00	11.6	98	415767	520969:01:04_30.00	520969	82.69999999999999	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415767:01:03_10.00	11.6	98	415767	409878:01:04_50.00	409878	82.5	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
415767:01:03_10.00	11.6	98	415767	520875:01:03_10.00	520875	82.1	57.2	10.0	90	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415767:01:03_10.00	11.6	98	415767	413167:01:02_05.00	413167	81.69999999999999	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
415767:01:03_10.00	11.6	98	415767	520875:01:04_10.00	520875	81.39999999999999	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415767:01:03_10.00	11.6	98	415767	381945:02:02_10.00	381945	81.39999999999999	61.0	10.0	94	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
415767:01:03_10.00	11.6	98	415767	413130:01:02_03.00	413130	81.3	7.4	3.0	88		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
415767:01:03_10.00	11.6	98	415767	246866:02:03_10.00	246866	81.10000000000001	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
415780:01:03_10.00	8.1	99	415780	412263:01:03_10.00	412263	79.5	18.8	10.0	101	BI-3663	BI-3663 is a degrader that tethers a highly selective PTK2 Kinase inhibitor to a CRL4CRBN E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein. BI-3663 potently and rapidly induces reversible, long-lasting, and preferential removal of PTK2 in cells.	False	COc1cc(C(=O)NCCOCCOCCOCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
415780:01:03_10.00	8.1	99	415780	409908:01:04_01.00	409908	77.8	49.2	1.0	99	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
415780:01:03_10.00	8.1	99	415780	409908:01:03_01.00	409908	76.6	48.9	1.0	100	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
415780:01:03_10.00	8.1	99	415780	413052:01:03_30.00	413052	75.4	42.0	30.0	87	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
415780:01:03_10.00	8.1	99	415780	392791:01:10_02.00	392791	74.7	55.3	2.0	83	Pacritinib	Pacritinib is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM).	False	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1
415780:01:03_10.00	8.1	99	415780	280852:01:06_00.20	280852	73.7	36.3	0.2	85	Phorbol 12-myristate 13-acetate, PMA	activates protein kinase C in vivo and in vitro, strong NO promoter, promotes expression of iNOS in cultured hepatocytes, T lymphocyte activator.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O
415780:01:03_10.00	8.1	99	415780	519809:01:04_50.00	519809	73.7	21.6	50.0	97		The in vivo molecule BI-1124 displays high potency in the inhibition of Cathepsin S (IC50 7 nM) and in the ovalbumin challenge T-cell assay (IC50 0.5 nM). Furthermore, BI-1124 has a superior PK profile and showed dose-dependent inhibition of the ovalbumin induced IL-2 secretion in a T cell receptor transgenic DO11 mouse model with an IC50 of 0.3 mg/kg. negative control = BI-1920	True	CCCN1CCC(C#N)(NC(=O)[C@H](CC(C)(C)C)NC(=O)N2CCOCC2)CC1
415780:01:03_10.00	8.1	99	415780	392215:01:02_02.00	392215	73.4	9.0	2.0	88		inhibitor of MAP kinase p38 alpha (IC50 = 0.13 ÂµM); Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors.    Organic Letters  (2005),  7(21),  4753-4756.	False	CN1CCN(CCCNc2nccc(-c3c(-c4ccc(F)cc4)nn4cc(C(F)(F)F)ccc34)n2)CC1
415780:01:03_10.00	8.1	99	415780	413085:01:06_10.00	413085	73.0	44.2	10.0	103	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
415780:01:03_10.00	8.1	99	415780	410136:01:05_06.00	410136	73.0	32.0	6.0	98	IPI-3063	IPI-3063 is a potent and selective PI3K p110.d. inhibitor with an IC50 of 2.5Â±1.2 nM.	True	CC(C)n1c([C@H](C)Nc2ncnc(N)c2C#N)cc2cccc(-c3ccc(=O)n(C)c3)c2c1=O
415807:01:03_10.00	19.9	100	415807	392736:02:03_02.00	392736	82.39999999999999	16.1	2.0	93	TAK-632	TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively.	False	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12
415807:01:03_10.00	19.9	100	415807	413151:01:02_05.00	413151	70.3	10.4	5.0	105		negative control to IPP/CNRS-A017	False	Cc1c(Oc2ccc(F)cc2)c(OC(C)C)nn1-c1ccc(C2CC2)cn1
415807:01:03_10.00	19.9	100	415807	410918:01:03_02.00	410918	67.80000000000001	21.2	2.0	99	Inauhzin	Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.	False	CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21
415807:01:03_10.00	19.9	100	415807	246536:01:04_10.00	246536	67.5	5.2	10.0	100	Diflorasone Diacetate	Glucocorticoid receptor (Ki = 2.907 nM), Progesterone receptor (Ki = 15 nM)	False	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
415816:01:03_10.00	12.3	92	415816	408552:01:09_03.00	408552	83.6	60.3	3.0	86	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 ÂµM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 ÂµM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
415816:01:03_10.00	12.3	92	415816	391925:03:04_00.20	391925	82.89999999999999	73.4	0.2	63	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 ÂµM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 ÂµM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
415816:01:03_10.00	12.3	92	415816	409343:02:02_03.00	409343	82.39999999999999	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
415816:01:03_10.00	12.3	92	415816	408410:02:04_03.00	408410	82.1	82.2	3.0	57	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
415816:01:03_10.00	12.3	92	415816	408410:02:03_03.00	408410	82.0	81.9	3.0	60	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
415816:01:03_10.00	12.3	92	415816	391925:03:05_00.20	391925	81.89999999999999	73.7	0.2	62	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 ÂµM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 ÂµM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
415816:01:03_10.00	12.3	92	415816	408410:02:04_01.00	408410	81.69999999999999	82.6	1.0	55	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
415816:01:03_10.00	12.3	92	415816	408552:01:08_03.00	408552	81.10000000000001	67.5	3.0	90	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 ÂµM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 ÂµM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
415816:01:03_10.00	12.3	92	415816	409914:01:03_03.00	409914	80.4	75.1	3.0	90	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and &gt;3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
415816:01:03_10.00	12.3	92	415816	408410:02:03_01.00	408410	80.4	79.1	1.0	55	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
415844:01:03_10.00	11.9	102	415844	280355:01:03_30.00	280355	86.1	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
415844:01:03_10.00	11.9	102	415844	280970:01:03_30.00	280970	85.7	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
415844:01:03_10.00	11.9	102	415844	528526:01:02_05.00	528526	84.1	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
415844:01:03_10.00	11.9	102	415844	281040:01:03_10.00	281040	83.6	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
415844:01:03_10.00	11.9	102	415844	247095:02:03_30.00	247095	82.3	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
415844:01:03_10.00	11.9	102	415844	280331:01:03_10.00	280331	82.3	9.8	10.0	97	(+)-Bromocriptine methanesulfonate	D2 dopamine receptor agonist, inhibits prolaction secretion.	False	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
415844:01:03_10.00	11.9	102	415844	407974:01:04_10.00	407974	82.1	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
415844:01:03_10.00	11.9	102	415844	280076:01:03_30.00	280076	81.6	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
415844:01:03_10.00	11.9	102	415844	519823:01:02_10.00	519823	81.2	9.8	10.0	94		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
415844:01:03_10.00	11.9	102	415844	281047:01:03_30.00	281047	81.0	21.9	30.0	93	YS-035 hydrochloride	L-type Ca2+ channel blocker, verapamil derivative.	False	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC
415863:01:03_10.00	15.4	98	415863	246883:01:04_10.00	246883	82.0	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415863:01:03_10.00	15.4	98	415863	413171:01:02_03.00	413171	81.69999999999999	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
415863:01:03_10.00	15.4	98	415863	413121:01:03_50.00	413121	81.69999999999999	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
415863:01:03_10.00	15.4	98	415863	520969:01:04_30.00	520969	81.5	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415863:01:03_10.00	15.4	98	415863	520969:01:04_50.00	520969	80.60000000000001	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
415863:01:03_10.00	15.4	98	415863	245325:02:04_10.00	245325	80.4	51.3	10.0	97	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
415863:01:03_10.00	15.4	98	415863	247095:01:04_10.00	247095	79.9	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
415863:01:03_10.00	15.4	98	415863	413221:01:03_10.00	413221	79.9	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
415863:01:03_10.00	15.4	98	415863	246883:01:04_30.00	246883	79.80000000000001	22.8	30.0	96	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
415863:01:03_10.00	15.4	98	415863	520875:02:02_01.00	520875	79.5	27.5	1.0	105	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415874:01:03_10.00	43.9	83	415874	410029:01:04_06.00	410029	82.6	48.2	6.0	81	Motolimod	Motolimod (VTX-2337;VTX-378) is a selective Toll-like receptor 8 (TLR8) agonist, with an EC50 of approximately 100 nM.	False	CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1
415874:01:03_10.00	43.9	83	415874	409343:02:02_03.00	409343	80.7	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
415874:01:03_10.00	43.9	83	415874	394207:02:03_02.00	394207	80.7	22.6	2.0	90	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with &gt;100-fold higher potency than NUAK2 (IC50 of &gt;10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
415874:01:03_10.00	43.9	83	415874	280655:01:03_30.00	280655	77.8	70.5	30.0	75	JWH-015	selective CB2 cannabinoid receptor agonist.	False	CCCn1c(C)c(C(=O)c2ccc3ccccc3c2)c2ccccc21
415874:01:03_10.00	43.9	83	415874	287906:02:09_10.00	287906	77.10000000000001	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
415874:01:03_10.00	43.9	83	415874	246330:01:04_10.00	246330	77.10000000000001	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
415874:01:03_10.00	43.9	83	415874	350507:02:04_10.00	350507	77.0	40.8	10.0	69	Autogramin-2	Autogramin-2 potently inhibits autophagy induced by either starvation (IC50=0.27 uM) or mTORC1 inhibition (Rapamycin; IC50=0.14 uM).	False	CC(C)Oc1ccc(C(=O)Nc2nc3c(s2)CN(C(=O)OC(C)(C)C)CC3)cc1
415874:01:03_10.00	43.9	83	415874	410129:01:03_02.00	410129	76.8	53.4	2.0	85	Anlotinib (AL3818) dihydrochloride	Anlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials.	False	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1
415874:01:03_10.00	43.9	83	415874	391915:01:02_02.00	391915	76.8	29.9	2.0	74		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0029 ÂµM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.018 ÂµM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)OC)nc4c3)cc2)c1
415874:01:03_10.00	43.9	83	415874	247020:01:04_10.00	247020	76.4	24.4	10.0	97	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
415919:01:03_10.00	7.6	102	415919	413171:01:02_03.00	413171	83.1	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
415919:01:03_10.00	7.6	102	415919	413094:01:04_30.00	413094	82.8	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
415919:01:03_10.00	7.6	102	415919	528524:01:02_03.00	528524	81.5	26.9	3.0	88		negative control to MRIA9	True	CN(C)c1ncc2cc(-c3ccc(-c4ncccc4F)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1
415919:01:03_10.00	7.6	102	415919	246332:01:09_03.00	246332	81.0	9.5	3.0	101	Dilazep dihydrochloride	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
415919:01:03_10.00	7.6	102	415919	280189:01:03_10.00	280189	80.80000000000001	13.1	10.0	101	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
415919:01:03_10.00	7.6	102	415919	413107:01:04_30.00	413107	80.30000000000001	42.1	30.0	106	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
415919:01:03_10.00	7.6	102	415919	413094:01:04_50.00	413094	80.10000000000001	38.9	50.0	99	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
415919:01:03_10.00	7.6	102	415919	246673:02:09_02.00	246673	79.5	32.1	2.0	103	Lapatinib (ditosylate)	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
415919:01:03_10.00	7.6	102	415919	413107:01:03_10.00	413107	79.10000000000001	17.4	10.0	95	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
415919:01:03_10.00	7.6	102	415919	246835:01:04_30.00	246835	79.0	16.2	30.0	99	Buspirone (hydrochloride)	5-HT1A Serotonin receptor agonist, non-benzodiazepine anxiolytic, serotonin receptor agonist, 5ht1a receptor agonist.	False	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
415923:01:03_10.00	11.2	100	415923	409837:01:03_10.00	409837	83.1	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
415923:01:03_10.00	11.2	100	415923	246866:02:03_10.00	246866	81.8	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
415923:01:03_10.00	11.2	100	415923	413121:01:03_30.00	413121	81.69999999999999	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
415923:01:03_10.00	11.2	100	415923	413167:01:02_03.00	413167	81.69999999999999	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
415923:01:03_10.00	11.2	100	415923	247067:02:03_10.00	247067	81.39999999999999	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
415923:01:03_10.00	11.2	100	415923	247095:01:04_10.00	247095	81.3	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
415923:01:03_10.00	11.2	100	415923	409878:01:04_50.00	409878	81.2	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
415923:01:03_10.00	11.2	100	415923	317004:02:10_10.00	317004	79.7	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
415923:01:03_10.00	11.2	100	415923	410662:01:04_10.00	410662	79.2	9.8	10.0	102	Ticagrelor	Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.	True	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
415923:01:03_10.00	11.2	100	415923	280904:01:03_30.00	280904	79.0	45.4	30.0	101	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
415979:01:03_10.00	13.1	92	415979	413161:01:02_03.00	413161	75.6	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
415979:01:03_10.00	13.1	92	415979	391764:01:02_02.00	391764	71.7	7.3	2.0	100		inhibitor of MAP kinase p38 alpha (IC50 = 0.18 ÂµM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1
415979:01:03_10.00	13.1	92	415979	246330:01:04_10.00	246330	71.6	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
415979:01:03_10.00	13.1	92	415979	409847:01:04_30.00	409847	71.6	25.6	30.0	86	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
415979:01:03_10.00	13.1	92	415979	528529:01:02_05.00	528529	70.39999999999999	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
415979:01:03_10.00	13.1	92	415979	246521:01:04_30.00	246521	70.39999999999999	13.3	30.0	92	Atracurium (besylate)	Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. Target: nAChRAtracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent . A 14C radiolabeled metabolism study in cats confirmed the lack of hepatic or renal involvement in the metabolism of atracurium: radioactivity eliminated in bile and urine was predominantly from metabolites rather than the unchanged parent drug .	False	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC
415979:01:03_10.00	13.1	92	415979	246801:02:03_10.00	246801	69.89999999999999	33.9	10.0	88	Ziprasidone, Hydrochloride	dopamine D2/serotonin 5-HT2 antagonist, atypical antipsychotic, FDA approved for the treatment of schizophrenia.	False	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
415979:01:03_10.00	13.1	92	415979	408407:01:04_10.00	408407	69.5	7.1	10.0	86	BI-1347	BI-1347 is a potent CDK8 inhibitor extracted from patent WO2017202719A1, product I-003, has an IC50 of 1.1 nM.	False	CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1
415979:01:03_10.00	13.1	92	415979	281048:01:03_30.00	281048	69.19999999999999	29.2	30.0	79	Lificiguat	Lificiguat binds to the .b. subunit of soluble guanylyl cyclase(sGC) with Kd of 0.6-1.1 uM in the presence of CO.	False	OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1
415979:01:03_10.00	13.1	92	415979	409853:01:02_10.00	409853	69.0	58.2	10.0	87	Tubacin	Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1.	True	O=C(CCCCCCC(=O)Nc1ccc([C@H]2O[C@@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)C[C@@H](c3ccc(CO)cc3)O2)cc1)NO
415982:01:03_10.00	11.7	96	415982	247155:02:03_10.00	247155	80.60000000000001	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
415982:01:03_10.00	11.7	96	415982	246456:01:04_10.00	246456	80.4	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
415982:01:03_10.00	11.7	96	415982	246897:01:04_10.00	246897	80.30000000000001	20.9	10.0	100	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
415982:01:03_10.00	11.7	96	415982	247293:02:03_10.00	247293	80.2	29.7	10.0	104	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
415982:01:03_10.00	11.7	96	415982	413092:01:04_30.00	413092	79.5	57.5	30.0	102	Zamifenacin	Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome.	True	c1ccc(C(O[C@@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1
415982:01:03_10.00	11.7	96	415982	280360:01:03_10.00	280360	79.3	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
415982:01:03_10.00	11.7	96	415982	520875:02:03_01.00	520875	79.2	16.8	1.0	99	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
415982:01:03_10.00	11.7	96	415982	247361:01:04_10.00	247361	79.2	18.5	10.0	110	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
415982:01:03_10.00	11.7	96	415982	247331:01:04_10.00	247331	79.0	27.6	10.0	100	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
415982:01:03_10.00	11.7	96	415982	280639:03:03_10.00	280639	78.4	17.6	10.0	99	ML-7 (hydrochloride)	ML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM). ML-7 hydrochloride also inhibits YAP/TAZ.	False	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1
416089:01:03_10.00	11.6	103	416089	413167:01:02_05.00	413167	85.6	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
416089:01:03_10.00	11.6	103	416089	247342:01:05_10.00	247342	85.2	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
416089:01:03_10.00	11.6	103	416089	246344:01:04_10.00	246344	84.8	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
416089:01:03_10.00	11.6	103	416089	410031:02:03_50.00	410031	84.7	63.7	50.0	95	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
416089:01:03_10.00	11.6	103	416089	413167:01:02_03.00	413167	84.39999999999999	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
416089:01:03_10.00	11.6	103	416089	247331:01:04_10.00	247331	83.89999999999999	27.6	10.0	100	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
416089:01:03_10.00	11.6	103	416089	247197:01:04_10.00	247197	83.8	30.4	10.0	102	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
416089:01:03_10.00	11.6	103	416089	392592:03:03_10.00	392592	83.7	52.3	10.0	98	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
416089:01:03_10.00	11.6	103	416089	409878:01:04_50.00	409878	83.1	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
416089:01:03_10.00	11.6	103	416089	282300:02:03_50.00	282300	83.0	17.3	50.0	106	Tacrolimus, FK506	immune suppressant, antifungal.	False	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC
416101:01:03_10.00	6.4	102	416101	392756:02:04_06.00	392756	73.3	29.4	6.0	95	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
416101:01:03_10.00	6.4	102	416101	246753:01:04_30.00	246753	72.5	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
416101:01:03_10.00	6.4	102	416101	247340:01:04_30.00	247340	71.5	17.4	30.0	101	Beclometasone dipropionate	Betamethasone dipropionate, the prodrug of Betamethasone, is an orally active and potent glucocorticoid with anti-inflammatory and immunosuppressive activity. Betamethasone appears to be an effective inhibitor of LPS-induced inflammation and MMP release.	True	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
416101:01:03_10.00	6.4	102	416101	413161:01:02_03.00	413161	71.2	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
416101:01:03_10.00	6.4	102	416101	407872:02:04_10.00	407872	71.0	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416101:01:03_10.00	6.4	102	416101	407872:02:04_06.00	407872	70.6	33.0	6.0	92	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416101:01:03_10.00	6.4	102	416101	413053:01:04_30.00	413053	70.39999999999999	15.5	30.0	93	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
416101:01:03_10.00	6.4	102	416101	407872:01:06_10.00	407872	69.8	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416101:01:03_10.00	6.4	102	416101	392290:02:04_10.00	392290	69.5	38.5	10.0	98	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
416101:01:03_10.00	6.4	102	416101	246825:01:04_30.00	246825	69.3	19.7	30.0	97	Canrenone	Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent.	True	C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1
416109:01:03_10.00	36.1	96	416109	246859:01:04_30.00	246859	89.5	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416109:01:03_10.00	36.1	96	416109	520746:01:02_50.00	520746	89.3	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
416109:01:03_10.00	36.1	96	416109	519823:01:02_30.00	519823	88.8	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
416109:01:03_10.00	36.1	96	416109	247178:01:04_30.00	247178	88.6	27.5	30.0	93	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
416109:01:03_10.00	36.1	96	416109	246866:02:03_10.00	246866	88.5	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416109:01:03_10.00	36.1	96	416109	520969:01:04_30.00	520969	88.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416109:01:03_10.00	36.1	96	416109	246846:01:05_30.00	246846	88.0	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416109:01:03_10.00	36.1	96	416109	528561:01:02_05.00	528561	87.9	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
416109:01:03_10.00	36.1	96	416109	246846:02:03_30.00	246846	87.9	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416109:01:03_10.00	36.1	96	416109	280902:01:03_30.00	280902	87.5	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
416148:01:03_10.00	5.7	98	416148	409343:02:02_03.00	409343	84.3	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
416148:01:03_10.00	5.7	98	416148	409814:01:04_03.00	409814	83.5	13.6	3.0	89	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibitsÂ in vitroÂ methylation of H3K4 with IC50Â = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50Â = 0.8 ÂµM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
416148:01:03_10.00	5.7	98	416148	247020:01:04_10.00	247020	83.1	24.4	10.0	97	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
416148:01:03_10.00	5.7	98	416148	413096:01:04_03.00	413096	83.1	17.8	3.0	94	BAN-ORL-24	BAN ORL 24 is a potent and selective NOP receptor antagonist. (IC50 values are 0.27, 2500, 6700 and &gt; 10000 nM for NOP, .k.-, .m.- and .d.-receptors respectively). BAN ORL 24 inhibits nociceptin-induced stimulation of [35S]-GTP.g.S binding and Ca2+ mobilization in CHO cells in vitro.	True	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1
416148:01:03_10.00	5.7	98	416148	280858:01:03_10.00	280858	82.19999999999999	23.3	10.0	95	Pergolide methanesulfonate, propylergoline methanesulfonate	dopamine receptor agonist, antiparkinsonian.	False	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
416148:01:03_10.00	5.7	98	416148	246861:01:12_03.00	246861	81.89999999999999	19.2	3.0	100	Astemizole	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.	False	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
416148:01:03_10.00	5.7	98	416148	409916:01:04_03.00	409916	81.3	29.0	3.0	96	TP-064	it is a potent inhibitor of protein arginine methyltransferase 4 (PRMT4, IC50 50 = 43 nM) in vitro. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1
416148:01:03_10.00	5.7	98	416148	246897:02:03_10.00	246897	81.3	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
416148:01:03_10.00	5.7	98	416148	287906:02:09_10.00	287906	81.10000000000001	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
416148:01:03_10.00	5.7	98	416148	413094:01:04_30.00	413094	81.10000000000001	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
416156:01:03_10.00	37.0	104	416156	247095:02:03_30.00	247095	86.4	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416156:01:03_10.00	37.0	104	416156	520969:01:04_30.00	520969	85.9	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416156:01:03_10.00	37.0	104	416156	246866:02:03_10.00	246866	85.6	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416156:01:03_10.00	37.0	104	416156	247209:01:04_30.00	247209	85.5	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
416156:01:03_10.00	37.0	104	416156	246363:01:04_30.00	246363	84.89999999999999	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416156:01:03_10.00	37.0	104	416156	101009:01:19_30.00	101009	84.89999999999999	30.9	30.0	89	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
416156:01:03_10.00	37.0	104	416156	280657:01:03_30.00	280657	84.6	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416156:01:03_10.00	37.0	104	416156	280076:01:03_30.00	280076	84.2	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
416156:01:03_10.00	37.0	104	416156	410031:02:03_30.00	410031	84.1	39.9	30.0	96	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
416156:01:03_10.00	37.0	104	416156	280571:01:03_30.00	280571	84.0	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
416157:01:03_10.00	10.7	97	416157	246883:01:04_10.00	246883	79.7	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416157:01:03_10.00	10.7	97	416157	413121:01:03_50.00	413121	77.5	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416157:01:03_10.00	10.7	97	416157	280302:01:03_10.00	280302	76.4	23.1	10.0	102	5-(N,N-hexamethylene)amiloride	Na+/ H+ antiport inhibitor.	False	NC(N)=NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N
416157:01:03_10.00	10.7	97	416157	413013:01:03_30.00	413013	76.3	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
416157:01:03_10.00	10.7	97	416157	382185:03:06_10.00	382185	75.9	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
416157:01:03_10.00	10.7	97	416157	410285:01:03_01.00	410285	75.3	9.0	1.0	103	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
416157:01:03_10.00	10.7	97	416157	246711:01:04_30.00	246711	74.4	22.8	30.0	98	Troglitazone	Troglitazone is a PPAR.g. agonist, with EC50s of 550 nM and 780 nM for human and murinePPAR.g. receptor, respectively.	False	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2
416157:01:03_10.00	10.7	97	416157	280189:01:03_10.00	280189	74.2	13.1	10.0	101	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
416157:01:03_10.00	10.7	97	416157	246617:01:04_10.00	246617	74.0	24.4	10.0	92	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
416157:01:03_10.00	10.7	97	416157	246820:12:03_50.00	246820	73.9	39.6	50.0	91	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
416216:01:03_10.00	7.4	95	416216	247067:02:03_10.00	247067	78.8	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
416216:01:03_10.00	7.4	95	416216	317004:02:10_10.00	317004	77.10000000000001	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
416216:01:03_10.00	7.4	95	416216	413219:01:04_50.00	413219	76.2	8.5	50.0	102	LDN-27219	LDN-27219 is a potent inhibitor of hTGase(Tissue transglutaminase) with an IC50 of 0.6 uM.IC50 value: 0.6 uM Target: hTGase inhibitorLDN-27219 is a potent inhibitor of the enzyme(hTGase), producing 100% inhibition at the screening concentration of 10 uM. To examine the enzyme selectivity of LDN-27219, it was tested as an inhibitor of coagulation Factor XIIIa and caspase 3. At concentrations as high as 50 Ã­M, the compound had no effect on the activities of either of these enzymes. LDN-27219 was found to be nontoxic at concentrations as high as 100 Ã­M in an assay that measures the viability of HT1080 cells, a fibrosarcoma tumor cell line.	False	NNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1
416216:01:03_10.00	7.4	95	416216	409837:01:03_10.00	409837	74.4	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
416216:01:03_10.00	7.4	95	416216	410662:01:04_10.00	410662	73.9	9.8	10.0	102	Ticagrelor	Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.	True	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
416216:01:03_10.00	7.4	95	416216	247342:02:04_10.00	247342	73.9	18.5	10.0	99	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
416216:01:03_10.00	7.4	95	416216	280639:03:03_10.00	280639	72.89999999999999	17.6	10.0	99	ML-7 (hydrochloride)	ML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM). ML-7 hydrochloride also inhibits YAP/TAZ.	False	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1
416216:01:03_10.00	7.4	95	416216	246791:02:03_30.00	246791	72.5	20.0	30.0	102	Chlorpheniramine (maleate)	Chlorpheniramine maleate is an histamine H1 receptor antagonist with IC50 of 12 nM.Target: Histamine H1 ReceptorChlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 uM . Chlorpheniramine displaces of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells with IC50 of 66 nM. Chlorpheniramine displays antimalarial activity against CQS strain (D6) and MDR strain (Dd2) of P. falciparum with IC50 of 61.2 uM and 3.9 uM, respectively. Chlorpheniramine displays cytotoxicity against the proliferation of concanavalin A-induced murine splenic lymphocytes with IC50 of 33.4 uM .Oral administration of Chlorpheniramine inhibits histamine-induced mortality in guinea pigs with an ED50 of 0.17 mg/kg . Oral administration of Chlorpheniramine (10 mg/kg) significantly inhibits short-duration scratching in BALB/c mice stimulated by ovalbumin active cutaneous anaphylaxis and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice, in contrast to that of dexamethasone or tacrolimus .	False	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
416216:01:03_10.00	7.4	95	416216	409831:01:03_01.00	409831	71.1	32.0	1.0	101	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
416216:01:03_10.00	7.4	95	416216	407872:01:03_10.00	407872	71.0	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416221:01:03_10.00	27.1	101	416221	247095:02:03_30.00	247095	88.6	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416221:01:03_10.00	27.1	101	416221	280127:01:04_30.00	280127	87.7	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
416221:01:03_10.00	27.1	101	416221	280474:01:03_30.00	280474	87.3	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416221:01:03_10.00	27.1	101	416221	413121:01:03_30.00	413121	87.3	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416221:01:03_10.00	27.1	101	416221	410031:02:03_30.00	410031	86.9	39.9	30.0	96	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
416221:01:03_10.00	27.1	101	416221	246363:01:04_30.00	246363	86.8	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416221:01:03_10.00	27.1	101	416221	520969:01:04_30.00	520969	86.7	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416221:01:03_10.00	27.1	101	416221	247419:02:03_30.00	247419	86.5	72.2	30.0	96	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
416221:01:03_10.00	27.1	101	416221	280670:01:03_30.00	280670	86.4	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
416221:01:03_10.00	27.1	101	416221	280657:01:03_30.00	280657	86.4	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416223:01:03_10.00	8.3	100	416223	280670:01:03_30.00	280670	83.0	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
416223:01:03_10.00	8.3	100	416223	280076:01:03_30.00	280076	80.0	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
416223:01:03_10.00	8.3	100	416223	247095:02:03_30.00	247095	79.80000000000001	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416223:01:03_10.00	8.3	100	416223	280107:01:03_30.00	280107	79.80000000000001	30.4	30.0	83	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
416223:01:03_10.00	8.3	100	416223	280657:01:03_30.00	280657	79.7	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416223:01:03_10.00	8.3	100	416223	410626:01:03_02.00	410626	79.3	11.2	2.0	98	Nebivolol HCl	Nebivolol HCl selectively inhibits Ã1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
416223:01:03_10.00	8.3	100	416223	280424:01:03_30.00	280424	79.3	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
416223:01:03_10.00	8.3	100	416223	410755:01:03_02.00	410755	78.7	21.2	2.0	99	L755507	L-755,507 is characterized as a potent and selective Ã3 adrenergic receptor partial agonist with EC50 of 0.43 nM. It is also recently identified to enhance CRISPR-mediated homology-directed repair (HDR) efficiency in human induced pluripotent stem cells (iPSCs) and other cell types.	True	CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1
416223:01:03_10.00	8.3	100	416223	280355:01:03_30.00	280355	78.10000000000001	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
416223:01:03_10.00	8.3	100	416223	245387:02:04_30.00	245387	78.10000000000001	15.9	30.0	104	Tolnaftate	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	False	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1
416225:01:03_10.00	17.1	94	416225	520969:01:04_30.00	520969	86.7	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416225:01:03_10.00	17.1	94	416225	413121:01:03_30.00	413121	86.0	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416225:01:03_10.00	17.1	94	416225	246363:01:04_30.00	246363	85.39999999999999	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416225:01:03_10.00	17.1	94	416225	247095:02:03_30.00	247095	85.3	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416225:01:03_10.00	17.1	94	416225	280657:01:03_30.00	280657	85.1	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416225:01:03_10.00	17.1	94	416225	280400:01:03_30.00	280400	85.1	29.2	30.0	92	Cyproterone acetate	androgen antagonist, synthetic steroid.	False	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
416225:01:03_10.00	17.1	94	416225	246846:01:05_30.00	246846	84.8	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416225:01:03_10.00	17.1	94	416225	246866:02:03_10.00	246866	84.39999999999999	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416225:01:03_10.00	17.1	94	416225	247209:01:04_30.00	247209	84.1	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
416225:01:03_10.00	17.1	94	416225	246859:01:04_30.00	246859	83.89999999999999	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416227:01:03_10.00	13.3	97	416227	409853:02:03_02.00	409853	78.4	14.7	2.0	97	Tubacin	Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1.	True	O=C(CCCCCCC(=O)Nc1ccc([C@H]2O[C@@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)C[C@@H](c3ccc(CO)cc3)O2)cc1)NO
416227:01:03_10.00	13.3	97	416227	283242:02:05_10.00	283242	77.7	24.0	10.0	100	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
416227:01:03_10.00	13.3	97	416227	280562:01:03_30.00	280562	77.3	24.4	30.0	95	Flupirtine (Maleate)	Flupirtine Maleate is an indirect N-methyl-D-aspartate receptor (NMDAR) antagonist. It is aÂ brainÂ penetrant, and orally bioavailable, non-opioid and centrally acting analgesic agent.	False	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N
416227:01:03_10.00	13.3	97	416227	413161:01:02_03.00	413161	76.5	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
416227:01:03_10.00	13.3	97	416227	407872:02:03_02.00	407872	76.2	13.5	2.0	100	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416227:01:03_10.00	13.3	97	416227	410626:01:03_02.00	410626	75.8	11.2	2.0	98	Nebivolol HCl	Nebivolol HCl selectively inhibits Ã1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
416227:01:03_10.00	13.3	97	416227	528529:01:02_01.00	528529	75.0	9.2	1.0	102		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
416227:01:03_10.00	13.3	97	416227	246753:01:04_30.00	246753	74.3	9.8	30.0	91	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
416227:01:03_10.00	13.3	97	416227	392523:01:09_02.00	392523	74.3	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
416227:01:03_10.00	13.3	97	416227	528554:01:02_05.00	528554	74.0	9.3	5.0	93		8RK59 is a covalent inhibitor of the deubiquitinating enzyme UCHL1, fluorescent probe.	True	CC1=CC(C)=[N+]2C1=C(CCCc1cn(CC(=O)N3CCc4nc(NC(=O)[C@H]5CCN(C#N)C5)sc4C3)nn1)c1c(C)cc(C)n1[B-]2(F)F
416257:01:03_10.00	19.0	99	416257	280474:01:03_30.00	280474	86.6	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416257:01:03_10.00	19.0	99	416257	246859:01:04_30.00	246859	86.4	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416257:01:03_10.00	19.0	99	416257	247095:02:03_30.00	247095	86.1	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416257:01:03_10.00	19.0	99	416257	528526:01:02_05.00	528526	86.0	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
416257:01:03_10.00	19.0	99	416257	246846:01:05_30.00	246846	85.2	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416257:01:03_10.00	19.0	99	416257	520746:01:02_50.00	520746	85.2	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
416257:01:03_10.00	19.0	99	416257	280962:01:03_30.00	280962	85.2	32.6	30.0	100	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
416257:01:03_10.00	19.0	99	416257	407974:01:04_10.00	407974	84.89999999999999	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
416257:01:03_10.00	19.0	99	416257	528561:01:02_05.00	528561	84.6	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
416257:01:03_10.00	19.0	99	416257	280076:01:03_30.00	280076	84.2	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
416279:01:03_10.00	6.4	98	416279	413126:02:02_00.30	413126	82.5	37.5	0.3	98		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
416279:01:03_10.00	6.4	98	416279	281030:01:03_10.00	281030	81.6	32.8	10.0	91	U-74389G maleate	free radical lipid peroxidation inhibitor.	False	C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12
416279:01:03_10.00	6.4	98	416279	247178:01:04_10.00	247178	81.0	18.1	10.0	94	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
416279:01:03_10.00	6.4	98	416279	246509:01:04_10.00	246509	80.80000000000001	28.2	10.0	96	Methotrimeprazine maleat salt	Glutaminase kidney isoform, mitochondrial; Isocitrate dehydrogenase [NADP] cytoplasmic	False	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2
416279:01:03_10.00	6.4	98	416279	419170:01:05_10.00	419170	80.60000000000001	55.8	10.0	97	Hydroxychloroquine (free base)	Hydroxychloroquine is used to treat or prevent malaria; lysosomotropic.	False	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
416279:01:03_10.00	6.4	98	416279	413126:02:02_00.50	413126	80.60000000000001	53.9	0.5	106		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
416279:01:03_10.00	6.4	98	416279	246817:01:04_10.00	246817	80.5	45.4	10.0	106	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
416279:01:03_10.00	6.4	98	416279	247361:01:04_10.00	247361	80.4	18.5	10.0	110	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
416279:01:03_10.00	6.4	98	416279	419170:01:02_10.00	419170	80.2	64.1	10.0	92	Hydroxychloroquine (free base)	Hydroxychloroquine is used to treat or prevent malaria; lysosomotropic.	False	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
416279:01:03_10.00	6.4	98	416279	413110:01:04_30.00	413110	80.10000000000001	17.6	30.0	91	Ibutilide (fumarate)	Ibutilide fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm.Target: Calcium ChannelIbutilide fumarate is the first &#x27;pure&#x27; class III antiarrhythmic drug to become available. Its predominant action is prolongation of the myocardial action potential duration. Intravenous ibutilide 0.01 to 0.025 mg/kg or 1 to 2 mg successfully converted atrial flutter or fibrillation to sinus rhythm in 33 to 49% of patients in 2 placebo-controlled trials involving 439 patients with sustained arrhythmia . Ibutilide fumarate appears to be an effective alternative method for rapid conversion of recent-onset AF or AFl. The drug may be particularly useful in patients who have undergone recent cardiac surgery or those who are not ideal candidates for DCC .	False	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1
416310:01:03_10.00	16.9	107	416310	523782:02:04_03.00	523782	86.2	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
416310:01:03_10.00	16.9	107	416310	246448:01:04_30.00	246448	85.3	32.5	30.0	93	Clebopride maleate	Inhibition of Dopamine D2 receptor (IC50 = 17 nM); Inhibition of human ERG ( IC50 = 602.56 nM 6.22); Inhibiton of Acetylcholinesterase (IC50 = 890 nM)	False	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
416310:01:03_10.00	16.9	107	416310	246866:02:03_10.00	246866	83.2	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416310:01:03_10.00	16.9	107	416310	246632:01:04_30.00	246632	83.1	25.6	30.0	95	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
416310:01:03_10.00	16.9	107	416310	281051:01:03_30.00	281051	83.0	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
416310:01:03_10.00	16.9	107	416310	280016:01:03_30.00	280016	82.8	40.6	30.0	97	LY-53,857 maleate	potent and selective 5-HT2 serotonin receptor antagonist.	False	CC(O)C(C)OC(=O)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C(C)C)C[C@H]2N(C)C1
416310:01:03_10.00	16.9	107	416310	409878:01:04_50.00	409878	82.3	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
416310:01:03_10.00	16.9	107	416310	246815:01:12_03.00	246815	82.19999999999999	16.2	3.0	95	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
416310:01:03_10.00	16.9	107	416310	410043:01:05_00.20	410043	82.19999999999999	23.1	0.2	95	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
416310:01:03_10.00	16.9	107	416310	246859:01:04_30.00	246859	82.0	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416320:01:03_10.00	13.1	92	416320	246498:01:04_30.00	246498	83.39999999999999	30.2	30.0	79	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
416320:01:03_10.00	13.1	92	416320	392621:01:09_02.00	410605	79.7	11.4	2.0	102	GSK690693	GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.	True	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
416320:01:03_10.00	13.1	92	416320	392756:02:03_02.00	392756	75.3	5.4	2.0	93	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
416320:01:03_10.00	13.1	92	416320	410605:01:03_02.00	410605	74.9	22.1	2.0	97	GSK690693	GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.	True	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
416320:01:03_10.00	13.1	92	416320	409847:01:02_10.00	409847	73.8	14.3	10.0	89	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
416320:01:03_10.00	13.1	92	416320	407972:02:03_02.00	407972	73.4	7.1	2.0	90	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
416320:01:03_10.00	13.1	92	416320	280402:04:03_10.00	280402	73.1	20.0	10.0	92	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
416320:01:03_10.00	13.1	92	416320	410991:01:03_02.00	410605	73.0	17.4	2.0	96	GSK690693	GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.	True	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
416320:01:03_10.00	13.1	92	416320	392087:01:02_00.20	392087	71.1	6.2	0.2	107		inhibitor of PDGFR (IC50 = 0.015 ÂµM); Uings I J; Spacey G D; Bonser R W  Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor.    Cellular signalling  (1999),  11(2),  95-100.	False	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O
416320:01:03_10.00	13.1	92	416320	392733:01:09_02.00	392733	71.0	15.9	2.0	90	BMS-345541	BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 uM, IKK-1 IC50=4 uM). BMS-345541 binds at an allosteric site of IKK.	False	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1
416356:01:03_10.00	11.4	103	416356	281047:01:03_30.00	281047	84.89999999999999	21.9	30.0	93	YS-035 hydrochloride	L-type Ca2+ channel blocker, verapamil derivative.	False	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC
416356:01:03_10.00	11.4	103	416356	392523:01:09_02.00	392523	83.7	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
416356:01:03_10.00	11.4	103	416356	283242:02:05_10.00	283242	83.3	24.0	10.0	100	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
416356:01:03_10.00	11.4	103	416356	392734:01:09_02.00	392734	83.2	7.3	2.0	94	XL019	XL019is a potentorally active, and selective JAK2 inhibitor, with IC50s of 2.2, 134.3, and 214.2 nM for JAK2, JAK1 and JAK3, respectively. XL019 shows 50-fold or greater selectivity for JAK2, versus a panel of over 100 serine/threonine and tyrosine kinases, including other members of the JAK family. XL019 potently inhibits STAT3 and STAT5 phosphorylation in cells harboring either JAK2V617F or wild-type JAK2.	False	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@@H]1CCCN1
416356:01:03_10.00	11.4	103	416356	410014:02:03_02.00	410014	82.1	6.2	2.0	103	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
416356:01:03_10.00	11.4	103	416356	407896:02:04_10.00	407896	81.0	30.9	10.0	96	BPTES	it  is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. Glutaminase converts glutamine to glutamate, which is an important excitatory neurotransmitter in brain and can be further oxidized to a-ketoglutarate to feed the tricarboxylic acid (TCA) cycle and to glutathione, which is important for controlling the level of reactive oxygen species (ROS), particularly important for cancer cell growth. BPTES was found to slow growth of glioma cells. BPTES is a noncompetitive inhibitor with a Ki of 3 ÂµM.	False	O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1
416356:01:03_10.00	11.4	103	416356	519823:01:02_10.00	519823	80.80000000000001	9.8	10.0	94		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
416356:01:03_10.00	11.4	103	416356	410622:01:03_02.00	410622	80.80000000000001	11.7	2.0	98	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
416356:01:03_10.00	11.4	103	416356	280562:01:03_30.00	280562	79.5	24.4	30.0	95	Flupirtine (Maleate)	Flupirtine Maleate is an indirect N-methyl-D-aspartate receptor (NMDAR) antagonist. It is aÂ brainÂ penetrant, and orally bioavailable, non-opioid and centrally acting analgesic agent.	False	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N
416356:01:03_10.00	11.4	103	416356	247095:02:03_30.00	247095	79.4	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416360:01:03_10.00	25.9	98	416360	392592:03:03_10.00	392592	83.0	52.3	10.0	98	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
416360:01:03_10.00	25.9	98	416360	280571:01:03_30.00	280571	82.8	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
416360:01:03_10.00	25.9	98	416360	101009:01:19_30.00	101009	82.5	30.9	30.0	89	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
416360:01:03_10.00	25.9	98	416360	246343:01:04_30.00	246343	82.5	30.9	30.0	82	Etofenamate	cyclooxygenase inhibitor.	False	O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1
416360:01:03_10.00	25.9	98	416360	247238:02:03_30.00	247238	82.3	50.6	30.0	104	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
416360:01:03_10.00	25.9	98	416360	409878:01:04_30.00	409878	82.3	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
416360:01:03_10.00	25.9	98	416360	409878:01:04_50.00	409878	82.1	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
416360:01:03_10.00	25.9	98	416360	246866:02:03_10.00	246866	82.1	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416360:01:03_10.00	25.9	98	416360	410031:02:03_30.00	410031	82.0	39.9	30.0	96	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
416360:01:03_10.00	25.9	98	416360	101009:01:19_50.00	101009	81.5	32.8	50.0	91	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
416366:01:03_10.00	21.1	98	416366	528526:01:02_05.00	528526	88.2	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
416366:01:03_10.00	21.1	98	416366	247095:02:03_30.00	247095	87.7	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416366:01:03_10.00	21.1	98	416366	280474:01:03_30.00	280474	86.5	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416366:01:03_10.00	21.1	98	416366	392523:01:09_02.00	392523	85.39999999999999	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
416366:01:03_10.00	21.1	98	416366	246859:01:04_30.00	246859	85.2	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416366:01:03_10.00	21.1	98	416366	280076:01:03_30.00	280076	84.89999999999999	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
416366:01:03_10.00	21.1	98	416366	247209:01:04_30.00	247209	84.8	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
416366:01:03_10.00	21.1	98	416366	407974:01:04_10.00	407974	84.7	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
416366:01:03_10.00	21.1	98	416366	280657:01:03_30.00	280657	84.6	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416366:01:03_10.00	21.1	98	416366	246866:02:03_10.00	246866	84.39999999999999	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416430:01:03_10.00	6.0	99	416430	407872:01:03_10.00	407872	81.10000000000001	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416430:01:03_10.00	6.0	99	416430	280197:01:04_30.00	280197	81.0	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
416430:01:03_10.00	6.0	99	416430	410622:01:04_06.00	410622	80.0	35.1	6.0	106	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
416430:01:03_10.00	6.0	99	416430	280115:01:03_30.00	280115	80.0	19.9	30.0	92	JX401	potent, non-cytotoxic, membrane permeable p38a MAPK inhibitor.	False	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1
416430:01:03_10.00	6.0	99	416430	408116:01:02_10.00	408116	79.9	21.2	10.0	103	Rimonabant (Hydrochloride)	potent and selective cannabinoid CB1 receptor antagonist (Ki = 1.98 nM). Also acts as an inverse agonist reversing adenylyl cyclase inhibition by WIN 55,212-2 (Cat.No. 1038) (IC50 = 48 nM). Displays no activity at CB2 receptors. Reduces food intake and body weight in orally dosed non-obese Wistar rats.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
416430:01:03_10.00	6.0	99	416430	280081:01:03_30.00	280081	79.60000000000001	21.9	30.0	91	R 59-022	R 59-022 (DKGI-I) is a diacylglycerol kinase inhibitor (IC50=2.8 uM). R 59-022 is a 5-HTR antagonist, and activates protein kinase C (PKC). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1
416430:01:03_10.00	6.0	99	416430	280732:01:03_30.00	280732	77.7	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
416430:01:03_10.00	6.0	99	416430	317004:02:10_10.00	317004	77.60000000000001	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
416430:01:03_10.00	6.0	99	416430	246883:07:04_06.00	246883	76.8	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416430:01:03_10.00	6.0	99	416430	410708:01:04_06.00	410708	76.6	31.6	6.0	98	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
416489:01:03_10.00	13.1	101	416489	413121:01:03_50.00	413121	81.3	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416489:01:03_10.00	13.1	101	416489	246617:01:04_10.00	246617	80.4	24.4	10.0	92	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
416489:01:03_10.00	13.1	101	416489	246820:12:03_30.00	246820	78.3	17.1	30.0	94	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
416489:01:03_10.00	13.1	101	416489	246820:12:03_50.00	246820	77.7	39.6	50.0	91	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
416489:01:03_10.00	13.1	101	416489	413013:01:03_30.00	413013	77.0	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
416489:01:03_10.00	13.1	101	416489	246883:01:04_10.00	246883	76.1	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416489:01:03_10.00	13.1	101	416489	246618:01:04_10.00	246618	76.0	14.0	10.0	94	Sertaconazole (nitrate)	ergosterol synthesis inhibitor.	False	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1
416489:01:03_10.00	13.1	101	416489	413121:01:03_30.00	413121	75.9	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416489:01:03_10.00	13.1	101	416489	412996:01:04_30.00	412996	75.8	24.2	30.0	96	FPS-ZM1	FPS-ZM1 is a high-affinity RAGE inhibitor with a Ki of 25 nM.	False	O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1
416489:01:03_10.00	13.1	101	416489	246886:01:04_10.00	246886	75.7	16.2	10.0	90	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of &gt;32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
416553:01:03_10.00	22.5	95	416553	407872:01:06_10.00	407872	85.0	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416553:01:03_10.00	22.5	95	416553	413005:01:02_30.00	413005	83.0	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
416553:01:03_10.00	22.5	95	416553	407872:02:04_10.00	407872	82.6	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416553:01:03_10.00	22.5	95	416553	407872:01:03_10.00	407872	81.6	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416553:01:03_10.00	22.5	95	416553	413161:01:02_03.00	413161	80.80000000000001	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
416553:01:03_10.00	22.5	95	416553	247278:01:04_30.00	247278	80.4	12.8	30.0	97	Chlorotrianisene	nuclear receptor ligand, estrogen.	False	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1
416553:01:03_10.00	22.5	95	416553	280355:01:03_30.00	280355	79.4	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
416553:01:03_10.00	22.5	95	416553	280970:01:03_30.00	280970	79.3	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416553:01:03_10.00	22.5	95	416553	392339:01:02_02.00	392339	79.10000000000001	8.1	2.0	98		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.01 ÂµM), inhibitor of  Epidermal growth factor receptor erbB2/Her2 (IC50 = 0.01 ÂµM); Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines.  Bioorg Med Chem Lett.  (2003),  13(4),  637-640.	False	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1
416553:01:03_10.00	22.5	95	416553	392097:01:02_02.00	392097	78.8	15.4	2.0	100		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.025 ÂµM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.028 ÂµM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1
416574:01:03_10.00	11.2	99	416574	407872:01:06_10.00	407872	72.89999999999999	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416574:01:03_10.00	11.2	99	416574	407872:02:04_10.00	407872	72.39999999999999	29.9	10.0	95	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416574:01:03_10.00	11.2	99	416574	381945:02:03_01.00	381945	72.3	6.4	1.0	112	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
416574:01:03_10.00	11.2	99	416574	280101:01:03_30.00	280101	71.0	7.9	30.0	92	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
416574:01:03_10.00	11.2	99	416574	407872:01:03_10.00	407872	69.69999999999999	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
416574:01:03_10.00	11.2	99	416574	410622:01:04_06.00	410622	68.89999999999999	35.1	6.0	106	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
416574:01:03_10.00	11.2	99	416574	280355:01:03_30.00	280355	68.10000000000001	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
416574:01:03_10.00	11.2	99	416574	392097:01:02_02.00	392097	67.2	15.4	2.0	100		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.025 ÂµM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.028 ÂµM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1
416574:01:03_10.00	11.2	99	416574	408117:01:02_10.00	408117	66.60000000000001	7.9	10.0	95	(Â±)-SLV 319	potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. Orally active.	False	C/N=C(/NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
416574:01:03_10.00	11.2	99	416574	247278:01:04_30.00	247278	66.5	12.8	30.0	97	Chlorotrianisene	nuclear receptor ligand, estrogen.	False	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1
416596:01:03_10.00	15.4	88	416596	280732:01:03_10.00	280732	82.1	11.4	10.0	102	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
416596:01:03_10.00	15.4	88	416596	528524:01:02_03.00	528524	81.5	26.9	3.0	88		negative control to MRIA9	True	CN(C)c1ncc2cc(-c3ccc(-c4ncccc4F)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1
416596:01:03_10.00	15.4	88	416596	413094:01:04_30.00	413094	79.0	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
416596:01:03_10.00	15.4	88	416596	528561:01:02_05.00	528561	78.10000000000001	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
416596:01:03_10.00	15.4	88	416596	519823:01:02_30.00	519823	78.0	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
416596:01:03_10.00	15.4	88	416596	413094:01:04_10.00	413094	77.60000000000001	6.4	10.0	101	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
416596:01:03_10.00	15.4	88	416596	281040:01:03_30.00	281040	77.3	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
416596:01:03_10.00	15.4	88	416596	317004:02:10_10.00	317004	76.9	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
416596:01:03_10.00	15.4	88	416596	409914:01:03_01.00	409914	76.9	6.6	1.0	96	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and &gt;3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
416596:01:03_10.00	15.4	88	416596	246332:01:09_03.00	246332	76.4	9.5	3.0	101	Dilazep dihydrochloride	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
416635:01:03_10.00	13.0	95	416635	280474:01:03_30.00	280474	84.3	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416635:01:03_10.00	13.0	95	416635	247095:02:03_30.00	247095	82.6	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416635:01:03_10.00	13.0	95	416635	392523:01:09_02.00	392523	82.19999999999999	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
416635:01:03_10.00	13.0	95	416635	281040:01:03_30.00	281040	81.39999999999999	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
416635:01:03_10.00	13.0	95	416635	280657:01:03_30.00	280657	81.2	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
416635:01:03_10.00	13.0	95	416635	280670:01:03_30.00	280670	81.10000000000001	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
416635:01:03_10.00	13.0	95	416635	246456:01:07_03.00	246456	81.10000000000001	8.5	3.0	99	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
416635:01:03_10.00	13.0	95	416635	281042:01:03_30.00	281042	80.4	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
416635:01:03_10.00	13.0	95	416635	246847:01:04_30.00	246847	80.30000000000001	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
416635:01:03_10.00	13.0	95	416635	528526:01:02_05.00	528526	80.30000000000001	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
416740:01:03_10.00	14.7	91	416740	247001:01:04_30.00	247001	81.0	10.9	30.0	92	Niflumic acid	Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Target: Othersniflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calcium channels or activate potassium channels. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels . Niflumic acid molecule is completely buried in the substrate-binding hydrophobic channel. The conformations of the binding site in PLA(2) as well as that of niflumic acid are not altered upon binding . Niflumic acid (NFA) produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site .	False	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1
416740:01:03_10.00	14.7	91	416740	246641:01:04_10.00	246641	79.80000000000001	10.4	10.0	104	Nandrolone	Androgen receptor (IC50 = 3.149 nM); Progesterone receptor (IC50 = 171.5 nM)	True	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O
416740:01:03_10.00	14.7	91	416740	246577:01:05_10.00	246577	76.0	15.2	10.0	98	Gabexate mesilate	serine protease inhibitor.	False	CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1
416740:01:03_10.00	14.7	91	416740	246881:01:12_02.00	246881	75.8	6.7	2.0	102	Dipyridamole	Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.Target: Phosphodiesterase (PDE)Dipyridamole concentrations of 1 nmol/ml blood caused 90% inhibition of adenosine metabolism. Dipyridamole at therapeutic concentrations causes significant inhibition of adenosine metabolism in whole blood . Dipyridamole has a dose-dependent inhibitory effect on thromboxane synthesis which was independent of aggregation. Dipyridamole also inhibited malonyldialdehyde production in response to both thrombin and arachidonic acid . Dipyridamole enhances platelet inhibition by amplifying the signaling of the NO donor sodium nitroprusside. These data support the concept that enhancement of endothelium-dependent NO/cGMP-mediated signaling may be an important in vivo component of dipyridamole action .; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
416740:01:03_10.00	14.7	91	416740	392421:01:02_00.20	392421	75.7	13.1	0.2	102		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0002 ÂµM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(F)c2)c2c(N)ncnc21
416740:01:03_10.00	14.7	91	416740	392489:01:09_00.20	392489	74.0	7.3	0.2	93	Enzastaurin	Enzastaurin (LY317615) is a potent and selective PKC.b. inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKC.a., PKC.g. and PKC.e..	False	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21
416740:01:03_10.00	14.7	91	416740	410848:01:03_00.20	410848	73.5	6.6	0.2	105	CAY10602	CAY10602 is a SIRT1 activator. CAY10602 dose-dependently suppresses the NF-.k.B-dependent induction of TNF-.a. by lipopolysaccharide in THP-1 cells.	False	Nc1c(S(=O)(=O)c2ccccc2)c2nc3ccccc3nc2n1-c1ccc(F)cc1
416740:01:03_10.00	14.7	91	416740	410940:01:03_00.20	410940	73.4	7.6	0.2	100	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
416740:01:03_10.00	14.7	91	416740	410756:01:04_06.00	410756	73.2	11.7	6.0	111	GW9508	GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities.	False	O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1
416740:01:03_10.00	14.7	91	416740	245488:05:06_02.00	245488	72.39999999999999	7.4	2.0	96	Emodin	p56lck Tyrosine kinase inhibitor.	False	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O
416765:01:03_10.00	12.6	103	416765	410031:02:03_50.00	410031	85.5	63.7	50.0	95	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 ÂµM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
416765:01:03_10.00	12.6	103	416765	280961:01:03_10.00	280961	85.5	52.5	10.0	102	SR 59230A oxalate	beta3-Adrenoceptor antagonist.	False	CCc1ccccc1OC[C@@H](O)CN[C@H]1CCc2ccccc2C1
416765:01:03_10.00	12.6	103	416765	520875:01:03_10.00	520875	85.3	57.2	10.0	90	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416765:01:03_10.00	12.6	103	416765	247331:01:04_10.00	247331	85.1	27.6	10.0	100	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
416765:01:03_10.00	12.6	103	416765	246815:01:04_10.00	246815	84.8	61.1	10.0	110	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
416765:01:03_10.00	12.6	103	416765	520875:02:03_03.00	520875	84.0	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416765:01:03_10.00	12.6	103	416765	246433:01:04_10.00	246433	83.7	14.3	10.0	106	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
416765:01:03_10.00	12.6	103	416765	246742:01:04_10.00	246742	83.7	25.4	10.0	107	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
416765:01:03_10.00	12.6	103	416765	246344:01:04_10.00	246344	83.3	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
416765:01:03_10.00	12.6	103	416765	520875:01:04_10.00	520875	82.6	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416804:01:03_10.00	12.6	111	416804	520875:01:04_30.00	520875	86.1	57.9	30.0	91	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416804:01:03_10.00	12.6	111	416804	520875:01:04_10.00	520875	85.7	55.6	10.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416804:01:03_10.00	12.6	111	416804	520875:01:04_50.00	520875	85.1	54.2	50.0	87	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416804:01:03_10.00	12.6	111	416804	413167:01:02_05.00	413167	85.0	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
416804:01:03_10.00	12.6	111	416804	520875:02:03_03.00	520875	84.89999999999999	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416804:01:03_10.00	12.6	111	416804	413008:01:03_10.00	413008	84.3	79.1	10.0	102	Src Inhibitor 1	Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.	False	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
416804:01:03_10.00	12.6	111	416804	528557:01:02_00.30	407971	84.2	15.9	0.3	102	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	True	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
416804:01:03_10.00	12.6	111	416804	408952:02:04_10.00	408952	83.6	76.5	10.0	100		BI-4659 is a potent inhibitor of Alk5 (TGFÃR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
416804:01:03_10.00	12.6	111	416804	410753:02:02_30.00	410753	83.6	77.2	30.0	98	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
416804:01:03_10.00	12.6	111	416804	412989:01:02_30.00	412989	83.5	66.7	30.0	80	OMDM-2	OMDM-2 is an endocannabinoid analog specifically designed to be a potent and selective inhibitor of the cellular uptake of arachidonoyl ethanolamide. Structurally, OMDM-2 is the amide of (R)-tyrosinol with oleic acid. In RBL-2H3 cells, OMDM-2 inhibits the cellular uptake of tritiated AEA with an IC50 of 3 uM, with negligible effects on the CB1 receptor and VR1.	True	CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1
416859:01:03_10.00	14.7	104	416859	317004:02:10_10.00	317004	80.5	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
416859:01:03_10.00	14.7	104	416859	410622:01:04_06.00	410622	79.80000000000001	35.1	6.0	106	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
416859:01:03_10.00	14.7	104	416859	246330:01:04_10.00	246330	78.10000000000001	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
416859:01:03_10.00	14.7	104	416859	280732:01:03_30.00	280732	77.8	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
416859:01:03_10.00	14.7	104	416859	246791:02:03_30.00	246791	77.7	20.0	30.0	102	Chlorpheniramine (maleate)	Chlorpheniramine maleate is an histamine H1 receptor antagonist with IC50 of 12 nM.Target: Histamine H1 ReceptorChlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 uM . Chlorpheniramine displaces of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells with IC50 of 66 nM. Chlorpheniramine displays antimalarial activity against CQS strain (D6) and MDR strain (Dd2) of P. falciparum with IC50 of 61.2 uM and 3.9 uM, respectively. Chlorpheniramine displays cytotoxicity against the proliferation of concanavalin A-induced murine splenic lymphocytes with IC50 of 33.4 uM .Oral administration of Chlorpheniramine inhibits histamine-induced mortality in guinea pigs with an ED50 of 0.17 mg/kg . Oral administration of Chlorpheniramine (10 mg/kg) significantly inhibits short-duration scratching in BALB/c mice stimulated by ovalbumin active cutaneous anaphylaxis and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice, in contrast to that of dexamethasone or tacrolimus .	False	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
416859:01:03_10.00	14.7	104	416859	246883:07:04_06.00	246883	77.2	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416859:01:03_10.00	14.7	104	416859	410708:01:04_06.00	410708	77.10000000000001	31.6	6.0	98	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
416859:01:03_10.00	14.7	104	416859	280197:01:04_30.00	280197	77.0	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
416859:01:03_10.00	14.7	104	416859	528529:01:02_05.00	528529	76.9	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
416859:01:03_10.00	14.7	104	416859	280081:01:03_30.00	280081	76.8	21.9	30.0	91	R 59-022	R 59-022 (DKGI-I) is a diacylglycerol kinase inhibitor (IC50=2.8 uM). R 59-022 is a 5-HTR antagonist, and activates protein kinase C (PKC). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1
416871:01:03_10.00	7.6	104	416871	413167:01:02_03.00	413167	77.5	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
416871:01:03_10.00	7.6	104	416871	382148:02:04_06.00	382148	70.1	9.8	6.0	98	SB-431542	SB-431542 is a potent and selective inhibitor of ALK5/TGF-.b. type I Receptor with an IC50 value of 94 nM.	False	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
416871:01:03_10.00	7.6	104	416871	410662:01:04_10.00	410662	69.0	9.8	10.0	102	Ticagrelor	Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.	True	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
416871:01:03_10.00	7.6	104	416871	392527:01:10_00.20	392527	68.60000000000001	6.7	0.2	101	WZ4002	WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
416871:01:03_10.00	7.6	104	416871	409947:02:03_00.20	409947	68.60000000000001	31.4	0.2	91	Belinostat	Belinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts.	False	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO
416871:01:03_10.00	7.6	104	416871	392088:01:02_02.00	392088	67.5	5.2	2.0	102		inhibitor of TGF-beta receptor type I (IC50 = 0.26 ÂµM); Identification of Novel Inhibitors of the Transforming Growth Factor .beta.1 (TGF-.beta.1) Type 1 Receptor (ALK5).    J Med Chem (2002),  45(5),  999-1001.	False	OCc1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
416871:01:03_10.00	7.6	104	416871	408877:01:04_50.00	408877	67.4	29.7	50.0	91	Acid Ceramidase Inhibitor 17a, ;ARN14974	it is a benzoxazolone carboxamide that potently inhibits acid ceramidase (IC50 = 79 nM). This effect is persistent, as it inhibits acid ceramidase activity in cells for up to 24 hours. ARN14974 is extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice. It causes a significant reduction in acid ceramidase activity in multiple organs in mice, including brain, liver, heart, lungs, and kidney.	False	O=C(NCCCCc1ccccc1)n1c(=O)oc2cc(-c3ccc(F)cc3)ccc21
416871:01:03_10.00	7.6	104	416871	101008:01:24_50.00	101008	67.4	58.7	50.0	75	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
416871:01:03_10.00	7.6	104	416871	410069:02:03_00.20	410069	67.2	32.1	0.2	95	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
416871:01:03_10.00	7.6	104	416871	391840:01:02_00.20	391840	66.60000000000001	8.3	0.2	101		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.022 ÂµM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccncc3)c3sccc3n2)n1
416872:01:03_10.00	48.2	98	416872	280086:01:03_10.00	280086	88.6	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416872:01:03_10.00	48.2	98	416872	247331:01:04_10.00	247331	88.4	27.6	10.0	100	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
416872:01:03_10.00	48.2	98	416872	246344:01:04_10.00	246344	87.6	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
416872:01:03_10.00	48.2	98	416872	409878:01:04_50.00	409878	87.5	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
416872:01:03_10.00	48.2	98	416872	520875:02:03_03.00	520875	87.2	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
416872:01:03_10.00	48.2	98	416872	382120:03:04_06.00	382120	87.0	33.7	6.0	87	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/&lt;5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
416872:01:03_10.00	48.2	98	416872	247342:01:05_10.00	247342	86.7	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
416872:01:03_10.00	48.2	98	416872	280998:01:03_10.00	280998	86.2	7.1	10.0	102	Tulobuterol (hydrochloride)	Tulobuterol hydrochloride (C-78) is a long-acting .b.2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation.	False	CC(C)(C)NCC(O)c1ccccc1Cl
416872:01:03_10.00	48.2	98	416872	520969:01:04_50.00	520969	86.1	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416872:01:03_10.00	48.2	98	416872	413130:01:02_05.00	413130	86.1	23.5	5.0	99		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
416877:01:03_10.00	24.4	95	416877	246330:01:04_10.00	246330	84.39999999999999	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
416877:01:03_10.00	24.4	95	416877	280474:01:03_30.00	280474	83.39999999999999	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416877:01:03_10.00	24.4	95	416877	409894:01:03_50.00	409894	83.39999999999999	23.3	50.0	109	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
416877:01:03_10.00	24.4	95	416877	281042:01:03_30.00	281042	82.89999999999999	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
416877:01:03_10.00	24.4	95	416877	280970:01:03_30.00	280970	82.8	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416877:01:03_10.00	24.4	95	416877	246801:02:03_10.00	246801	82.8	33.9	10.0	88	Ziprasidone, Hydrochloride	dopamine D2/serotonin 5-HT2 antagonist, atypical antipsychotic, FDA approved for the treatment of schizophrenia.	False	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
416877:01:03_10.00	24.4	95	416877	407880:01:03_10.00	407880	82.69999999999999	28.2	10.0	97	ML385	ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 uM.	False	Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21
416877:01:03_10.00	24.4	95	416877	413161:01:02_03.00	413161	82.39999999999999	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
416877:01:03_10.00	24.4	95	416877	280091:01:03_30.00	280091	82.3	37.8	30.0	88	DAPH, CGP 52411	protein tyrosine kinase inhibitor, specific for EGFR, Also inhibits amyloid beta fibril formation.	False	O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21
416877:01:03_10.00	24.4	95	416877	317004:02:10_10.00	317004	82.19999999999999	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
416879:01:03_10.00	26.3	104	416879	520969:01:04_30.00	520969	87.8	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416879:01:03_10.00	26.3	104	416879	280086:01:03_10.00	280086	87.5	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
416879:01:03_10.00	26.3	104	416879	413171:01:02_03.00	413171	86.9	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
416879:01:03_10.00	26.3	104	416879	246883:01:04_30.00	246883	86.6	22.8	30.0	96	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416879:01:03_10.00	26.3	104	416879	280127:01:04_30.00	280127	86.0	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
416879:01:03_10.00	26.3	104	416879	246846:01:05_30.00	246846	85.5	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416879:01:03_10.00	26.3	104	416879	246981:02:03_30.00	246981	85.39999999999999	53.9	30.0	92	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
416879:01:03_10.00	26.3	104	416879	520969:01:04_50.00	520969	85.3	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416879:01:03_10.00	26.3	104	416879	413221:01:03_10.00	413221	85.3	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
416879:01:03_10.00	26.3	104	416879	410626:01:04_06.00	410626	85.3	43.2	6.0	97	Nebivolol HCl	Nebivolol HCl selectively inhibits Ã1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
416882:01:03_10.00	18.5	101	416882	280424:01:03_30.00	280424	84.39999999999999	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
416882:01:03_10.00	18.5	101	416882	247095:02:03_30.00	247095	84.3	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416882:01:03_10.00	18.5	101	416882	280670:01:03_30.00	280670	84.2	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
416882:01:03_10.00	18.5	101	416882	280474:01:03_30.00	280474	83.89999999999999	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416882:01:03_10.00	18.5	101	416882	280355:01:03_30.00	280355	83.39999999999999	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
416882:01:03_10.00	18.5	101	416882	413117:01:03_10.00	413117	83.3	12.4	10.0	95	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
416882:01:03_10.00	18.5	101	416882	247082:01:04_30.00	247082	82.8	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416882:01:03_10.00	18.5	101	416882	280400:01:03_30.00	280400	82.5	29.2	30.0	92	Cyproterone acetate	androgen antagonist, synthetic steroid.	False	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
416882:01:03_10.00	18.5	101	416882	280081:01:03_30.00	280081	82.5	21.9	30.0	91	R 59-022	R 59-022 (DKGI-I) is a diacylglycerol kinase inhibitor (IC50=2.8 uM). R 59-022 is a 5-HTR antagonist, and activates protein kinase C (PKC). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1
416882:01:03_10.00	18.5	101	416882	281042:01:03_30.00	281042	82.39999999999999	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
416889:01:03_10.00	22.5	92	416889	101009:01:16_30.00	101009	77.3	13.3	30.0	96	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
416889:01:03_10.00	22.5	92	416889	337185:02:16_30.00	337185	76.1	9.2	30.0	96	Lipoxygenin	inhibitor of 5-lipoxygenase (5-LO) of the Wnt pathway.; Cell Chem. Biol. 2018, 95, 1095	False	COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC
416889:01:03_10.00	22.5	92	416889	280904:01:03_10.00	280904	74.4	11.9	10.0	95	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
416889:01:03_10.00	22.5	92	416889	247197:01:04_10.00	247197	73.4	30.4	10.0	102	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
416889:01:03_10.00	22.5	92	416889	246883:01:04_10.00	246883	72.7	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416889:01:03_10.00	22.5	92	416889	246811:01:04_10.00	246811	72.3	9.7	10.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
416889:01:03_10.00	22.5	92	416889	413013:01:03_30.00	413013	72.2	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
416889:01:03_10.00	22.5	92	416889	246722:01:04_30.00	246722	72.1	12.4	30.0	94	Felodipine, Plendil	L-type calcium channel blocker, L-type Ca2+ channels blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl
416889:01:03_10.00	22.5	92	416889	413167:01:02_03.00	413167	71.2	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
416889:01:03_10.00	22.5	92	416889	246617:01:04_10.00	246617	71.0	24.4	10.0	92	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
416890:01:03_10.00	18.5	92	416890	413013:01:03_30.00	413013	81.39999999999999	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
416890:01:03_10.00	18.5	92	416890	246617:01:04_10.00	246617	79.4	24.4	10.0	92	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
416890:01:03_10.00	18.5	92	416890	413121:01:03_30.00	413121	79.0	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416890:01:03_10.00	18.5	92	416890	101009:01:16_30.00	101009	78.4	13.3	30.0	96	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
416890:01:03_10.00	18.5	92	416890	413013:01:03_50.00	413013	77.60000000000001	15.2	50.0	97	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
416890:01:03_10.00	18.5	92	416890	246820:12:03_30.00	246820	77.3	17.1	30.0	94	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
416890:01:03_10.00	18.5	92	416890	413121:01:03_50.00	413121	77.10000000000001	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416890:01:03_10.00	18.5	92	416890	409889:01:03_30.00	409889	76.9	32.1	30.0	96	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
416890:01:03_10.00	18.5	92	416890	246883:01:04_10.00	246883	76.5	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
416890:01:03_10.00	18.5	92	416890	246811:01:04_10.00	246811	76.4	9.7	10.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
416925:01:03_10.00	17.4	92	416925	528524:01:02_03.00	528524	85.39999999999999	26.9	3.0	88		negative control to MRIA9	True	CN(C)c1ncc2cc(-c3ccc(-c4ncccc4F)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1
416925:01:03_10.00	17.4	92	416925	247164:01:10_03.00	247164	82.6	10.9	3.0	96	Bromperidol	Bromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.	False	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1
416925:01:03_10.00	17.4	92	416925	246344:01:04_10.00	246344	81.8	19.3	10.0	113	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
416925:01:03_10.00	17.4	92	416925	247155:01:04_10.00	247155	81.8	32.8	10.0	92	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
416925:01:03_10.00	17.4	92	416925	246456:01:04_10.00	246456	81.3	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
416925:01:03_10.00	17.4	92	416925	280360:01:03_10.00	280360	81.2	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
416925:01:03_10.00	17.4	92	416925	280637:01:03_30.00	280637	81.10000000000001	10.4	30.0	103	IMID-4F hydrochloride	imidazoline-based K(ATP) channel blocker.	False	Fc1ccc(CN(C2=NCCN2)c2c(Cl)cccc2Cl)cc1
416925:01:03_10.00	17.4	92	416925	412998:01:02_10.00	412998	81.0	33.2	10.0	106	Halopemide	Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent.	False	O=C(NCCN1CCC(n2c(O)nc3cc(Cl)ccc32)CC1)c1ccc(F)cc1
416925:01:03_10.00	17.4	92	416925	246835:01:04_30.00	246835	80.7	16.2	30.0	99	Buspirone (hydrochloride)	5-HT1A Serotonin receptor agonist, non-benzodiazepine anxiolytic, serotonin receptor agonist, 5ht1a receptor agonist.	False	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
416925:01:03_10.00	17.4	92	416925	247331:02:03_30.00	247331	80.60000000000001	32.0	30.0	99	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
416926:01:03_10.00	25.2	90	416926	520969:01:04_30.00	520969	85.9	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
416926:01:03_10.00	25.2	90	416926	246363:01:04_30.00	246363	85.8	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
416926:01:03_10.00	25.2	90	416926	413121:01:03_30.00	413121	85.6	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
416926:01:03_10.00	25.2	90	416926	247095:02:03_30.00	247095	84.8	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
416926:01:03_10.00	25.2	90	416926	280474:01:03_30.00	280474	84.7	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
416926:01:03_10.00	25.2	90	416926	246847:01:04_30.00	246847	84.39999999999999	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
416926:01:03_10.00	25.2	90	416926	246846:01:05_30.00	246846	83.7	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
416926:01:03_10.00	25.2	90	416926	528526:01:02_05.00	528526	83.7	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
416926:01:03_10.00	25.2	90	416926	246859:01:04_30.00	246859	83.39999999999999	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
416926:01:03_10.00	25.2	90	416926	280670:01:03_30.00	280670	83.1	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
417108:01:03_10.00	5.9	94	417108	410884:02:04_10.00	410884	76.9	80.7	10.0	50	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of &lt;1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
417108:01:03_10.00	5.9	94	417108	392343:01:02_02.00	392343	76.3	28.7	2.0	79		inhibitor of PLK1 kinase (IC50 = 0.035 ÂµM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1ccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)cc1
417108:01:03_10.00	5.9	94	417108	522774:02:04_50.00	522774	76.0	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
417108:01:03_10.00	5.9	94	417108	409977:01:04_06.00	409977	75.6	32.5	6.0	88	Pimobendan	Pimobendan (UD-CG115) is a selective inhibitor of PDE3 with IC50 of 0.32 uM.	False	COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1
417108:01:03_10.00	5.9	94	417108	280847:01:03_10.00	280847	75.1	15.7	10.0	96	PDMP hydrochloride	glucosylceramide synthase inhibitor, blocks formation of glucosylceramide from ceramide.	False	CCCCCCCCCC(=O)NC(CN1CCOCC1)[C@H](O)c1ccccc1
417108:01:03_10.00	5.9	94	417108	101008:01:24_30.00	101008	75.0	71.0	30.0	76	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
417108:01:03_10.00	5.9	94	417108	519823:01:02_30.00	519823	74.8	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
417108:01:03_10.00	5.9	94	417108	392762:02:04_10.00	392762	74.6	77.9	10.0	84	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
417108:01:03_10.00	5.9	94	417108	413130:01:02_03.00	413130	74.1	7.4	3.0	88		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
417108:01:03_10.00	5.9	94	417108	246866:02:03_10.00	246866	74.0	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417131:01:03_10.00	8.5	100	417131	382185:03:06_10.00	382185	80.9	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
417131:01:03_10.00	8.5	100	417131	247067:02:03_10.00	247067	79.10000000000001	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
417131:01:03_10.00	8.5	100	417131	280639:03:03_10.00	280639	77.4	17.6	10.0	99	ML-7 (hydrochloride)	ML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM). ML-7 hydrochloride also inhibits YAP/TAZ.	False	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1
417131:01:03_10.00	8.5	100	417131	337185:02:16_30.00	337185	77.4	9.2	30.0	96	Lipoxygenin	inhibitor of 5-lipoxygenase (5-LO) of the Wnt pathway.; Cell Chem. Biol. 2018, 95, 1095	False	COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC
417131:01:03_10.00	8.5	100	417131	317004:02:10_10.00	317004	77.0	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
417131:01:03_10.00	8.5	100	417131	280189:01:03_10.00	280189	75.9	13.1	10.0	101	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
417131:01:03_10.00	8.5	100	417131	413121:01:03_30.00	413121	75.4	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
417131:01:03_10.00	8.5	100	417131	247342:02:04_10.00	247342	75.1	18.5	10.0	99	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
417131:01:03_10.00	8.5	100	417131	247042:02:05_03.00	247042	75.0	30.7	3.0	101	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
417131:01:03_10.00	8.5	100	417131	280115:01:03_30.00	280115	75.0	19.9	30.0	92	JX401	potent, non-cytotoxic, membrane permeable p38a MAPK inhibitor.	False	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1
417202:01:03_10.00	6.7	96	417202	413121:01:03_50.00	413121	83.39999999999999	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
417202:01:03_10.00	6.7	96	417202	413221:01:03_10.00	413221	82.19999999999999	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
417202:01:03_10.00	6.7	96	417202	247342:01:05_10.00	247342	79.0	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
417202:01:03_10.00	6.7	96	417202	413223:01:04_50.00	413223	78.8	14.2	50.0	89	UCSF924	UCSF924 is a selective, high-affinity dopamine D4 receptor (DRD4) partial agonist (Ki = 3 nM for human D4) with a 7.4-fold bias toward arrestin recruitment over G.a.i (G.a.i/0; Gi/G0) signaling activation with respect to quinpirole. UCSF924 exhibits no detectable affinity for D2, D3 or the F261V/L328F D4 mutant and no agonist activity toward a panel of 320 nonolfactory GPCRs even at a high concentration of 1 uM.	False	Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
417202:01:03_10.00	6.7	96	417202	519808:01:04_30.00	519808	78.5	57.5	30.0	96		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
417202:01:03_10.00	6.7	96	417202	382185:03:06_10.00	382185	78.5	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
417202:01:03_10.00	6.7	96	417202	413092:01:04_30.00	413092	78.4	57.5	30.0	102	Zamifenacin	Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome.	True	c1ccc(C(O[C@@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1
417202:01:03_10.00	6.7	96	417202	413171:01:02_03.00	413171	78.3	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
417202:01:03_10.00	6.7	96	417202	409343:02:02_03.00	409343	78.2	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
417202:01:03_10.00	6.7	96	417202	413121:01:03_30.00	413121	78.2	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
417218:01:03_10.00	24.2	91	417218	247155:02:03_10.00	247155	85.5	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
417218:01:03_10.00	24.2	91	417218	246897:02:03_10.00	246897	84.6	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
417218:01:03_10.00	24.2	91	417218	247361:01:04_10.00	247361	84.39999999999999	18.5	10.0	110	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
417218:01:03_10.00	24.2	91	417218	246456:01:04_10.00	246456	83.89999999999999	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
417218:01:03_10.00	24.2	91	417218	280360:01:03_10.00	280360	83.7	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
417218:01:03_10.00	24.2	91	417218	246628:01:04_10.00	246628	83.3	58.4	10.0	102	Zuclopenthixol hydrochloride	antagonist at D1 and D2 dopamine receptors; inhibitory activity against Geminin, Aberrant vpr protein (HIV), Glucagon-like peptide 1 receptor, (Plasmodium falciparum)	False	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1
417218:01:03_10.00	24.2	91	417218	247419:02:03_10.00	247419	83.1	6.4	10.0	106	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
417218:01:03_10.00	24.2	91	417218	247167:01:04_10.00	247167	83.0	7.3	10.0	100	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
417218:01:03_10.00	24.2	91	417218	246897:01:04_10.00	246897	83.0	20.9	10.0	100	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
417218:01:03_10.00	24.2	91	417218	247342:01:05_10.00	247342	82.89999999999999	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
417265:01:03_10.00	7.4	99	417265	409878:01:04_50.00	409878	80.5	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
417265:01:03_10.00	7.4	99	417265	247238:02:03_30.00	247238	80.2	50.6	30.0	104	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
417265:01:03_10.00	7.4	99	417265	246866:02:03_10.00	246866	79.10000000000001	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417265:01:03_10.00	7.4	99	417265	409878:01:04_30.00	409878	78.8	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
417265:01:03_10.00	7.4	99	417265	413167:01:02_03.00	413167	78.4	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
417265:01:03_10.00	7.4	99	417265	280086:01:03_10.00	280086	78.0	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417265:01:03_10.00	7.4	99	417265	317004:02:10_10.00	317004	78.0	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
417265:01:03_10.00	7.4	99	417265	280571:01:03_30.00	280571	77.9	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
417265:01:03_10.00	7.4	99	417265	280904:01:03_30.00	280904	77.3	45.4	30.0	101	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
417265:01:03_10.00	7.4	99	417265	280016:01:03_30.00	280016	77.3	40.6	30.0	97	LY-53,857 maleate	potent and selective 5-HT2 serotonin receptor antagonist.	False	CC(O)C(C)OC(=O)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C(C)C)C[C@H]2N(C)C1
417281:01:03_10.00	14.3	101	417281	246866:02:03_10.00	246866	81.8	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417281:01:03_10.00	14.3	101	417281	407974:01:04_10.00	407974	81.39999999999999	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
417281:01:03_10.00	14.3	101	417281	280474:01:03_30.00	280474	80.60000000000001	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
417281:01:03_10.00	14.3	101	417281	281040:01:03_10.00	281040	80.10000000000001	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
417281:01:03_10.00	14.3	101	417281	382185:04:07_03.00	382185	80.10000000000001	20.0	3.0	95	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
417281:01:03_10.00	14.3	101	417281	317004:02:10_10.00	317004	79.7	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
417281:01:03_10.00	14.3	101	417281	409837:01:03_10.00	409837	79.60000000000001	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
417281:01:03_10.00	14.3	101	417281	246363:01:04_30.00	246363	79.4	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
417281:01:03_10.00	14.3	101	417281	528526:01:02_05.00	528526	78.8	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
417281:01:03_10.00	14.3	101	417281	280571:01:03_30.00	280571	78.3	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
417387:01:03_10.00	12.3	100	417387	246663:01:04_10.00	246663	85.3	35.1	10.0	92	Gefitinib	Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity.; Brehmer et al., Cellular targets of gefitinib. Cancer Res 65, 379-82 (2005). Yadav et al., Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors. Biochim Biophys Acta. 1860, 2178-90 (2016).	False	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1
417387:01:03_10.00	12.3	100	417387	412477:01:03_50.00	412477	84.0	55.8	50.0	93		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 &gt; 50 ÂµM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
417387:01:03_10.00	12.3	100	417387	413100:01:03_10.00	413100	83.6	42.0	10.0	85	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
417387:01:03_10.00	12.3	100	417387	411129:01:03_10.00	411129	83.3	41.5	10.0	92	Borussertib	Borussertib is a covalent-allosteric and first-in-class inhibitor of protein kinase Akt, with an IC50 of 0.8 nM and a Ki of 2.2 nM for Aktwt.	False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5nc6ccnc(O)c6cc5-c5ccccc5)cc4)CC3)c2c1
417387:01:03_10.00	12.3	100	417387	413107:01:04_30.00	413107	82.89999999999999	42.1	30.0	106	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
417387:01:03_10.00	12.3	100	417387	520873:01:03_10.00	520873	82.69999999999999	51.1	10.0	93	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
417387:01:03_10.00	12.3	100	417387	413100:01:05_10.00	413100	82.39999999999999	42.5	10.0	93	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
417387:01:03_10.00	12.3	100	417387	413190:01:02_05.00	413190	82.3	20.4	5.0	96	BAY-985	BAY-985 is a highly potent, orally active and selective ATP-competitive dual inhibitor of TBK1 and IKK.e. with IC50s of 2/30 and 2 nM for TBK1 (low/high ATP) and IKK.e., respectively. Antitumor efficacy.	True	C[C@H](c1ccnc(Nc2nc3cc(-c4cc(N(C)C)ncn4)ccc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1
417387:01:03_10.00	12.3	100	417387	280894:01:03_30.00	280894	82.3	20.9	30.0	91	Ro 25-6981 hydrochloride	NR2B-selective, NMDA glutamate receptor antagonist.	False	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1
417387:01:03_10.00	12.3	100	417387	392491:01:09_02.00	392491	82.19999999999999	13.1	2.0	92	Masitinib	Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFR.a./.b. (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
417403:01:03_10.00	26.3	99	417403	280081:01:03_30.00	280081	82.1	21.9	30.0	91	R 59-022	R 59-022 (DKGI-I) is a diacylglycerol kinase inhibitor (IC50=2.8 uM). R 59-022 is a 5-HTR antagonist, and activates protein kinase C (PKC). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1
417403:01:03_10.00	26.3	99	417403	413161:01:02_03.00	413161	82.0	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
417403:01:03_10.00	26.3	99	417403	280474:01:03_30.00	280474	80.0	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
417403:01:03_10.00	26.3	99	417403	407872:01:03_10.00	407872	79.9	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
417403:01:03_10.00	26.3	99	417403	280190:01:03_30.00	280190	78.2	31.6	30.0	95	Caroverine hydrochloride	nonselective NMDA and AMPA glutamate receptor antagonist.	False	CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21
417403:01:03_10.00	26.3	99	417403	280732:01:03_30.00	280732	78.0	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
417403:01:03_10.00	26.3	99	417403	280309:01:03_30.00	280309	77.9	34.5	30.0	95	Benoxathian hydrochloride	selective alpha1 adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1CSc2ccccc2O1
417403:01:03_10.00	26.3	99	417403	246883:07:04_06.00	246883	77.5	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
417403:01:03_10.00	26.3	99	417403	280400:01:03_30.00	280400	77.5	29.2	30.0	92	Cyproterone acetate	androgen antagonist, synthetic steroid.	False	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
417403:01:03_10.00	26.3	99	417403	246742:01:04_30.00	246742	77.4	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
417413:01:03_10.00	11.6	108	417413	280474:01:03_30.00	280474	86.8	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
417413:01:03_10.00	11.6	108	417413	280732:01:03_30.00	280732	86.7	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
417413:01:03_10.00	11.6	108	417413	280902:01:03_30.00	280902	86.5	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
417413:01:03_10.00	11.6	108	417413	246330:01:04_10.00	246330	86.0	20.0	10.0	92	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
417413:01:03_10.00	11.6	108	417413	528529:01:02_05.00	528529	86.0	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
417413:01:03_10.00	11.6	108	417413	246846:01:05_30.00	246846	85.8	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
417413:01:03_10.00	11.6	108	417413	317004:02:10_10.00	317004	85.6	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
417413:01:03_10.00	11.6	108	417413	287906:02:09_10.00	287906	85.3	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
417413:01:03_10.00	11.6	108	417413	246742:01:04_30.00	246742	85.3	24.4	30.0	101	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
417413:01:03_10.00	11.6	108	417413	407970:01:03_10.00	407970	85.0	31.4	10.0	106	A-395	A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM.	True	CN(C)[C@H]1CN(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1
417531:01:03_10.00	6.6	98	417531	392290:03:03_30.00	392290	75.2	26.3	30.0	91	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417531:01:03_10.00	6.6	98	417531	392290:03:03_50.00	392290	72.7	28.0	50.0	98	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417531:01:03_10.00	6.6	98	417531	413196:01:02_05.00	528551	72.6	6.0	5.0	99		An inhibitor of Complex I quinone binding site (core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase). Active in cellular mechanistic assay demonstrating cellular target engagement. Proliferation assays: IC50 = 79 nM (H1299 (human lung); IC50 = 33 nM (H1299 (human lung). Negative control = BAY-070	False	c1ccc2oc(-c3csc(C4CCN(Cc5nc6cccnc6[nH]5)CC4)n3)cc2c1
417531:01:03_10.00	6.6	98	417531	392290:03:03_10.00	392290	71.1	14.2	10.0	94	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417531:01:03_10.00	6.6	98	417531	412994:01:03_10.00	412994	70.5	30.9	10.0	95	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
417531:01:03_10.00	6.6	98	417531	412994:01:03_06.00	412994	65.8	22.6	6.0	90	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
417571:01:03_10.00	15.0	104	417571	246811:02:03_50.00	246811	87.4	44.6	50.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
417571:01:03_10.00	15.0	104	417571	280086:01:03_10.00	280086	86.6	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417571:01:03_10.00	15.0	104	417571	246811:02:03_30.00	246811	85.9	43.5	30.0	89	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
417571:01:03_10.00	15.0	104	417571	246820:12:03_50.00	246820	85.6	39.6	50.0	91	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
417571:01:03_10.00	15.0	104	417571	413221:01:03_10.00	413221	83.6	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
417571:01:03_10.00	15.0	104	417571	413085:01:07_03.00	413085	83.39999999999999	29.4	3.0	91	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
417571:01:03_10.00	15.0	104	417571	382150:02:04_50.00	382150	83.3	29.5	50.0	98	GW788388	selective inhibitor of TGF-ÃRI.	False	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1
417571:01:03_10.00	15.0	104	417571	519808:01:04_30.00	519808	83.2	57.5	30.0	96		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
417571:01:03_10.00	15.0	104	417571	520969:01:04_50.00	520969	82.8	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
417571:01:03_10.00	15.0	104	417571	413171:01:02_03.00	413171	82.69999999999999	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
417572:01:03_10.00	8.1	100	417572	280360:01:03_10.00	280360	78.5	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
417572:01:03_10.00	8.1	100	417572	528559:01:02_03.00	528559	77.9	10.9	3.0	95		GSK973 is a BD2 selective inhibitor of BRD2, BRD3, BRD4 and BRDT. BRD2 (BD2) pIC50 = 7.5; BRD3 (BD2) pIC50 = 7.8; BRD4 (BD2) pIC50 = 7.8; BRDT (BD2) pIC50 = 7.4	True	CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1
417572:01:03_10.00	8.1	100	417572	246456:01:04_10.00	246456	76.1	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
417572:01:03_10.00	8.1	100	417572	412681:01:04_30.00	412681	75.5	59.9	30.0	70	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
417572:01:03_10.00	8.1	100	417572	519823:01:02_30.00	519823	75.4	25.4	30.0	98		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
417572:01:03_10.00	8.1	100	417572	413179:01:02_03.00	413179	75.2	7.4	3.0	103		PPTN is an antagonist of P2RY14 (GPR105). IC50 = 0.5 nM (FLIPR assay). Negative control = PPTN-1-NC	False	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
417572:01:03_10.00	8.1	100	417572	280128:01:04_10.00	280128	75.0	51.3	10.0	99	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
417572:01:03_10.00	8.1	100	417572	413008:01:03_10.00	413008	74.9	79.1	10.0	102	Src Inhibitor 1	Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.	False	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
417572:01:03_10.00	8.1	100	417572	413134:02:04_30.00	413134	74.8	11.4	30.0	96	Ogerin negative control	Ogerin negative control is a structurally similar analog of ogerin (catalog no. SML1482). Ogerin is a selective positive allosteric modulator of an orphan GPCR, GPR68, also known as Ovarian cancer G-protein coupled receptor 1 (OGR1).	False	Nc1nc(NCc2ccccc2)nc(-c2cccc(CO)c2)n1
417572:01:03_10.00	8.1	100	417572	246897:02:03_10.00	246897	74.7	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
417594:01:03_10.00	29.2	100	417594	413094:01:04_30.00	413094	87.2	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
417594:01:03_10.00	29.2	100	417594	409343:02:02_03.00	409343	86.2	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
417594:01:03_10.00	29.2	100	417594	287906:02:09_10.00	287906	85.7	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
417594:01:03_10.00	29.2	100	417594	246897:02:03_10.00	246897	84.39999999999999	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
417594:01:03_10.00	29.2	100	417594	247020:01:04_10.00	247020	84.2	24.4	10.0	97	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
417594:01:03_10.00	29.2	100	417594	520969:01:04_50.00	520969	84.1	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
417594:01:03_10.00	29.2	100	417594	391492:01:14_10.00	391492	84.1	21.6	10.0	95	SAR405	the activity of SAR405 was evaluated on a dedicated Vps34 cellular assay. Using a GFP-FYVEÂ¿transfected HeLa cell line, treatment with SAR405 triggered the relocalization of GFP-FYVE inside the cell without affecting GFP intensity. Binding of SAR405 to the ATP site of protein and lipid kinases from the lysate of Jurkat cells was measured after incubation at 1 ÂµM, which is more than 600-fold the KD for recombinant Vps34. Results confirmed very potent binding to endogenous Vps34 (&gt;94% inhibition).	True	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2
417594:01:03_10.00	29.2	100	417594	520746:01:02_50.00	520746	83.89999999999999	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
417594:01:03_10.00	29.2	100	417594	247342:01:05_10.00	247342	83.6	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
417594:01:03_10.00	29.2	100	417594	528529:01:02_03.00	528529	83.39999999999999	11.2	3.0	101		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
417609:01:03_10.00	7.9	84	417609	247197:01:04_10.00	247197	80.2	30.4	10.0	102	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
417609:01:03_10.00	7.9	84	417609	246456:01:04_10.00	246456	79.9	35.8	10.0	97	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
417609:01:03_10.00	7.9	84	417609	247342:01:05_10.00	247342	78.9	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
417609:01:03_10.00	7.9	84	417609	280360:01:03_10.00	280360	78.8	19.3	10.0	105	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
417609:01:03_10.00	7.9	84	417609	412681:01:04_30.00	412681	78.8	59.9	30.0	70	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
417609:01:03_10.00	7.9	84	417609	247167:01:04_10.00	247167	78.60000000000001	7.3	10.0	100	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
417609:01:03_10.00	7.9	84	417609	246433:01:04_10.00	246433	78.60000000000001	14.3	10.0	106	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
417609:01:03_10.00	7.9	84	417609	382135:02:03_30.00	382135	78.4	30.7	30.0	98	CH-223191	CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist. It inhibited TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibited TCDD-induced luciferase activity with an IC50 of 30nM.	False	Cc1ccccc1/N=N/c1ccc(NC(=O)c2ccnn2C)c(C)c1
417609:01:03_10.00	7.9	84	417609	382185:03:06_10.00	382185	78.2	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
417609:01:03_10.00	7.9	84	417609	412998:01:02_10.00	412998	78.0	33.2	10.0	106	Halopemide	Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent.	False	O=C(NCCN1CCC(n2c(O)nc3cc(Cl)ccc32)CC1)c1ccc(F)cc1
417626:01:03_10.00	22.6	101	417626	413117:01:03_10.00	413117	80.4	12.4	10.0	95	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
417626:01:03_10.00	22.6	101	417626	413161:01:02_03.00	413161	78.3	6.2	3.0	99		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
417626:01:03_10.00	22.6	101	417626	407872:01:03_10.00	407872	77.4	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
417626:01:03_10.00	22.6	101	417626	280115:01:03_30.00	280115	77.2	19.9	30.0	92	JX401	potent, non-cytotoxic, membrane permeable p38a MAPK inhibitor.	False	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1
417626:01:03_10.00	22.6	101	417626	407872:01:06_10.00	407872	76.8	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
417626:01:03_10.00	22.6	101	417626	280355:01:03_30.00	280355	76.5	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
417626:01:03_10.00	22.6	101	417626	280670:01:03_30.00	280670	76.4	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
417626:01:03_10.00	22.6	101	417626	519813:01:03_10.00	519813	76.4	11.6	10.0	101		BI-3257 is an inhibitor of HIV replication with nanomolar activity. It prevents the formation of the capsid core structure that encapsulates the viral genome and its associated enzymes, reverse transcriptase and integrase. BI-3257 binds to an induced pocket in the N-terminal domain of the capsid protein and induces significant structural changes (displacement of the .a.1-helix), likely affecting the protein-protein interactions that define the regular structures of the viral capsid core. The binding location of BI-3257-type compounds in the capsid monomer was elucidated by X-ray crystallography, and electron microscopy allowed the elucidation of its mode of action. Due to this innovative mechanism of viral replication, BI-3257 is equally potent against the wild-type as well as mutant viruses that are resistant to the four major classes of antiretroviral inhibitors	False	CCCn1cc(-c2cc(C3C(=O)N(CC)c4ccc(C(F)(F)F)cc4N(c4ccccc4)C3=O)cc(OC)c2O)cn1
417626:01:03_10.00	22.6	101	417626	280424:01:03_30.00	280424	76.3	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
417626:01:03_10.00	22.6	101	417626	412994:01:03_06.00	412994	76.2	22.6	6.0	90	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
417631:01:03_10.00	35.9	96	417631	247238:02:03_30.00	247238	87.0	50.6	30.0	104	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
417631:01:03_10.00	35.9	96	417631	409878:01:04_50.00	409878	86.4	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
417631:01:03_10.00	35.9	96	417631	280571:01:03_30.00	280571	85.6	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
417631:01:03_10.00	35.9	96	417631	280904:01:03_30.00	280904	85.3	45.4	30.0	101	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
417631:01:03_10.00	35.9	96	417631	246866:02:03_10.00	246866	85.2	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
417631:01:03_10.00	35.9	96	417631	280468:01:03_30.00	280468	84.2	31.1	30.0	95	WB-4101 hydrochloride	alpha1A Adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
417631:01:03_10.00	35.9	96	417631	280016:01:03_30.00	280016	84.0	40.6	30.0	97	LY-53,857 maleate	potent and selective 5-HT2 serotonin receptor antagonist.	False	CC(O)C(C)OC(=O)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C(C)C)C[C@H]2N(C)C1
417631:01:03_10.00	35.9	96	417631	520969:01:04_50.00	520969	83.39999999999999	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
417631:01:03_10.00	35.9	96	417631	409878:01:04_30.00	409878	83.39999999999999	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
417631:01:03_10.00	35.9	96	417631	520969:01:04_30.00	520969	83.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
417665:01:03_10.00	14.7	104	417665	392290:03:03_50.00	392290	84.0	28.0	50.0	98	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417665:01:03_10.00	14.7	104	417665	392290:03:03_30.00	392290	78.60000000000001	26.3	30.0	91	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417665:01:03_10.00	14.7	104	417665	392290:03:03_10.00	392290	75.1	14.2	10.0	94	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
417665:01:03_10.00	14.7	104	417665	412994:01:03_06.00	412994	72.3	22.6	6.0	90	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
417665:01:03_10.00	14.7	104	417665	412994:01:03_10.00	412994	71.6	30.9	10.0	95	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
417665:01:03_10.00	14.7	104	417665	519808:01:04_50.00	519808	68.5	47.0	50.0	77		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
417718:01:03_10.00	11.4	99	417718	247001:01:04_30.00	247001	81.2	10.9	30.0	92	Niflumic acid	Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Target: Othersniflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calcium channels or activate potassium channels. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels . Niflumic acid molecule is completely buried in the substrate-binding hydrophobic channel. The conformations of the binding site in PLA(2) as well as that of niflumic acid are not altered upon binding . Niflumic acid (NFA) produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site .	False	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1
417718:01:03_10.00	11.4	99	417718	246881:01:12_02.00	246881	78.5	6.7	2.0	102	Dipyridamole	Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.Target: Phosphodiesterase (PDE)Dipyridamole concentrations of 1 nmol/ml blood caused 90% inhibition of adenosine metabolism. Dipyridamole at therapeutic concentrations causes significant inhibition of adenosine metabolism in whole blood . Dipyridamole has a dose-dependent inhibitory effect on thromboxane synthesis which was independent of aggregation. Dipyridamole also inhibited malonyldialdehyde production in response to both thrombin and arachidonic acid . Dipyridamole enhances platelet inhibition by amplifying the signaling of the NO donor sodium nitroprusside. These data support the concept that enhancement of endothelium-dependent NO/cGMP-mediated signaling may be an important in vivo component of dipyridamole action .; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
417718:01:03_10.00	11.4	99	417718	246641:01:04_10.00	246641	76.1	10.4	10.0	104	Nandrolone	Androgen receptor (IC50 = 3.149 nM); Progesterone receptor (IC50 = 171.5 nM)	True	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O
417718:01:03_10.00	11.4	99	417718	246673:02:09_00.20	246673	73.9	9.8	0.2	107	Lapatinib (ditosylate)	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
417718:01:03_10.00	11.4	99	417718	392421:01:02_00.20	392421	73.3	13.1	0.2	102		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0002 ÂµM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(F)c2)c2c(N)ncnc21
417718:01:03_10.00	11.4	99	417718	392489:01:09_00.20	392489	73.0	7.3	0.2	93	Enzastaurin	Enzastaurin (LY317615) is a potent and selective PKC.b. inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKC.a., PKC.g. and PKC.e..	False	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21
417718:01:03_10.00	11.4	99	417718	246577:01:05_10.00	246577	72.8	15.2	10.0	98	Gabexate mesilate	serine protease inhibitor.	False	CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1
417718:01:03_10.00	11.4	99	417718	410898:01:03_00.20	410898	72.6	7.8	0.2	98	Sulforaphane	Sulforaphane is an isothiocyanate present naturally in widely consumed vegetables; has shown anticancer and cardioprotective activities.	False	CS(=O)CCCCN=C=S
417718:01:03_10.00	11.4	99	417718	247318:01:04_30.00	247318	71.89999999999999	19.3	30.0	104	Sulfamonomethoxine	Sulfamonomethoxine is a long acting sulfonamide antibacterial agent, used in blood kinetic studies,and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.	False	COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1
417718:01:03_10.00	11.4	99	417718	410756:01:04_06.00	410756	71.2	11.7	6.0	111	GW9508	GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities.	False	O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1
417753:01:03_10.00	22.1	86	417753	410141:01:04_10.00	410141	75.5	32.6	10.0	89	VX-11e	VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki &lt; 2 nM.	True	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1
417753:01:03_10.00	22.1	86	417753	280547:01:03_30.00	280547	74.7	21.2	30.0	100	FPL 64176	potent L-type Ca2+ channel activator.	False	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1
417753:01:03_10.00	22.1	86	417753	413121:01:03_30.00	413121	74.5	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
417753:01:03_10.00	22.1	86	417753	246847:01:04_30.00	246847	73.2	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
417753:01:03_10.00	22.1	86	417753	280424:01:03_30.00	280424	73.1	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
417753:01:03_10.00	22.1	86	417753	280655:01:03_30.00	280655	73.1	70.5	30.0	75	JWH-015	selective CB2 cannabinoid receptor agonist.	False	CCCn1c(C)c(C(=O)c2ccc3ccccc3c2)c2ccccc21
417753:01:03_10.00	22.1	86	417753	413117:01:03_10.00	413117	73.0	12.4	10.0	95	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
417753:01:03_10.00	22.1	86	417753	413013:01:03_30.00	413013	72.89999999999999	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
417753:01:03_10.00	22.1	86	417753	407880:01:03_10.00	407880	72.3	28.2	10.0	97	ML385	ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 uM.	False	Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21
417753:01:03_10.00	22.1	86	417753	246598:01:04_30.00	246598	71.2	20.2	30.0	90	Moricizine hydrochloride	sodium channel inhibitor.	False	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2
417787:01:03_10.00	7.3	103	417787	410043:01:04_00.60	410043	85.8	50.9	0.6	107	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
417787:01:03_10.00	7.3	103	417787	247331:02:03_30.00	247331	84.2	32.0	30.0	99	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
417787:01:03_10.00	7.3	103	417787	409814:01:04_03.00	409814	84.0	13.6	3.0	89	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibitsÂ in vitroÂ methylation of H3K4 with IC50Â = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50Â = 0.8 ÂµM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
417787:01:03_10.00	7.3	103	417787	410043:01:05_00.60	410043	83.8	59.1	0.6	99	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
417787:01:03_10.00	7.3	103	417787	246897:02:03_10.00	246897	83.39999999999999	9.5	10.0	87	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
417787:01:03_10.00	7.3	103	417787	409343:02:02_03.00	409343	82.3	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
417787:01:03_10.00	7.3	103	417787	246877:02:03_10.00	246877	81.5	11.1	10.0	103	(Â±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
417787:01:03_10.00	7.3	103	417787	280586:01:03_30.00	280586	81.5	10.2	30.0	100	R-(+)-8-Hydroxy-DPAT hydrobromide	full 5-HT1A serotonin receptor agonist, active enantiomer of (Â±)-8-hydroxy-DPAT.	False	CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1
417787:01:03_10.00	7.3	103	417787	280128:01:04_10.00	280128	81.39999999999999	51.3	10.0	99	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
417787:01:03_10.00	7.3	103	417787	410510:01:05_50.00	410510	81.39999999999999	57.9	50.0	115		it was synthesized during a campaign to develop third generation of ?2-agonists (KD = 84 pM). BI-167107 is not a selective beta2 agonist. BI-167107 is also very a active agonist of the ?1AR (IC50 = 3.2 nM) and shows some activity as ?1A antagonist (IC50 = 32 nM). BI-167107 showed also weaker activity on other targets: 5-HT transporter (IC50 = 6.1 ÂµM), 5-HT1A (IC50 = 1.4 ÂµM), 5-HT1B (IC50 = 0.25 ÂµM), D2S (IC50 = 5.9 ÂµM), dopamine transporter (IC50 = 7.2 ÂµM), ? (MOP) (IC50 = 6.5 ÂµM).	True	Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2
417927:01:03_10.00	12.1	93	417927	280960:01:04_10.00	280960	69.8	19.3	10.0	94	SU 4312	vascular endothelial growth factor (VEGF) receptor protein tyrosine kinase 1/2 (KDR) and platelet derived growth factor (PDGF) receptor inhibitor.	False	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1
417927:01:03_10.00	12.1	93	417927	246886:01:04_10.00	246886	68.5	16.2	10.0	90	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of &gt;32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
417927:01:03_10.00	12.1	93	417927	413121:01:03_50.00	413121	67.5	35.6	50.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
417927:01:03_10.00	12.1	93	417927	413085:01:06_50.00	413085	67.10000000000001	61.7	50.0	80	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
417927:01:03_10.00	12.1	93	417927	247419:02:03_10.00	247419	67.0	6.4	10.0	106	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
417927:01:03_10.00	12.1	93	417927	413052:01:03_30.00	413052	66.9	42.0	30.0	87	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
417927:01:03_10.00	12.1	93	417927	382185:03:06_10.00	382185	66.8	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
417927:01:03_10.00	12.1	93	417927	413085:01:07_03.00	413085	66.8	29.4	3.0	91	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
417927:01:03_10.00	12.1	93	417927	411033:02:03_10.00	411033	66.5	40.1	10.0	66	MZ 1	MZ 1 is a BRD4 protein degrader based on PROTAC technology.	False	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
417927:01:03_10.00	12.1	93	417927	413085:01:07_01.00	413085	66.3	9.0	1.0	102	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
417929:01:03_10.00	14.9	91	417929	280706:01:03_10.00	280706	79.4	21.2	10.0	86	MRS 1523	selective A3 adenosine receptor antagonist in rat.	False	CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC
417929:01:03_10.00	14.9	91	417929	247000:02:03_10.00	247000	79.10000000000001	44.2	10.0	98	Nortriptyline (hydrochloride)	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride) is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and used to relieve the symptoms of depression.	False	CNCCC=C1c2ccccc2CCc2ccccc21
417929:01:03_10.00	14.9	91	417929	409860:01:03_01.00	409860	78.9	30.2	1.0	89	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of &lt;2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
417929:01:03_10.00	14.9	91	417929	413159:01:02_05.00	413159	78.7	6.2	5.0	100		negative control to A-079	False	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1
417929:01:03_10.00	14.9	91	417929	409921:01:02_02.00	409921	78.60000000000001	38.0	2.0	67	MZ1	it is a hybrid compound that drives the selective proteasomal degradation of bromodomain-containing protein 4 (BRD4). It is characterized as a proteolysis-targeting chimera (PROTAC) and contains JQ-1, which binds bromo- and extra-terminal (BET) proteins, linked to a ligand for the E3 ubiquitin ligase VHL. MZ1 induces the selective degradation of BRD4 in HeLa cells when used at 0.1-0.5 ÂµM. At concentrations of 2-10 ÂµM, MZ1 causes the removal of BRD2, BRD3, and BRD4. BRD protein removal is evident within four hours of adding MZ1 and persists for at least 48 hours, unless MZ1 is removed.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
417929:01:03_10.00	14.9	91	417929	246307:01:04_30.00	246307	78.4	11.6	30.0	85	Hexestrol	nuclear receptor ligand.	False	CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1
417929:01:03_10.00	14.9	91	417929	280791:01:03_10.00	280791	77.10000000000001	6.9	10.0	96	Olomoucine	potent and selective inhibitor of cdc2, cdk and cyclin-dependent kinases.	False	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21
417929:01:03_10.00	14.9	91	417929	391925:02:09_00.20	391925	77.0	37.7	0.2	77	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 ÂµM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 ÂµM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
417929:01:03_10.00	14.9	91	417929	246817:01:04_30.00	246817	77.0	56.5	30.0	100	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
417929:01:03_10.00	14.9	91	417929	280491:01:03_10.00	280491	76.9	24.4	10.0	84	(-)-alpha-Methylnorepinephrine, Levonordefrin	active enantiomer, adrenoceptor agonist, vasoconstrictor, antihypertensive.	False	CC(N)[C@H](O)c1ccc(O)c(O)c1
417941:01:03_10.00	30.4	100	417941	392736:02:03_02.00	392736	80.9	16.1	2.0	93	TAK-632	TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively.	False	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12
417941:01:03_10.00	30.4	100	417941	413151:01:02_05.00	413151	74.3	10.4	5.0	105		negative control to IPP/CNRS-A017	False	Cc1c(Oc2ccc(F)cc2)c(OC(C)C)nn1-c1ccc(C2CC2)cn1
417941:01:03_10.00	30.4	100	417941	410918:01:03_02.00	410918	71.0	21.2	2.0	99	Inauhzin	Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.	False	CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21
417941:01:03_10.00	30.4	100	417941	392421:01:02_00.20	392421	69.1	13.1	0.2	102		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0002 ÂµM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(F)c2)c2c(N)ncnc21
418009:01:03_10.00	8.6	95	418009	246898:01:04_10.00	246898	81.3	5.5	10.0	95	Oxfendazole	Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. Target: AntiparasiticOxfendazole is the sulfoxide form of fenbendazole, a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms.. Pigs in the treated group received Oxfendazole orally at 30 mg/kg dose. At five days post-treatment, animals were sacrificed and the clinical efficacy of the Oxfendazole treatment was established following the currently available WAAVP guidelines for a controlled efficacy test. None of the animals involved in this experiment showed any adverse events during the study. Oxfendazole treatment given as a single 30 mg/kg oral dose showed a 100% efficacy against all the nematode parasites present in the three experiments. In conclusion, under the current experimental conditions, Oxfendazole orally administered to naturally parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult stages of A. suum, Oesophagostomum spp., T. suis and Metastrongylus spp . 	False	COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1
418009:01:03_10.00	8.6	95	418009	392515:01:09_00.20	392515	73.4	9.3	0.2	97	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
418009:01:03_10.00	8.6	95	418009	280630:01:11_01.00	280630	70.89999999999999	12.1	1.0	91	IC261	IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 uM, 1 uM, 16 uM for Cki.d., Cki.e. and Cki.a.1, respectively.	False	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1
418009:01:03_10.00	8.6	95	418009	392607:01:09_02.00	392607	70.8	5.7	2.0	82	Buparlisib	Buparlisib (BKM120; NVP-BKM120) is a pan-class I PI3K inhibitor, with IC50s of 52, 166, 116 and 262 nM for p110.a., p110.b., p110.d. and p110.g., respectively.	False	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1
418009:01:03_10.00	8.6	95	418009	392593:01:09_00.20	392593	68.7	7.3	0.2	92	TAK-901	TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.	False	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1
418009:01:03_10.00	8.6	95	418009	280986:01:03_30.00	280986	68.7	13.1	30.0	86	AG-494	AG-494 (Tyrphostin AG 494) is a potent and selective EGFR tyrosine kinase inhibitor (IC50=0.7 uM). AG-494 inhibits the autophosphorylation of EGFR, ErbB2, HER1-2 and PDGF-R with IC50s 1.1, 39, 45 and 6 uM, respectively. AG-494 blocks Cdk2 activation and inhibits EGF-dependent DNA synthesis.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1
418009:01:03_10.00	8.6	95	418009	410613:01:05_00.60	410613	68.10000000000001	8.6	0.6	100	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
418009:01:03_10.00	8.6	95	418009	343866:01:08_50.00	343866	67.9	6.7	50.0	98	Tissue-Nonspecific Alkaline Phosphatase Inhibitor, ;MLS-0038949	a cell-permeable quinolinyl-benzenesulfonamide compound that acts as a potent reversible inhibitor against tissue-nonspecific (TN) alkaline phosphatase (AP) activity (IC50 = 190 nM) with CYP2C19 being the only other known target, while exhibiting little or no inhibitory activity in over 250 assays involving other enzymes, including, but not limited to, placental and intestinal APs (IC50 &gt; 100 ÂµM), PHOSPHO1 phosphatase, and NPP1 phosphodiesterase. Kinetic studies indicate that the inhibition is uncompetitive with respect to the phosphate donor substrate and noncompetitive with respect to the acceptor substrate, indicating an allosteric inhibition mechanism. Subcutaneous dosing in rats in vivo is reported to result in plasma inhibitor concentrations in the therapeutic range (Cmax = 1.5 Âµg/ml 1 hr after 4.13 mg/kg by s.c.).	False	COc1ccc(OC)c(S(=O)(=O)Nc2cnc3ccccc3c2)c1
418009:01:03_10.00	8.6	95	418009	280340:01:03_10.00	280340	66.8	16.4	10.0	95	5-Bromo-2'-deoxyuridine, Br-dU	thymidine analog, incorporated into DNA during S-phase of cell cycle.	False	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br
418009:01:03_10.00	8.6	95	418009	408563:02:02_50.00	408563	66.4	16.8	50.0	87	2,4-Bis(1,1-dimethylethyl)phenol phosphate (bDtBPP)		False	CC(C)(C)c1ccc(OP(=O)(O)Oc2ccc(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)c1
418045:01:03_10.00	7.1	94	418045	413094:01:04_30.00	413094	78.4	22.3	30.0	96	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
418045:01:03_10.00	7.1	94	418045	520873:01:03_10.00	520873	77.7	51.1	10.0	93	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
418045:01:03_10.00	7.1	94	418045	412477:01:03_50.00	412477	76.6	55.8	50.0	93		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 &gt; 50 ÂµM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
418045:01:03_10.00	7.1	94	418045	413126:02:02_00.50	413126	76.6	53.9	0.5	106		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
418045:01:03_10.00	7.1	94	418045	412270:01:02_10.00	412270	76.5	50.1	10.0	85	cis-ACBI1	cis-ACBI1 is the negative control to ACBI. The hydroxy proline of the VHL binding part is in the inactive cis-conformation, which prevents binding to VHL and thereby protein degradation.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
418045:01:03_10.00	7.1	94	418045	246478:01:04_30.00	246478	75.8	42.3	30.0	100	Mesoridazine besylate	D antagonist.	False	CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21
418045:01:03_10.00	7.1	94	418045	281030:01:03_10.00	281030	75.4	32.8	10.0	91	U-74389G maleate	free radical lipid peroxidation inhibitor.	False	C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12
418045:01:03_10.00	7.1	94	418045	246817:01:04_10.00	246817	75.3	45.4	10.0	106	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
418045:01:03_10.00	7.1	94	418045	280740:01:04_10.00	280740	74.7	15.9	10.0	99	MDL 28170, Z-Val-Phe-CHO	cell permeable calpain I and II inhibitor.	False	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1
418045:01:03_10.00	7.1	94	418045	413090:01:05_50.00	413090	74.7	48.5	50.0	83	VU591	VU591 is a potent, selective renal outer medullary potassium channel (ROMK or Kir1.1) inhibitor, with an IC50 of 0.24 uM.	False	O=[N+]([O-])c1ccc2[nH]c(COCc3nc4cc([N+](=O)[O-])ccc4[nH]3)nc2c1
418081:01:03_10.00	17.4	100	418081	280127:01:04_10.00	280127	80.9	21.9	10.0	101	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
418081:01:03_10.00	17.4	100	418081	413094:01:04_50.00	413094	80.2	38.9	50.0	99	PF-05190457	PF-5190457 is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36.	True	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1
418081:01:03_10.00	17.4	100	418081	246811:02:03_50.00	246811	79.2	44.6	50.0	92	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
418081:01:03_10.00	17.4	100	418081	280944:01:03_10.00	280944	79.2	48.7	10.0	96	SKF 95282 dimaleate, Zolantidine	H2 Histamine receptor antagonist.	False	c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3s2)c1
418081:01:03_10.00	17.4	100	418081	247155:02:03_10.00	247155	79.0	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
418081:01:03_10.00	17.4	100	418081	413126:02:02_00.30	413126	78.4	37.5	0.3	98		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
418081:01:03_10.00	17.4	100	418081	280128:01:04_10.00	280128	78.10000000000001	51.3	10.0	99	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
418081:01:03_10.00	17.4	100	418081	247293:02:03_10.00	247293	78.0	29.7	10.0	104	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
418081:01:03_10.00	17.4	100	418081	247196:01:04_10.00	247196	77.9	21.8	10.0	102	Acepromazine maleate	dopaminergic antagonist ?, sedative.	False	CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
418081:01:03_10.00	17.4	100	418081	413149:01:02_05.00	413149	77.9	9.2	5.0	93		negative control to BAY-985	False	CN(C)c1ncnc(-c2ccc3[nH]c(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)nc3c2)c1Cl
418111:01:03_10.00	20.7	84	418111	528531:01:02_05.00	528531	76.1	36.1	5.0	82		MU1210 is a potent probe for CLK1/2/4 with IC50 values of 8/20/12 nM, respectively with corresponding good cellular potency in NanoBRET assays (84/91/23 nM), respectively. CLK3 was not inhibited by MU1210 at concentrations up to 3 ÂµM.	False	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1
418111:01:03_10.00	20.7	84	418111	409829:01:05_50.00	409829	72.6	18.1	50.0	70	A-1155463	A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell.	False	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1
418111:01:03_10.00	20.7	84	418111	280697:01:03_10.00	280697	72.39999999999999	20.0	10.0	88	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
418111:01:03_10.00	20.7	84	418111	392062:01:02_02.00	392062	72.0	41.3	2.0	78		GSK-3 beta inhibitor (Ki = 0.03 ÂµM), inhibitor of CDK2 (Ki = 0.01 ÂµM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1
418111:01:03_10.00	20.7	84	418111	409860:01:03_01.00	409860	71.7	30.2	1.0	89	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of &lt;2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
418111:01:03_10.00	20.7	84	418111	409921:01:02_02.00	409921	71.6	38.0	2.0	67	MZ1	it is a hybrid compound that drives the selective proteasomal degradation of bromodomain-containing protein 4 (BRD4). It is characterized as a proteolysis-targeting chimera (PROTAC) and contains JQ-1, which binds bromo- and extra-terminal (BET) proteins, linked to a ligand for the E3 ubiquitin ligase VHL. MZ1 induces the selective degradation of BRD4 in HeLa cells when used at 0.1-0.5 ÂµM. At concentrations of 2-10 ÂµM, MZ1 causes the removal of BRD2, BRD3, and BRD4. BRD protein removal is evident within four hours of adding MZ1 and persists for at least 48 hours, unless MZ1 is removed.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
418111:01:03_10.00	20.7	84	418111	280697:01:03_30.00	280697	71.5	49.9	30.0	103	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
418111:01:03_10.00	20.7	84	418111	245373:02:04_10.00	245373	71.5	7.3	10.0	105	Oxybutynin Chloride	muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
418111:01:03_10.00	20.7	84	418111	410105:01:04_00.60	410105	70.89999999999999	29.5	0.6	95	CB-5083	CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP.  CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM	False	Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2
418111:01:03_10.00	20.7	84	418111	391925:02:09_00.20	391925	70.8	37.7	0.2	77	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 ÂµM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 ÂµM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
418163:01:03_10.00	35.9	98	418163	280086:01:03_10.00	280086	87.0	44.0	10.0	98	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
418163:01:03_10.00	35.9	98	418163	245325:02:04_10.00	245325	86.0	51.3	10.0	97	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
418163:01:03_10.00	35.9	98	418163	413171:01:02_03.00	413171	84.89999999999999	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
418163:01:03_10.00	35.9	98	418163	410622:01:04_10.00	410622	84.8	47.5	10.0	98	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
418163:01:03_10.00	35.9	98	418163	246883:01:04_10.00	246883	84.5	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
418163:01:03_10.00	35.9	98	418163	520875:02:03_03.00	520875	84.39999999999999	47.2	3.0	98	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
418163:01:03_10.00	35.9	98	418163	520875:02:02_01.00	520875	84.39999999999999	27.5	1.0	105	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
418163:01:03_10.00	35.9	98	418163	247197:01:04_10.00	247197	84.3	30.4	10.0	102	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
418163:01:03_10.00	35.9	98	418163	392705:01:09_02.00	392705	84.2	40.8	2.0	99	JNK-IN-8	JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively.	False	Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1
418163:01:03_10.00	35.9	98	418163	247342:01:05_10.00	247342	83.89999999999999	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
418164:01:03_10.00	15.0	94	418164	528526:01:02_05.00	528526	86.0	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
418164:01:03_10.00	15.0	94	418164	392523:01:09_02.00	392523	84.6	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
418164:01:03_10.00	15.0	94	418164	520746:01:02_50.00	520746	83.39999999999999	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
418164:01:03_10.00	15.0	94	418164	247095:02:03_30.00	247095	83.0	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418164:01:03_10.00	15.0	94	418164	247209:01:04_30.00	247209	82.89999999999999	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
418164:01:03_10.00	15.0	94	418164	520969:01:04_30.00	520969	82.39999999999999	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418164:01:03_10.00	15.0	94	418164	247178:01:04_30.00	247178	82.39999999999999	27.5	30.0	93	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
418164:01:03_10.00	15.0	94	418164	280657:01:03_30.00	280657	82.19999999999999	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
418164:01:03_10.00	15.0	94	418164	522774:02:04_10.00	522774	82.1	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
418164:01:03_10.00	15.0	94	418164	519823:01:02_10.00	519823	82.1	9.8	10.0	94		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
418165:01:03_10.00	20.7	89	418165	283253:01:04_10.00	283253	83.6	35.4	10.0	99	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
418165:01:03_10.00	20.7	89	418165	410043:01:04_00.60	410043	83.1	50.9	0.6	107	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
418165:01:03_10.00	20.7	89	418165	280171:03:02_01.00	280171	82.69999999999999	54.7	1.0	83	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 ÂµM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 ÂµM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
418165:01:03_10.00	20.7	89	418165	419170:01:05_10.00	419170	82.6	55.8	10.0	97	Hydroxychloroquine (free base)	Hydroxychloroquine is used to treat or prevent malaria; lysosomotropic.	False	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
418165:01:03_10.00	20.7	89	418165	410043:01:05_00.60	410043	82.5	59.1	0.6	99	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
418165:01:03_10.00	20.7	89	418165	419170:01:02_10.00	419170	82.39999999999999	64.1	10.0	92	Hydroxychloroquine (free base)	Hydroxychloroquine is used to treat or prevent malaria; lysosomotropic.	False	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
418165:01:03_10.00	20.7	89	418165	246429:01:05_30.00	246429	82.19999999999999	59.9	30.0	74	Quinacrine (dihydrochloride)	Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-.k.B and activate p53 signaling, which results in the induction of the apoptosis.	False	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
418165:01:03_10.00	20.7	89	418165	280171:05:03_01.00	280171	82.0	53.7	1.0	90	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 ÂµM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 ÂµM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
418165:01:03_10.00	20.7	89	418165	409849:01:04_01.00	409849	81.69999999999999	55.4	1.0	96	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
418165:01:03_10.00	20.7	89	418165	409860:01:04_01.00	409860	81.6	45.8	1.0	93	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of &lt;2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
418236:01:03_10.00	12.8	103	418236	280657:01:03_30.00	280657	82.39999999999999	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
418236:01:03_10.00	12.8	103	418236	280474:01:03_30.00	280474	81.5	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
418236:01:03_10.00	12.8	103	418236	247082:01:04_30.00	247082	81.0	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
418236:01:03_10.00	12.8	103	418236	247095:02:03_30.00	247095	80.80000000000001	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418236:01:03_10.00	12.8	103	418236	280670:01:03_30.00	280670	80.10000000000001	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
418236:01:03_10.00	12.8	103	418236	280076:01:03_30.00	280076	79.9	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
418236:01:03_10.00	12.8	103	418236	247380:01:04_30.00	247380	79.9	15.9	30.0	100	Nimodipine	potent L-type Ca2+ channel antagonist, Calcium channel blocker, vasodilator.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
418236:01:03_10.00	12.8	103	418236	246600:01:04_30.00	246600	79.7	14.9	30.0	98	Nomegestrol acetate	Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors.	True	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
418236:01:03_10.00	12.8	103	418236	246363:01:04_30.00	246363	78.9	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
418236:01:03_10.00	12.8	103	418236	280970:01:03_30.00	280970	77.7	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
418278:01:03_10.00	9.3	104	418278	520969:01:04_30.00	520969	87.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418278:01:03_10.00	9.3	104	418278	246981:02:03_30.00	246981	86.2	53.9	30.0	92	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
418278:01:03_10.00	9.3	104	418278	246981:01:04_30.00	246981	85.9	33.0	30.0	100	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
418278:01:03_10.00	9.3	104	418278	520969:01:04_50.00	520969	85.39999999999999	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418278:01:03_10.00	9.3	104	418278	247067:01:04_10.00	247067	85.2	21.8	10.0	103	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
418278:01:03_10.00	9.3	104	418278	247419:02:03_30.00	247419	82.8	72.2	30.0	96	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
418278:01:03_10.00	9.3	104	418278	247042:01:04_30.00	247042	82.6	32.0	30.0	89	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
418278:01:03_10.00	9.3	104	418278	392891:01:14_03.00	392891	82.6	17.8	3.0	91	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
418278:01:03_10.00	9.3	104	418278	246846:02:03_30.00	246846	82.39999999999999	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
418278:01:03_10.00	9.3	104	418278	409889:01:02_10.00	409889	82.19999999999999	11.6	10.0	99	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
418284:01:03_10.00	13.6	106	418284	528542:01:02_03.00	528542	85.1	9.0	3.0	107			False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5ccc6c(c5)NC(=O)CO6)cc4)CC3)c2c1
418284:01:03_10.00	13.6	106	418284	382185:03:06_10.00	382185	83.2	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
418284:01:03_10.00	13.6	106	418284	280302:01:03_10.00	280302	80.10000000000001	23.1	10.0	102	5-(N,N-hexamethylene)amiloride	Na+/ H+ antiport inhibitor.	False	NC(N)=NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N
418284:01:03_10.00	13.6	106	418284	409831:01:04_01.00	409831	79.7	34.9	1.0	103	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
418284:01:03_10.00	13.6	106	418284	247147:01:04_30.00	247147	79.5	34.7	30.0	98	Progesterone	Progesterone is a steroid hormone that regulates the menstrual cycle and is crucial for pregnancy.	True	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
418284:01:03_10.00	13.6	106	418284	409861:01:03_01.00	409861	79.2	45.4	1.0	100	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of &lt;10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
418284:01:03_10.00	13.6	106	418284	409831:01:03_01.00	409831	78.8	32.0	1.0	101	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
418284:01:03_10.00	13.6	106	418284	280115:01:03_30.00	280115	78.60000000000001	19.9	30.0	92	JX401	potent, non-cytotoxic, membrane permeable p38a MAPK inhibitor.	False	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1
418284:01:03_10.00	13.6	106	418284	280695:01:03_30.00	280695	78.4	28.3	30.0	104	p-MPPI hydrochloride	selective 5-HT1A serotonin receptor antagonist which crosses the blood-brain barrier.	False	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1
418284:01:03_10.00	13.6	106	418284	280165:01:03_30.00	280165	78.4	37.5	30.0	100	A-3 (hydrochloride)	A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. It against PKA (Ki=4.3 uM), casein kinase II (Ki=5.1 uM) and myosin light chain kinase (MLCK) (Ki=7.4 uM). A-3 hydrochloride also inhibits PKC and casein kinase I with Ki values of 47 uM and 80 uM, respectively.	False	NCCNS(=O)(=O)c1cccc2c(Cl)cccc12
418286:01:03_10.00	25.6	100	418286	247164:01:10_03.00	247164	87.5	10.9	3.0	96	Bromperidol	Bromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.	False	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1
418286:01:03_10.00	25.6	100	418286	247159:01:04_30.00	247159	87.3	34.7	30.0	104	Biperiden hydrochloride	anticholinergic.	False	OC(CCN1CCCCC1)(c1ccccc1)C1C[C@@H]2C=C[C@H]1C2
418286:01:03_10.00	25.6	100	418286	247342:01:05_10.00	247342	86.7	10.0	10.0	103	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
418286:01:03_10.00	25.6	100	418286	409878:01:04_50.00	409878	86.5	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
418286:01:03_10.00	25.6	100	418286	520969:01:04_50.00	520969	86.3	72.9	50.0	95	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418286:01:03_10.00	25.6	100	418286	520969:01:04_30.00	520969	86.1	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418286:01:03_10.00	25.6	100	418286	413171:01:02_03.00	413171	86.0	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
418286:01:03_10.00	25.6	100	418286	246866:02:03_10.00	246866	85.9	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
418286:01:03_10.00	25.6	100	418286	520875:02:02_01.00	520875	85.9	27.5	1.0	105	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
418286:01:03_10.00	25.6	100	418286	413228:01:04_02.00	413228	85.8	16.6	2.0	100	CYM-5442	Sphingosine-1-phosphate (S1P) is an extracellular lipid mediator whose major effects are mediated through five distinct G protein-coupled receptors, S1P1/EDG-1, S1P2/EDG-5, S1P3/EDG-3, S1P4/EDG-6, and S1P5/EDG-8. CYM 5442 is a full agonist for S1P1 internalization, phosphorylation, and ubiquitination (EC50 = 1.35 nM). It is ineffective at S1P2, S1P3, S1P4, and S1P5 at concentrations up to 10 uM.2 CYM 5442 has been found to activate S1P1-mediated p42/p44 MAPK phosphorylation in CHO-K1 cells transfected with S1P1 with an EC50 value of 46 nM.	False	CCOc1ccc(-c2nc(-c3cccc4c3CCC4NCCO)no2)cc1OCC
418294:01:03_10.00	6.4	100	418294	246861:01:12_03.00	246861	77.60000000000001	19.2	3.0	100	Astemizole	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.	False	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
418294:01:03_10.00	6.4	100	418294	523782:02:04_03.00	523782	76.8	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
418294:01:03_10.00	6.4	100	418294	391492:01:14_10.00	391492	76.7	21.6	10.0	95	SAR405	the activity of SAR405 was evaluated on a dedicated Vps34 cellular assay. Using a GFP-FYVEÂ¿transfected HeLa cell line, treatment with SAR405 triggered the relocalization of GFP-FYVE inside the cell without affecting GFP intensity. Binding of SAR405 to the ATP site of protein and lipid kinases from the lysate of Jurkat cells was measured after incubation at 1 ÂµM, which is more than 600-fold the KD for recombinant Vps34. Results confirmed very potent binding to endogenous Vps34 (&gt;94% inhibition).	True	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2
418294:01:03_10.00	6.4	100	418294	409814:01:04_03.00	409814	76.4	13.6	3.0	89	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibitsÂ in vitroÂ methylation of H3K4 with IC50Â = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50Â = 0.8 ÂµM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
418294:01:03_10.00	6.4	100	418294	246632:01:04_30.00	246632	75.8	25.6	30.0	95	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
418294:01:03_10.00	6.4	100	418294	286060:01:16_10.00	286060	75.5	20.4	10.0	97	Cyclopamine, V. californicum	it inhibits the Hedgehog signaling pathway with an IC50 of 46 nM, and blocks the activity of human Smo receptor expressed in CHO-K1 cells in [3H]Hh-Ag binding assay with an IC50 of 280 nM. Cyclopamine significantly inhibits Hedgehog pathway activity in a dose-dependent manner in gut-derived tumor cell lines expressing Patched (PTCH) mRNA, and induces growth inhibition of those tumor cell lines by 75-95% at the concentration of 3 ÂµM, but ineffective towards the colon tumor cells without PTCH mRNA expression, suggesting the effects of Cyclopamine treatment are Hedgehog pathway related rather than generally cytotoxic. By blocking Hedgehog signaling through direct interaction with Smo, Cyclopamine (10 ÂµM) inhibits the proliferation of SMOhigh Cyclopamine-responsive cell lines L3.6sl and Panc 05.04 by 75-80%, and increases the apoptosis by 2.5- to 3.5-fold, without affecting the BxPC3-SMOlow cell line. Cyclopamine treatment significantly decreases of Snail mRNA and increasea E-cadherin transcripts in the E3LZ10.7 cell line. Independent of inhibition of cell growth, Cyclopamine treatment significantly inhibits the invasive phenotype of Hedgehog-dependent L3.6pl cells, causing a &gt;500-fold reduction in the number of transmigrating cells, but not that of the Hedgehog-independent cell line Panc-1.	False	CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
418294:01:03_10.00	6.4	100	418294	246801:02:03_10.00	246801	75.1	33.9	10.0	88	Ziprasidone, Hydrochloride	dopamine D2/serotonin 5-HT2 antagonist, atypical antipsychotic, FDA approved for the treatment of schizophrenia.	False	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
418294:01:03_10.00	6.4	100	418294	409894:01:03_30.00	409894	74.9	25.6	30.0	97	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
418294:01:03_10.00	6.4	100	418294	280190:01:03_30.00	280190	74.0	31.6	30.0	95	Caroverine hydrochloride	nonselective NMDA and AMPA glutamate receptor antagonist.	False	CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21
418294:01:03_10.00	6.4	100	418294	528529:01:02_03.00	528529	73.9	11.2	3.0	101		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
418308:01:03_10.00	17.3	93	418308	392756:02:04_06.00	392756	78.3	29.4	6.0	95	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
418308:01:03_10.00	17.3	93	418308	410511:01:03_30.00	410511	76.7	34.2	30.0	88		negative control of BI-1942.	True	CC[C@@H](C(=O)OC)n1c(=O)c2ccccc2n(Cc2cn(C)c3cccc(C)c23)c1=O
418308:01:03_10.00	17.3	93	418308	280107:01:03_10.00	280107	76.2	5.4	10.0	97	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
418308:01:03_10.00	17.3	93	418308	412368:01:02_10.00	412368	74.3	47.2	10.0	81		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	True	COc1ccc2[nH]c3c(c2c1)CCOC31CC[C@@]2(Oc3c(Cl)c(OC)cc(OC)c3C2=O)[C@H](C)C1
418308:01:03_10.00	17.3	93	418308	407972:01:03_10.00	407972	74.2	15.0	10.0	103	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
418308:01:03_10.00	17.3	93	418308	410511:01:03_50.00	410511	74.2	31.1	50.0	86		negative control of BI-1942.	True	CC[C@@H](C(=O)OC)n1c(=O)c2ccccc2n(Cc2cn(C)c3cccc(C)c23)c1=O
418308:01:03_10.00	17.3	93	418308	404607:01:10_10.00	404607	73.6	45.9	10.0	73	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
418308:01:03_10.00	17.3	93	418308	410741:01:04_06.00	410741	72.2	15.5	6.0	93	STF-118804	STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 &lt;10 nM.IC50 value:Target: NAMPT inhibitorin vitro:  improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia, and targets leukemia stem cells. STF-118804 displays distinctive cytotoxicity by inducing apoptosis without causing a phase-specific cell cycle arrest. Over-expression of NAMPT rendered 293T cells more resistant to STF-118804 resulting in a higher IC50 (106 nM, 95% CI 74Â151 nM) compared to control cells (17 nM, 95% CI 13Â23 nM), further confirming that NAMPT protein levels dictate sensitivity to STF-118804 .in vivo: STF-118804 displayed high efficacy in a xenograft model of ALL. Mice treated with STF-118804 over a 20-day period survived an average of 34 days longer than vehicle-treated animals. During treatment, bioimaging showed regression of tumor followed by suppression of disease. STF-118804 was tolerated in the efficacious dose range, and the absence of adverse physical or pathological effects indicated that toxicity was not limiting in a 20-day study of mock transplanted mice .	False	Cc1ccc(S(=O)(=O)Cc2nc(-c3ccc(C(=O)NCc4cccnc4)cc3)oc2C)cc1
418308:01:03_10.00	17.3	93	418308	392302:01:02_02.00	392302	72.2	7.9	2.0	98		inhibitor of MAP kinase p38 alpha (IC50 = 0.01 ÂµM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Cc1ccc(C)c(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1
418308:01:03_10.00	17.3	93	418308	410512:01:05_50.00	410512	71.89999999999999	36.4	50.0	76		it is a highly potent inhibitor of human chymase (IC50 = 0.4 nM) that can be used to test biological hypotheses involving this target in vitro. Chymase plays an important and diverse role in the homeostasis for a number of cardiovascular processes and has been linked to heart failure. Chymase is a chymotrypsin-like serine protease that is stored in a latent form in the secretory granules of mast cells. Upon stimulation, it is released in its active form into the local tissue, contributing to the activation of TGF-Ã, matrix metalloproteases and cytokines.	True	CC[C@H](CC(=O)O)n1c(=O)c2ncccc2n(Cc2cn(C)c3cc(C)cc(C)c23)c1=O
418356:01:03_10.00	38.0	92	418356	411033:02:03_50.00	411033	79.80000000000001	55.3	50.0	67	MZ 1	MZ 1 is a BRD4 protein degrader based on PROTAC technology.	False	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
418356:01:03_10.00	38.0	92	418356	392069:01:02_02.00	392069	78.60000000000001	39.2	2.0	87		GSK-3 inhibitor (IC50 = 0.005 ÂµM); Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.  Bioorg Med Chem Lett.  (2006),  16(8),  2091-2094.	False	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1
418356:01:03_10.00	38.0	92	418356	280841:01:03_10.00	280841	78.10000000000001	11.1	10.0	92	Phenylephrine hydrochloride	alpha1 Adrenoceptor agonist, mydriatic, decongestant.	False	CNC[C@H](O)c1cccc(O)c1
418356:01:03_10.00	38.0	92	418356	408552:01:08_01.00	408552	77.60000000000001	9.7	1.0	94	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 ÂµM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 ÂµM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
418356:01:03_10.00	38.0	92	418356	409831:01:03_03.00	409831	76.8	78.9	3.0	82	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
418356:01:03_10.00	38.0	92	418356	280706:01:03_10.00	280706	76.6	21.2	10.0	86	MRS 1523	selective A3 adenosine receptor antagonist in rat.	False	CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC
418356:01:03_10.00	38.0	92	418356	392503:01:09_02.00	392503	75.9	16.2	2.0	95	GDC-0879	GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM.	False	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1
418356:01:03_10.00	38.0	92	418356	247374:01:04_10.00	247374	75.9	9.3	10.0	96	(+)-Isoproterenol (+)-bitartrate salt	adernergic receptor agonist.	True	CC(C)NC[C@@H](O)c1ccc(O)c(O)c1
418356:01:03_10.00	38.0	92	418356	408552:01:08_03.00	408552	75.8	67.5	3.0	90	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 ÂµM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 ÂµM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
418356:01:03_10.00	38.0	92	418356	407875:01:03_10.00	407875	75.8	73.2	10.0	51	Piperlongumine	Piperlongumine is a natural alkaloid isolated from Piper longum Linn, possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway.	False	COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC
418368:01:03_10.00	22.1	92	418368	246859:01:04_30.00	246859	85.2	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
418368:01:03_10.00	22.1	92	418368	246632:01:04_30.00	246632	85.1	25.6	30.0	95	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
418368:01:03_10.00	22.1	92	418368	410043:01:05_00.20	410043	83.8	23.1	0.2	95	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
418368:01:03_10.00	22.1	92	418368	409343:02:02_03.00	409343	83.7	57.2	3.0	92	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
418368:01:03_10.00	22.1	92	418368	520969:01:04_30.00	520969	83.5	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418368:01:03_10.00	22.1	92	418368	519808:01:04_10.00	519808	83.0	27.5	10.0	84		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
418368:01:03_10.00	22.1	92	418368	280189:01:03_30.00	280189	82.69999999999999	65.1	30.0	74	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
418368:01:03_10.00	22.1	92	418368	246365:01:04_30.00	246365	82.69999999999999	20.9	30.0	102	Lobelanidine hydrochloride	nicotinic ligand.	False	CN1C(CC(O)c2ccccc2)CCCC1CC(O)c1ccccc1
418368:01:03_10.00	22.1	92	418368	246598:01:04_30.00	246598	82.19999999999999	20.2	30.0	90	Moricizine hydrochloride	sodium channel inhibitor.	False	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2
418368:01:03_10.00	22.1	92	418368	391492:01:14_10.00	391492	81.89999999999999	21.6	10.0	95	SAR405	the activity of SAR405 was evaluated on a dedicated Vps34 cellular assay. Using a GFP-FYVEÂ¿transfected HeLa cell line, treatment with SAR405 triggered the relocalization of GFP-FYVE inside the cell without affecting GFP intensity. Binding of SAR405 to the ATP site of protein and lipid kinases from the lysate of Jurkat cells was measured after incubation at 1 ÂµM, which is more than 600-fold the KD for recombinant Vps34. Results confirmed very potent binding to endogenous Vps34 (&gt;94% inhibition).	True	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2
418375:01:03_10.00	7.1	96	418375	246883:07:04_06.00	246883	82.5	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
418375:01:03_10.00	7.1	96	418375	281040:01:03_30.00	281040	82.39999999999999	39.0	30.0	87	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
418375:01:03_10.00	7.1	96	418375	280732:01:03_10.00	280732	81.8	11.4	10.0	102	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
418375:01:03_10.00	7.1	96	418375	528561:01:02_05.00	528561	81.3	25.2	5.0	103		JNJ-54119936 an inverse agonist of Retinoic Acid-Related Orphan Receptor RORC with Kd = 5.3 nM	True	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1
418375:01:03_10.00	7.1	96	418375	528529:01:02_05.00	528529	81.2	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
418375:01:03_10.00	7.1	96	418375	410622:01:04_06.00	410622	81.0	35.1	6.0	106	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
418375:01:03_10.00	7.1	96	418375	409894:01:03_30.00	409894	80.80000000000001	25.6	30.0	97	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
418375:01:03_10.00	7.1	96	418375	280197:01:04_30.00	280197	80.60000000000001	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
418375:01:03_10.00	7.1	96	418375	280902:01:03_30.00	280902	80.4	43.2	30.0	103	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
418375:01:03_10.00	7.1	96	418375	280474:01:03_30.00	280474	80.30000000000001	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
418508:01:03_10.00	24.0	103	418508	392793:01:09_02.00	392793	77.2	32.6	2.0	95	Osimertinib	Osimertinib (AZD-9291) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.	False	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
418508:01:03_10.00	24.0	103	418508	413171:01:02_03.00	413171	76.1	37.5	3.0	107		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
418508:01:03_10.00	24.0	103	418508	528542:01:02_03.00	528542	76.0	9.0	3.0	107			False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5ccc6c(c5)NC(=O)CO6)cc4)CC3)c2c1
418508:01:03_10.00	24.0	103	418508	413100:01:03_10.00	413100	75.9	42.0	10.0	85	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
418508:01:03_10.00	24.0	103	418508	280127:01:04_10.00	280127	75.7	21.9	10.0	101	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
418508:01:03_10.00	24.0	103	418508	410865:01:03_02.00	410865	75.5	30.7	2.0	107	JAK3-IN-1	JAK3-IN-1 is a potent, selective and orally active JAK3 inhibitor with an IC50 of 4.8 nM. JAK3-IN-1 shows over 180-fold more selective for JAK3 than JAK1 (IC50 of 896 nM) and JAK2 (IC50 of 1050 nM).	False	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
418508:01:03_10.00	24.0	103	418508	247101:02:03_10.00	247101	74.6	21.4	10.0	92	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
418508:01:03_10.00	24.0	103	418508	280302:01:03_10.00	280302	74.6	23.1	10.0	102	5-(N,N-hexamethylene)amiloride	Na+/ H+ antiport inhibitor.	False	NC(N)=NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N
418508:01:03_10.00	24.0	103	418508	246883:01:04_10.00	246883	74.5	23.1	10.0	104	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
418508:01:03_10.00	24.0	103	418508	246888:01:04_30.00	246888	74.1	21.1	30.0	104	Melengestrol acetate	Androgen Receptor agonist; glucocorticoid receptor agonist	True	C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O
418520:01:03_10.00	8.1	106	418520	247419:02:03_10.00	247419	85.2	6.4	10.0	106	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
418520:01:03_10.00	8.1	106	418520	286060:01:16_10.00	286060	83.89999999999999	20.4	10.0	97	Cyclopamine, V. californicum	it inhibits the Hedgehog signaling pathway with an IC50 of 46 nM, and blocks the activity of human Smo receptor expressed in CHO-K1 cells in [3H]Hh-Ag binding assay with an IC50 of 280 nM. Cyclopamine significantly inhibits Hedgehog pathway activity in a dose-dependent manner in gut-derived tumor cell lines expressing Patched (PTCH) mRNA, and induces growth inhibition of those tumor cell lines by 75-95% at the concentration of 3 ÂµM, but ineffective towards the colon tumor cells without PTCH mRNA expression, suggesting the effects of Cyclopamine treatment are Hedgehog pathway related rather than generally cytotoxic. By blocking Hedgehog signaling through direct interaction with Smo, Cyclopamine (10 ÂµM) inhibits the proliferation of SMOhigh Cyclopamine-responsive cell lines L3.6sl and Panc 05.04 by 75-80%, and increases the apoptosis by 2.5- to 3.5-fold, without affecting the BxPC3-SMOlow cell line. Cyclopamine treatment significantly decreases of Snail mRNA and increasea E-cadherin transcripts in the E3LZ10.7 cell line. Independent of inhibition of cell growth, Cyclopamine treatment significantly inhibits the invasive phenotype of Hedgehog-dependent L3.6pl cells, causing a &gt;500-fold reduction in the number of transmigrating cells, but not that of the Hedgehog-independent cell line Panc-1.	False	CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
418520:01:03_10.00	8.1	106	418520	382185:03:06_10.00	382185	83.1	25.7	10.0	98	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
418520:01:03_10.00	8.1	106	418520	287906:02:09_10.00	287906	83.0	38.3	10.0	98	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIÃ.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
418520:01:03_10.00	8.1	106	418520	247019:01:04_30.00	247019	81.6	31.6	30.0	105	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
418520:01:03_10.00	8.1	106	418520	413221:01:03_10.00	413221	81.5	29.2	10.0	104	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
418520:01:03_10.00	8.1	106	418520	247147:01:04_30.00	247147	81.5	34.7	30.0	98	Progesterone	Progesterone is a steroid hormone that regulates the menstrual cycle and is crucial for pregnancy.	True	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
418520:01:03_10.00	8.1	106	418520	409894:01:03_30.00	409894	81.39999999999999	25.6	30.0	97	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
418520:01:03_10.00	8.1	106	418520	247155:02:03_10.00	247155	81.39999999999999	20.4	10.0	105	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
418520:01:03_10.00	8.1	106	418520	409831:01:03_01.00	409831	81.39999999999999	32.0	1.0	101	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
418536:01:03_10.00	9.5	101	418536	407872:01:03_10.00	407872	80.10000000000001	23.3	10.0	108	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
418536:01:03_10.00	9.5	101	418536	410622:01:04_06.00	410622	80.10000000000001	35.1	6.0	106	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
418536:01:03_10.00	9.5	101	418536	280197:01:04_30.00	280197	79.7	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
418536:01:03_10.00	9.5	101	418536	317004:02:10_10.00	317004	78.3	34.5	10.0	90	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
418536:01:03_10.00	9.5	101	418536	280732:01:03_30.00	280732	78.10000000000001	49.1	30.0	97	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
418536:01:03_10.00	9.5	101	418536	528529:01:02_05.00	528529	78.10000000000001	15.9	5.0	99		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
418536:01:03_10.00	9.5	101	418536	246883:07:04_06.00	246883	76.9	27.1	6.0	97	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
418536:01:03_10.00	9.5	101	418536	247419:02:03_10.00	247419	76.7	6.4	10.0	106	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
418536:01:03_10.00	9.5	101	418536	280331:01:03_10.00	280331	76.7	9.8	10.0	97	(+)-Bromocriptine methanesulfonate	D2 dopamine receptor agonist, inhibits prolaction secretion.	False	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
418536:01:03_10.00	9.5	101	418536	246791:02:03_30.00	246791	76.7	20.0	30.0	102	Chlorpheniramine (maleate)	Chlorpheniramine maleate is an histamine H1 receptor antagonist with IC50 of 12 nM.Target: Histamine H1 ReceptorChlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 uM . Chlorpheniramine displaces of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells with IC50 of 66 nM. Chlorpheniramine displays antimalarial activity against CQS strain (D6) and MDR strain (Dd2) of P. falciparum with IC50 of 61.2 uM and 3.9 uM, respectively. Chlorpheniramine displays cytotoxicity against the proliferation of concanavalin A-induced murine splenic lymphocytes with IC50 of 33.4 uM .Oral administration of Chlorpheniramine inhibits histamine-induced mortality in guinea pigs with an ED50 of 0.17 mg/kg . Oral administration of Chlorpheniramine (10 mg/kg) significantly inhibits short-duration scratching in BALB/c mice stimulated by ovalbumin active cutaneous anaphylaxis and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice, in contrast to that of dexamethasone or tacrolimus .	False	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
418561:01:03_10.00	29.7	87	418561	412866:01:04_10.00	412866	79.5	46.6	10.0	65	GSTO1-IN-1	GSTO1-IN-1 is a potent glutathione S-transferase omega 1 (GSTO1) inhibitor with an IC50 of 31 nM.	False	CN(C)S(=O)(=O)c1cc(NC(=O)CCl)ccc1Cl
418561:01:03_10.00	29.7	87	418561	412866:01:04_03.00	412866	78.4	23.8	3.0	93	GSTO1-IN-1	GSTO1-IN-1 is a potent glutathione S-transferase omega 1 (GSTO1) inhibitor with an IC50 of 31 nM.	False	CN(C)S(=O)(=O)c1cc(NC(=O)CCl)ccc1Cl
418561:01:03_10.00	29.7	87	418561	246297:01:04_10.00	246297	77.10000000000001	33.0	10.0	91	Erlotinib	Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer.	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
418561:01:03_10.00	29.7	87	418561	247387:01:04_10.00	247387	75.1	16.1	10.0	90	Idazoxan hydrochloride, RX 781094	I2-imidazoline agonist, I1-imidazoline antagonist, alpha2-Adrenergic antagonist, Alpha2 agonist.	False	c1ccc2c(c1)OCC(C1=NCCN1)O2
418561:01:03_10.00	29.7	87	418561	419165:01:03_100.00	419165	71.5	14.2	100.0	83	Dimethyl fumarate	Dimethyl fumarate is a nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator and induces upregulation of antioxidant gene expression.	False	COC(=O)/C=C/C(=O)OC
418561:01:03_10.00	29.7	87	418561	280484:02:05_10.00	280484	71.39999999999999	40.4	10.0	57	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
418561:01:03_10.00	29.7	87	418561	419165:01:03_60.00	419165	71.3	9.0	60.0	96	Dimethyl fumarate	Dimethyl fumarate is a nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator and induces upregulation of antioxidant gene expression.	False	COC(=O)/C=C/C(=O)OC
418561:01:03_10.00	29.7	87	418561	382127:03:03_02.00	382127	71.1	14.2	2.0	93	WHI-P154	WHI-P154 is a potent EGFR inhibitor, and also modestly blocks JAK3, with IC50s of 4 nM and 1.8 ÂµM, respectively.	False	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC
418561:01:03_10.00	29.7	87	418561	280936:01:03_10.00	280936	70.89999999999999	18.7	10.0	94	SB 415286	SB 415286 is a potent and selective cell permeable inhibitor of GSK-3.a., with an IC50 of 77.5 nM, and a Ki of 30.75 nM; SB 415286 is equally effective at inhibiting human GSK-3.a. and GSK-3.b..	False	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1
418561:01:03_10.00	29.7	87	418561	392684:02:04_10.00	392684	70.8	23.3	10.0	109	Icotinib	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	False	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
418563:01:03_10.00	18.1	88	418563	382169:06:06_00.60	382169	76.0	39.0	0.6	78	Ponatinib	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFR.a., VEGFR2, FGFR1, and Src, respectively.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
418563:01:03_10.00	18.1	88	418563	280960:01:04_10.00	280960	75.4	19.3	10.0	94	SU 4312	vascular endothelial growth factor (VEGF) receptor protein tyrosine kinase 1/2 (KDR) and platelet derived growth factor (PDGF) receptor inhibitor.	False	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1
418563:01:03_10.00	18.1	88	418563	413053:01:04_50.00	413053	74.0	31.8	50.0	95	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
418563:01:03_10.00	18.1	88	418563	280958:01:03_10.00	280958	72.8	10.5	10.0	98	Semaxinib	Semaxinib (SU5416) is a potent and selective inhibitor of VEGFR (Flk-1/KDR) with an IC50 of 1.23 uM.	False	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
418563:01:03_10.00	18.1	88	418563	519808:01:04_30.00	519808	72.3	57.5	30.0	96		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
418563:01:03_10.00	18.1	88	418563	246820:12:03_50.00	246820	72.2	39.6	50.0	91	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
418563:01:03_10.00	18.1	88	418563	246820:12:03_30.00	246820	71.6	17.1	30.0	94	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
418563:01:03_10.00	18.1	88	418563	413052:01:03_30.00	413052	71.0	42.0	30.0	87	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
418563:01:03_10.00	18.1	88	418563	246886:01:04_10.00	246886	70.89999999999999	16.2	10.0	90	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of &gt;32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
418563:01:03_10.00	18.1	88	418563	280791:03:03_50.00	280791	70.6	14.0	50.0	89	Olomoucine	potent and selective inhibitor of cdc2, cdk and cyclin-dependent kinases.	False	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21
418571:01:03_10.00	5.2	103	418571	280355:01:03_30.00	280355	76.0	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
418571:01:03_10.00	5.2	103	418571	280076:01:03_30.00	280076	75.1	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
418571:01:03_10.00	5.2	103	418571	280962:01:03_30.00	280962	74.7	32.6	30.0	100	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
418571:01:03_10.00	5.2	103	418571	280197:01:04_30.00	280197	74.4	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
418571:01:03_10.00	5.2	103	418571	246363:01:04_30.00	246363	73.4	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
418571:01:03_10.00	5.2	103	418571	528529:01:02_01.00	528529	73.3	9.2	1.0	102		negative control to FM-381	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1
418571:01:03_10.00	5.2	103	418571	409900:01:02_10.00	409900	73.0	20.9	10.0	99	PF-CBP1	it is an inhibitor of the CBP and p300 bromodomains (IC50s = 125 and 363 nM, respectively). It displays greater than 100-fold selectivity for the bromodomain of CBP over those of BRD4 and a panel of other proteins. PF-CBP1 reduces the expression of inflammatory cytokines by LPS-stimulated primary macrophages. It also suppresses the expression of RGS4 (regulator of G protein signaling 4) in primary cortical neurons.	False	CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1
418571:01:03_10.00	5.2	103	418571	280424:01:03_30.00	280424	72.7	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
418571:01:03_10.00	5.2	103	418571	247082:01:04_30.00	247082	72.7	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
418571:01:03_10.00	5.2	103	418571	283242:02:06_30.00	283242	72.7	23.7	30.0	100	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
418614:01:03_10.00	34.2	99	418614	520969:01:04_30.00	520969	87.8	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418614:01:03_10.00	34.2	99	418614	413121:01:03_30.00	413121	87.1	21.2	30.0	87	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
418614:01:03_10.00	34.2	99	418614	246363:01:04_30.00	246363	85.39999999999999	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
418614:01:03_10.00	34.2	99	418614	247095:02:03_30.00	247095	84.6	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418614:01:03_10.00	34.2	99	418614	412994:01:03_06.00	412994	84.2	22.6	6.0	90	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
418614:01:03_10.00	34.2	99	418614	246846:01:05_30.00	246846	84.1	33.0	30.0	100	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
418614:01:03_10.00	34.2	99	418614	280127:01:04_30.00	280127	83.8	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
418614:01:03_10.00	34.2	99	418614	407880:01:03_10.00	407880	83.8	28.2	10.0	97	ML385	ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 uM.	False	Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21
418614:01:03_10.00	34.2	99	418614	280962:01:03_30.00	280962	83.39999999999999	32.6	30.0	100	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
418614:01:03_10.00	34.2	99	418614	247082:01:04_30.00	247082	83.2	28.8	30.0	99	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
418721:01:03_10.00	19.5	101	418721	247095:02:03_30.00	247095	88.1	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418721:01:03_10.00	19.5	101	418721	280670:01:03_30.00	280670	87.1	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
418721:01:03_10.00	19.5	101	418721	246847:01:04_30.00	246847	86.7	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
418721:01:03_10.00	19.5	101	418721	280657:01:03_30.00	280657	86.7	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
418721:01:03_10.00	19.5	101	418721	280671:01:03_30.00	280671	85.8	40.2	30.0	93	LY310762	LY310762 is a 5-HT1D receptor antagonist with Ki of 249 nM, having a weaker affinity for 5-HT1B receptor.IC50 value: 249 nM (Ki) Target: 5-HT1D in vitro: LY310762 has a higher affinity for the guinea pig 5-HT1D receptor than for the 5-HT1B receptor. LY310762 potentiates the potassium-induced [3H]5-HT outflow from guinea pig cortical slices with an EC50 of 30 nM. The maximum potentiation of the potassium-induced outflow which is obtained with LY310762 is about 40% . LY310762 blocks the decreased EPSC amplitude induced by Sumatriptan . in vivo: Systemic administration of LY310762 (10 mg/kg i.p.) produces a further significant enhancement in the 5-HT response to fluoxetine (20 mg/kg i.p.) when compared to animals receiving a control vehicle injection. In fluoxetine treated animals, levels of 5-HT increases from 312Â±43% to a maximum of 683% after LY310762. In control animals, levels of 5-HT remains unchanged (250%). LY310762 administered alone also significantly increases basal levels of 5-HT above vehicle controls, reaching a maximum of 258% compared to the pre-injection control .	False	CC1(C)C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc21
418721:01:03_10.00	19.5	101	418721	246846:02:03_30.00	246846	85.6	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
418721:01:03_10.00	19.5	101	418721	528526:01:02_05.00	528526	85.39999999999999	11.9	5.0	109		NR162 is a potent and selective CASK (Ca2+/calmodulin-dependent Ser/Thr kinase) inhibitor with a Kd of 22 nM in ITC and IC50 of 80 nM in NanoBRET assay.	False	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br
418721:01:03_10.00	19.5	101	418721	247042:01:04_30.00	247042	85.3	32.0	30.0	89	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
418721:01:03_10.00	19.5	101	418721	247419:02:03_30.00	247419	85.2	72.2	30.0	96	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
418721:01:03_10.00	19.5	101	418721	280127:01:04_30.00	280127	85.1	46.5	30.0	91	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
418723:01:03_10.00	18.8	90	418723	413130:01:02_05.00	413130	78.9	23.5	5.0	99		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
418723:01:03_10.00	18.8	90	418723	413130:01:02_03.00	413130	78.8	7.4	3.0	88		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
418723:01:03_10.00	18.8	90	418723	413167:01:02_05.00	413167	77.3	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
418723:01:03_10.00	18.8	90	418723	246617:01:04_10.00	246617	77.2	24.4	10.0	92	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
418723:01:03_10.00	18.8	90	418723	247095:01:04_10.00	247095	76.9	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418723:01:03_10.00	18.8	90	418723	413223:01:04_50.00	413223	76.8	14.2	50.0	89	UCSF924	UCSF924 is a selective, high-affinity dopamine D4 receptor (DRD4) partial agonist (Ki = 3 nM for human D4) with a 7.4-fold bias toward arrestin recruitment over G.a.i (G.a.i/0; Gi/G0) signaling activation with respect to quinpirole. UCSF924 exhibits no detectable affinity for D2, D3 or the F261V/L328F D4 mutant and no agonist activity toward a panel of 320 nonolfactory GPCRs even at a high concentration of 1 uM.	False	Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
418723:01:03_10.00	18.8	90	418723	522774:02:04_50.00	522774	76.8	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
418723:01:03_10.00	18.8	90	418723	246671:01:04_10.00	246671	76.5	14.2	10.0	99	Lacidipine	dihydropyridinr calcium channel blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C
418723:01:03_10.00	18.8	90	418723	413167:01:02_03.00	413167	76.3	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
418723:01:03_10.00	18.8	90	418723	412681:01:04_50.00	412681	75.2	80.0	50.0	55	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
418778:01:03_10.00	36.1	105	418778	394207:01:08_10.00	394207	79.5	74.4	10.0	70	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with &gt;100-fold higher potency than NUAK2 (IC50 of &gt;10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
418778:01:03_10.00	36.1	105	418778	392600:01:09_02.00	392600	79.5	82.9	2.0	57	Volasertib (BI 6727)	BI6727 (Volasertib) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM. It shows 6- and 65-fold greater selectivity against Plk2 and Plk3. Phase 2.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C
418778:01:03_10.00	36.1	105	418778	392772:01:09_02.00	392772	79.4	83.2	2.0	59	Ro3280	Ro3280 is a potent, highly selective inhibitor of PLK1 with an IC50 and a Kd of 3 nM and 0.09 nM, respectively, and nearly has no effect on PLK2 and PLK3.	False	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C
418778:01:03_10.00	36.1	105	418778	392507:01:09_02.00	392507	78.8	83.4	2.0	59	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
418778:01:03_10.00	36.1	105	418778	392507:02:03_02.00	392507	78.2	82.7	2.0	56	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
418778:01:03_10.00	36.1	105	418778	408410:02:04_01.00	408410	77.5	82.6	1.0	55	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
418778:01:03_10.00	36.1	105	418778	392593:01:09_02.00	392593	77.5	51.8	2.0	58	TAK-901	TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.	False	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1
418778:01:03_10.00	36.1	105	418778	392594:02:03_02.00	392594	77.5	72.7	2.0	73	TG101209	TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, appr 30-fold selective for JAK2 than JAK3, and sensitive to JAK2V617F and MPLW515L/K mutations.	False	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
418778:01:03_10.00	36.1	105	418778	410871:04:05_10.00	410871	77.5	84.3	10.0	53	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
418778:01:03_10.00	36.1	105	418778	410624:03:07_03.00	410624	77.5	81.0	3.0	56	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
418820:01:03_10.00	15.9	96	418820	246859:01:04_30.00	246859	86.0	34.2	30.0	108	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
418820:01:03_10.00	15.9	96	418820	523782:02:04_03.00	523782	85.8	18.1	3.0	95	TTP-8307	TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC50=1.2 uM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP).	True	C[C@@H](NC(=O)c1cccc(-c2c[nH]c(-c3cc4ccccc4cn3)n2)c1)c1ccc(F)cc1
418820:01:03_10.00	15.9	96	418820	247178:01:04_30.00	247178	85.7	27.5	30.0	93	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
418820:01:03_10.00	15.9	96	418820	520746:01:02_50.00	520746	85.6	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
418820:01:03_10.00	15.9	96	418820	247019:04:04_06.00	247019	84.8	10.9	6.0	89	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
418820:01:03_10.00	15.9	96	418820	281051:01:03_30.00	281051	84.7	39.2	30.0	94	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
418820:01:03_10.00	15.9	96	418820	247019:02:03_30.00	247019	84.7	21.9	30.0	94	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
418820:01:03_10.00	15.9	96	418820	246866:02:03_10.00	246866	84.7	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
418820:01:03_10.00	15.9	96	418820	246981:02:03_30.00	246981	84.6	53.9	30.0	92	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
418820:01:03_10.00	15.9	96	418820	246365:01:04_30.00	246365	84.6	20.9	30.0	102	Lobelanidine hydrochloride	nicotinic ligand.	False	CN1C(CC(O)c2ccccc2)CCCC1CC(O)c1ccccc1
418828:01:03_10.00	7.6	94	418828	246847:01:04_30.00	246847	81.0	24.7	30.0	91	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
418828:01:03_10.00	7.6	94	418828	280424:01:03_30.00	280424	80.80000000000001	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
418828:01:03_10.00	7.6	94	418828	247081:01:05_30.00	247081	79.80000000000001	16.9	30.0	101	Troleandomycin	ribosomal protein synthesis inhibitor.	True	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
418828:01:03_10.00	7.6	94	418828	280547:01:03_30.00	280547	79.80000000000001	21.2	30.0	100	FPL 64176	potent L-type Ca2+ channel activator.	False	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1
418828:01:03_10.00	7.6	94	418828	409343:02:02_01.00	409343	79.5	19.0	1.0	100	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
418828:01:03_10.00	7.6	94	418828	280670:01:03_30.00	280670	79.2	34.5	30.0	96	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
418828:01:03_10.00	7.6	94	418828	281042:01:03_30.00	281042	79.2	27.3	30.0	95	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
418828:01:03_10.00	7.6	94	418828	413117:01:03_10.00	413117	79.0	12.4	10.0	95	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
418828:01:03_10.00	7.6	94	418828	392523:01:09_02.00	392523	78.8	19.7	2.0	99	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
418828:01:03_10.00	7.6	94	418828	247095:02:03_30.00	247095	78.3	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418924:01:03_10.00	13.0	105	418924	520969:01:04_30.00	520969	83.89999999999999	43.2	30.0	92	ML241 (hydrochloride)	ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.	False	c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1
418924:01:03_10.00	13.0	105	418924	409878:01:04_50.00	409878	83.2	56.0	50.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
418924:01:03_10.00	13.0	105	418924	247095:01:04_10.00	247095	83.0	7.9	10.0	98	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
418924:01:03_10.00	13.0	105	418924	413130:01:02_05.00	413130	82.8	23.5	5.0	99		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
418924:01:03_10.00	13.0	105	418924	413167:01:02_05.00	413167	82.5	24.9	5.0	100		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
418924:01:03_10.00	13.0	105	418924	246866:02:03_10.00	246866	81.89999999999999	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
418924:01:03_10.00	13.0	105	418924	409878:01:04_30.00	409878	81.69999999999999	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
418924:01:03_10.00	13.0	105	418924	382120:03:04_06.00	382120	81.2	33.7	6.0	87	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/&lt;5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
418924:01:03_10.00	13.0	105	418924	382120:03:04_10.00	382120	81.2	26.8	10.0	98	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/&lt;5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
418924:01:03_10.00	13.0	105	418924	413167:01:02_03.00	413167	80.4	16.4	3.0	102		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
419025:01:03_10.00	19.9	108	419025	280657:01:03_30.00	280657	84.2	52.3	30.0	91	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
419025:01:03_10.00	19.9	108	419025	247095:02:03_30.00	247095	84.0	36.3	30.0	101	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
419025:01:03_10.00	19.9	108	419025	247209:01:04_30.00	247209	82.8	19.5	30.0	93	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
419025:01:03_10.00	19.9	108	419025	246363:01:04_30.00	246363	82.0	26.9	30.0	99	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
419025:01:03_10.00	19.9	108	419025	520746:01:02_50.00	520746	81.89999999999999	17.1	50.0	105	Emerione A		True	CC1=C[C@@]2(C)[C@@H](/C(C)=C/[C@]3(C)O[C@H](C)[C@@]4(C)O[C@H]43)[C@](C)([C@@H](O)[C@@H](C)C(=O)C(C)C)[C@H]2[C@]2(C)O[C@H]12
419025:01:03_10.00	19.9	108	419025	280474:01:03_30.00	280474	81.2	31.8	30.0	92	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
419025:01:03_10.00	19.9	108	419025	280571:01:03_30.00	280571	81.2	76.2	30.0	88	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 ÂµM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 ÂµM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
419025:01:03_10.00	19.9	108	419025	246981:02:03_30.00	246981	81.0	53.9	30.0	92	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
419025:01:03_10.00	19.9	108	419025	280076:01:03_30.00	280076	80.9	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
419025:01:03_10.00	19.9	108	419025	246846:02:03_30.00	246846	80.80000000000001	51.1	30.0	95	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4&gt;&gt;&gt;D1&gt;D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
419075:01:03_10.00	5.5	107	419075	280894:01:03_30.00	280894	81.2	20.9	30.0	91	Ro 25-6981 hydrochloride	NR2B-selective, NMDA glutamate receptor antagonist.	False	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1
419075:01:03_10.00	5.5	107	419075	528544:01:02_05.00	528544	81.10000000000001	21.1	5.0	111			False	c1ccc(C2CCN(c3cnc4c(N5CCOCC5)nccn34)CC2)cc1
419075:01:03_10.00	5.5	107	419075	246445:01:04_30.00	246445	81.0	29.5	30.0	100	Ketanserin tartrate hydrate	5-HT2 antagonist.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
419075:01:03_10.00	5.5	107	419075	413107:01:04_10.00	413107	80.2	14.2	10.0	106	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
419075:01:03_10.00	5.5	107	419075	410974:01:03_02.00	410974	80.10000000000001	38.3	2.0	102	GSK126	GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM.	False	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)nc3O)cc(-c3ccc(N4CCNCC4)nc3)cc21
419075:01:03_10.00	5.5	107	419075	281025:01:03_30.00	281025	79.80000000000001	27.5	30.0	99	U-101958 maleate	selective D4 dopamine receptor antagonist.	False	CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1
419075:01:03_10.00	5.5	107	419075	409831:01:04_01.00	409831	79.60000000000001	34.9	1.0	103	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
419075:01:03_10.00	5.5	107	419075	246889:01:09_03.00	246889	79.60000000000001	30.1	3.0	103	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
419075:01:03_10.00	5.5	107	419075	280454:01:03_30.00	280454	79.5	18.5	30.0	96	R(+)-SCH-23390 hydrochloride	selective D1 dopamine receptor antagonist.	False	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
419075:01:03_10.00	5.5	107	419075	245381:03:03_10.00	245381	79.5	15.9	10.0	99	Flunarizine dihydrochloride	Ca2+/Na+ channel blocker, vasodilator.	False	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
419094:01:03_10.00	17.3	105	419094	413013:01:03_30.00	413013	79.5	12.6	30.0	93	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
419094:01:03_10.00	17.3	105	419094	101009:01:16_30.00	101009	78.0	13.3	30.0	96	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
419094:01:03_10.00	17.3	105	419094	280355:01:03_30.00	280355	77.5	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
419094:01:03_10.00	17.3	105	419094	280943:01:03_30.00	280943	76.8	23.7	30.0	97	SB 222200	non-peptide NK3 tachykinin receptor antagonist.	False	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1
419094:01:03_10.00	17.3	105	419094	408117:01:02_10.00	408117	75.0	7.9	10.0	95	(Â±)-SLV 319	potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. Orally active.	False	C/N=C(/NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
419094:01:03_10.00	17.3	105	419094	407872:01:06_10.00	407872	74.6	22.3	10.0	104	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 ÂµM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
419094:01:03_10.00	17.3	105	419094	413005:01:02_30.00	413005	73.9	18.3	30.0	99	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
419094:01:03_10.00	17.3	105	419094	101009:01:16_50.00	101009	73.8	17.1	50.0	85	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
419094:01:03_10.00	17.3	105	419094	246722:01:04_30.00	246722	73.4	12.4	30.0	94	Felodipine, Plendil	L-type calcium channel blocker, L-type Ca2+ channels blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl
419094:01:03_10.00	17.3	105	419094	281040:01:03_10.00	281040	73.3	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
419097:01:03_10.00	10.7	105	419097	280355:01:03_30.00	280355	77.9	19.3	30.0	100	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
419097:01:03_10.00	10.7	105	419097	247067:02:03_10.00	247067	75.9	12.1	10.0	93	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
419097:01:03_10.00	10.7	105	419097	280424:01:03_30.00	280424	75.2	17.8	30.0	96	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
419097:01:03_10.00	10.7	105	419097	409837:01:03_10.00	409837	74.8	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
419097:01:03_10.00	10.7	105	419097	280197:01:04_30.00	280197	74.8	21.4	30.0	101	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
419097:01:03_10.00	10.7	105	419097	408116:01:02_10.00	408116	74.4	21.2	10.0	103	Rimonabant (Hydrochloride)	potent and selective cannabinoid CB1 receptor antagonist (Ki = 1.98 nM). Also acts as an inverse agonist reversing adenylyl cyclase inhibition by WIN 55,212-2 (Cat.No. 1038) (IC50 = 48 nM). Displays no activity at CB2 receptors. Reduces food intake and body weight in orally dosed non-obese Wistar rats.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
419097:01:03_10.00	10.7	105	419097	281001:01:03_30.00	281001	74.2	7.4	30.0	103	F3	nicotinic acetylcholine receptor antagonist.	False	CC(COc1ccc(/C=C/c2ccccc2)cc1)[N+](C)(C)C
419097:01:03_10.00	10.7	105	419097	280970:01:03_30.00	280970	74.1	24.7	30.0	93	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
419097:01:03_10.00	10.7	105	419097	381945:02:03_01.00	381945	74.0	6.4	1.0	112	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
419097:01:03_10.00	10.7	105	419097	247380:01:04_30.00	247380	73.6	15.9	30.0	100	Nimodipine	potent L-type Ca2+ channel antagonist, Calcium channel blocker, vasodilator.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
419099:01:03_10.00	12.3	101	419099	522774:02:04_10.00	522774	80.9	5.9	10.0	96	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
419099:01:03_10.00	12.3	101	419099	522774:02:04_50.00	522774	80.4	29.5	50.0	101	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
419099:01:03_10.00	12.3	101	419099	522774:02:04_30.00	522774	80.2	23.0	30.0	92	NS13001	NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 uM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.	False	Cc1cc(C)n(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)n1
419099:01:03_10.00	12.3	101	419099	407974:01:04_10.00	407974	80.10000000000001	19.2	10.0	97	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 ÂµM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
419099:01:03_10.00	12.3	101	419099	101009:01:19_30.00	101009	78.8	30.9	30.0	89	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
419099:01:03_10.00	12.3	101	419099	280076:01:03_30.00	280076	78.5	20.9	30.0	108	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
419099:01:03_10.00	12.3	101	419099	409837:01:03_10.00	409837	78.4	13.1	10.0	97	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
419099:01:03_10.00	12.3	101	419099	409878:01:04_30.00	409878	78.4	43.4	30.0	98	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
419099:01:03_10.00	12.3	101	419099	246866:02:03_10.00	246866	78.3	27.8	10.0	94	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
419099:01:03_10.00	12.3	101	419099	281040:01:03_10.00	281040	78.2	16.8	10.0	99	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12Cc3cn4c(nc3C=C1CCC1C2CC[C@@]2(C)[C@H]1CC[C@@]2(O)C#N)nc1ccccc14
419137:01:03_10.00	10.4	94	419137	246998:02:04_30.00	246998	75.1	81.3	30.0	105	Alprenolol (hydrochloride)	Alprenolol (hydrochloride) is a non-selective beta blocker as well as 5-HT1A receptor antagonist.The reference for administration is 10 mg/kg.	False	C=CCc1ccccc1OCC(O)CNC(C)C
419137:01:03_10.00	10.4	94	419137	409891:01:05_03.00	409891	74.0	78.4	3.0	74	NVS-CECR2-1	it is a potent inhibitor of CECR2 (cat eye syndrome chromosome region, candidate 2), a component of chromatin complexes that regulate gene expression controlling development. It binds CECR2 with high affinity (IC50 = 0.047 ÂµM by Alpha screen, Kd = 0.80 ÂµM by ITC). NVS-CECR2-1 demonstrates no crossreactivity in a panel of 48 bromodomains and has no major activity in kinase, protease, and receptor panels. It shows robust activity in cells by FRAP assay, due to its slow off-rate, and has no acute toxicity. See the Structural Genomics Consortium (SGC) website for more information.	False	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1
419137:01:03_10.00	10.4	94	419137	392722:02:08_10.00	392722	73.3	29.2	10.0	84	Triciribine	Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.	False	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23
419137:01:03_10.00	10.4	94	419137	410613:01:04_00.60	410613	73.0	15.5	0.6	86	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
419137:01:03_10.00	10.4	94	419137	413007:01:05_03.00	413007	73.0	34.2	3.0	84	Purvalanol A	Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.	True	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1
419137:01:03_10.00	10.4	94	419137	410613:01:05_00.60	410613	72.7	8.6	0.6	100	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1Â¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
419137:01:03_10.00	10.4	94	419137	382124:04:03_00.20	382124	72.3	36.4	0.2	96	A-769662	A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 uM.	False	N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O
419137:01:03_10.00	10.4	94	419137	280793:01:03_30.00	280793	71.39999999999999	58.9	30.0	58	N-Oleoyldopamine, OLDA	endogenous vanilloid, weak CB1 cannabinoid receptor ligand.	False	CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(O)c(O)c1
419137:01:03_10.00	10.4	94	419137	410692:01:04_00.20	410692	71.3	18.1	0.2	82	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
419137:01:03_10.00	10.4	94	419137	247272:02:03_10.00	247272	70.89999999999999	6.2	10.0	95	Isoetharine mesylate	beta-Adrenoceptor agonist, bronchodilator, Beta adrenergic agonist.	False	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1
